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 i 
Thesis Abstract 
Furan and its derivatives are commonly found in numerous compounds such as natural 
products, polymers and medicines. The furan ring system is not only the core 
component to many natural products, but also serves as a key synthetic intermediate to 
access other more complex molecules. Among furan derivatives, furan fatty acids (F-
acids) are an important class of natural products which are widely distributed in nature, 
and occupy a unique place in the field of medicinal chemistry because of their potent 
biological and pharmacological activity. 
This thesis examines the development of novel approaches towards highly substituted 
furans, with the ultimate goal of applying novel and high efficiency methods to the 
synthesis of F-acids and their derivatives. 
The first total synthesis of a natural product, an F-acids metabolite originally isolated 
from shark (Lamna ditropis) bile,1 was accomplished by the utilisation of an 
iodocyclisation of the corresponding 3-alkyne-1,2-diol to construct the furan nucleus; 
the synthetic route will be discussed in this thesis. 
Through the study of palladium-catalysis of a formal cyclisation to construct the furan 
ring system, a general route to access different F-acids has been developed. Splitting 
the F-acids into relatively simple fragments allows for easy preparation and 
modification of two fragments to produce a range of F-acids. The synthetic route was 
then applied to the formal synthesis of a natural product, F-acid F6. After optimisation 
of the synthetic route, total synthesis of F-acids F4, F6 and their analogues was 
accomplished.  
  
 ii 
Acknowledgments  
Firstly, I would like to express my special thanks of gratitude to my dear supervisor, 
Gareth Pritchard, for providing me a much-coveted and influential research and practice 
platform, for the trust, assistance, motivation and inspiration you have provided me 
over the last four years, and for paving the way for my research and its outcomes. I 
would also like to thank my dear second supervisor, Marc Kimber, for your kindness 
help, wise guidance and intimate support all along these years. In these ‘endless’ total 
syntheses, I really appreciate your encouragement and help. Thanks to both of you, 
letting me have an insight into the variety of beer in the pub. 
I want to say thank you to so many members of staff in the department, for your help 
and support over these years.   
I am also grateful to my fellow colleagues and friends I have met in the ground floor 
organic chemistry lab during my PhD, especially Sam, Ross, Carlos, Yubai, Bo, Bea, 
Shuqi, Yassir, Dani and Kay. Special thanks to dear Nat and Robert for the proofreading 
of my thesis, the help of during my daily lab work.  
I would like to thank my parents for your continuously support and encouraging me 
through this journey of discovery in the UK. Thank you for everything!  
A big thanks to my gorgeous wife, Yingying. I love you! 
 iii 
List of Abbreviations  
AA 
Ac 
Arachidonic acid 
Acetyl 
aq. Aqueous 
Bn 
b.p. 
br 
Bu 
Benzyl 
Boiling point 
Broad 
n-Butyl 
BuLi 
CAN 
Butyllithium 
Ceric ammonium nitrate 
Cat.  Catalytic 
COX 
d 
dba 
Cyclooxygenase 
Doublet 
Dibenzylidene acetone  
DCC N,N'-Dicyclohexylcarbodiimide 
DCU Dicyclohexylurea 
DEPT 
DHA 
Dibal-H 
Distortionless enhancement by polarization transfer 
Docosahexaenoic Acid 
Diisobutyl aluminium hydride 
DMAP 
DMF 
DMSO 
dppe 
4-Dimethylaminopyridine 
Dimethylformamide 
Dimethyl sulfoxide  
1,2-bis(Diphenylphosphino)ethane  
EI Electron Ionisation 
Et 
EtOAc 
EtOH 
Ethyl 
Ethyl acetate 
Ethanol 
 iv 
EPA Eicosapentaenoic Acid 
Equiv. 
F-acids 
Equivalents 
Furan Fatty Acids 
GC-MS Gas Chromatography–Mass Spectrometry 
h Hour 
Hz Hertz 
IR 
LOX 
Infra-red 
Lipoxygenase 
J 
mCPBA 
Coupling Constant 
meta-Chloroperoxybenzoic acid  
min. 
Me 
Ms 
Minutes 
Methyl 
Mesylate 
m/z 
NBS 
Mass to Charge Ratio 
N-Bromosuccinimide  
NASID 
NMR 
PCC 
PDC 
Ph 
Nonsteroidal Anti-inflammatory Drug 
Nuclear Magnetic Resonance 
Pyridinium chlorochromate 
Pyridinium dichromate  
Phenyl 
ppm Parts per million 
PPTS 
PUFA 
Pyridinium p-Toluenesulfonate   
Polyunsaturated Fatty Acid 
q Quartet 
r.t. Room Temperature 
s Singlet  
t 
t-Bu 
Triplet 
tert-Butyl 
 v 
TBDPSCl tert-Butyldiphenylsilyl Chloride 
TBSCl 
TFA 
Tf 
tert-Butyldimethylsilyl Chloride 
Trifluoroacetic acid  
Triflate  
THF 
THP 
Tetrahydrofuran 
Tetrahydropyran 
TLC 
TMS 
TPAP 
Ts 
Thin Layer Chromatography 
Trimethylsilyl 
tetra-n-Propylammonium perruthenate 
Tosylate 
UV Ultra Violet 
  
 vi 
Table of Contents 
Thesis Abstract…………………………………………………………………………i 
Acknowledgments………………………………………………….……………….…ii 
List of Abbreviations…………………………………………………………….……iii 
Table of Contents……………………………………………….……………….……vi 
Introduction……………………………………………………………………………1  
1.0 Introduction to Furan Fatty Acids ………...………………………………………2 
1.1 Inflammation and FattyAcids………….……………………………………...2  
1.2 F-acids………………….………………….…………………………….…....6 
1.2.1 Introduction…………………………………………………………..6 
1.2.2 Anti-inflammatory Activity of F-acids……………………...………10  
2.0 Furans………………………………………………………….…………………12  
2.1 Furan…………………………………………………………………………12  
2.2 Syntheses of Furans……………………………….…………………………14  
3.0 Previous Synthetic Routes to F-acids……………………….……………………24 
4.0 Aims……………………………………………………………………………...35 
Results and Discussion…………………………………………….…………………36 
5.0 First Total Synthesis of F-acid metabolite………………………….……………37 
5.1 Preparation of the 3-Alkyne-1,2-diol Intermediate………….….…………...38 
5.2 Optimisation of the Iodocyclisation………………………...……………….45 
5.3 Synthesis of the F-acid Intermediate………………………………..………49 
 vii 
5.4 Synthesis of the F-acid Metabolite………………………….………………63 
6.0 Synthesis of F-acids and their Analogues…………………………….………….69 
6.1 Palladium Catalysed Cyclisation to Furans………………..………………..69 
6.2 Initial Synthetic Route to F-acids F4 and F6…………………………………75 
6.3 Second Synthetic Route of F-acids F4 and F6……………………………….86 
6.4 Synthesis of F-acid Modified Analogues…………….……….…..…………96 
7.0 Conclusions and Future Work………………………………..…………………..99 
Experimental……………………………………………………….……………….102 
8.0 Experimental……………………………………………………………………103 
8.1 General Experimental………………………………...……………………103 
8.2 Synthetic Procedures………………………………………………………104 
8.2.1 First Total Synthesis of F-acid Metabolite (chapter 5.0) ….….…..104 
8.2.2 Pd-Catalysed Cyclisation to Furans (chapter 6.1) …………..….…125 
8.2.3 Initial Synthesis Route to F4 and F6 (chapter 6.2) ………….….….134 
8.2.4 Second Synthetic Route to F4 and F6 (chapter 6.3) ………...….….146 
8.2.5 Synthesis of F-acid modified analogues (chapter 6.4) ……..….….157 
References………………………………………………………………..…………164 
 
 
  
 1 
 
 
 
 
 
 
 
                Introduction 
  
 2 
1.0 Introduction to Furan Fatty Acids 
1.1 Inflammation and Fatty Acids 
Inflammation, one of the primary responses of the body’s innate immune system after 
tissue injury and infection, has been associated with a number of human diseases.2 
Generally, inflammation can be divided into acute inflammation and chronic 
inflammation. The acute inflammation, the most commonly encountered inflammatory 
response, is an immediate effect and self-limiting. If a continued response is required, 
chronic inflammation may develop and can continue for weeks or months.3 
The inflammatory response is a necessary and an important part of the immune 
response, which consists of the release of pro-inflammatory mediators, and a resolution 
phase where the system is returned to normal. It is always accompanied with a variety 
of symptoms such as redness, swelling, heat, pain, vasodiliation and diapedesis.3–5 
These symptoms are the direct results of the interaction and activation of various 
cellular components and chemicals found in the blood and tissues (Figure 1).6 Tissue 
damage stimulates mast cells to release a variety of inflammatory mediators such as 
histamine, chemotactic factors and prostaglandins.7 Inflammatory mediators mainly 
trigger three actions, vasodilation, chemotaxis and increased vascular permeability.6,8 
These actions eventually lead to target tissue healing. 
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Figure 1. The inflammatory response.6 
 
Chronic inflammation may have numerous consequences associated with increased risk 
of chronic disease. Chronic inflammation has been reported to be an underlying 
disorder in a wide range of diseases including asthma,5 diabetes,5 rheumatoid arthritis,8 
Alzheimer’s disease,9 cardiovascular disease2 and cancer10. 
For the treatment of chronic inflammation, steroids (e.g. dexamethasone 1) and 
nonsteroidal anti-inflammatory drugs (NASIDs) such as aspirin 2 and ibuprofen 3 are 
widely used (Figure 2). However, long-term use of corticosteroids drugs has been 
recognized to produce a dependence and lead to side effects such as adrenal function 
decline.2 
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Figure 2. Steroids and NASIDs drugs.  
 
Prostaglandins, inflammatory mediators produced in response to mast cell stimulation, 
are able to cause pain and increased vascular permeability.6 The mechanism of action 
of NASIDs in the body is considered to be via the inhibition of the arachidonic acid 
metabolic pathway from arachidonic acid to prostaglandins (Figure 3).6 NASIDs block 
the production of prostaglandins by inhibiting enzyme cyclo-oxygenase (COX), 
thereby inhibiting inflammation and reducing pain and fever.6 Unlike NASIDs, steroids 
achieve their anti-inflammatory abilities by inhibiting the production of phospholipase 
from mast cells.3 
 
 
Figure 3. Arachidonic acid metabolic pathway.6 
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The classic major fatty acids isolated from lipids such as 𝜔-3 polyunsaturated fatty 
acids (PUFAs) have been extensively studied and it has been proved to have an 
important role in biological activity.2,11,12 Two representative 𝜔 -3 PUFAs, 
eicosapentaenoic acid (EPA) 4 and docosahexaenoic acid (DHA) 5, have been 
determined as the active components of marine food and fish oils (Figure 4). Research 
indicates that EPA and DHA play a protective role in inflammatory diseases (e.g. 
inflammatory bowel diseases and rheumatoid arthritis).3 
 
 
Figure 4. The chemical structures of EPA, DHA and AA. 
 
The anti-inflammatory activity of 𝜔 -3 PUFAs is thought to inhibit the metabolic 
pathway from arachidonic acid (AA) 6 to inflammatory mediators (prostaglandins and 
leukotrienes). 𝜔-3 PUFAs such as EPA and DHA are competitive substrates for COX 
and 5-lipoxygenase (LOX) enzymes, thereby decreasing production of inflammatory 
mediators from mast cells.11 
In terms of these 𝜔-3 PUFAs, especially of EPA and DHA, are the major components 
of lipids of fish and fish oil. For a long time, it has been assumed that ingestion of 𝜔-
3 PUFAs leads to the protective properties of fish and fish oil diets against chronic 
inflammatory diseases. Until last three decades, studies have recognized that other trace 
bioactive fatty acids in lipids are related to the anti-inflammatory activity as well as 𝜔-
3 PUFAs.13 
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1.2 Furan Fatty Acids (F-acids) 
F-acids, mainly isolated from fish lipids, are widely found in plants, marine and fresh 
water fish. F-acids occur as minor compounds in the lipids of different samples.14 F-
acids are a class of heterocyclic lipid components with a furan moiety in the central part 
of the molecule. Reports on minor F-acids in literature are rather scarce, although they 
are considered as particularly valuable natural products. 
 
1.2.1 Introduction 
It is only since the 1970s that F-acids were discovered and studied.14 Prior to this, F-
acids were confused with some PUFAs. Determination of GC retention indices was the 
most common method used to identify fatty acids in earlier research, in which there are 
no obvious differences between the GC retention indices of F-acids and PUFAs.14 In 
1974, Glass et al. first discovered F-acids in the Northern pike (Esox Lucius) by using 
EI mass spectrometry for compound characterization, which allowed for unequivocal 
distinction between F-acids and PUFAs.14 After that, F-acids were found widely 
distributed in nature, particularly in fish, cod liver oil, marine bacteria, plants and even 
food fats.15–17 For example, F-acids F5 7 and F6 8 were two representative F-acids 
detected in the New Zealand green-lipped mussel Perna canaliculus (Figure 5).18 
 
 
Figure 5. Typical F-acids isolated from the green-lipped mussel Perna canaliculus.18 
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F-acids are a large group of tri- or tetra-substituted furan derivatives, which typically 
carry a propyl or pentyl side chain in one 𝛼-position and an unbranched long fatty acid 
chain in the other 𝛼-position. Either both β-positions of the furan ring are substituted 
by a methyl group or else there is only one methyl group in the β-position adjacent to 
the long chain. Because of the low stability of F-acids, they are often converted to fatty 
acid methyl esters to avoid degradation in analysis. F-acids methyl esters demonstrate 
very characteristic mass spectra, which provide complete structural information of F-
acids.19 According to their increasing GC elution times of the methyl esters, the F-acids 
are numbered (Table 1).19 
 
 
Number Compound m n R 
1 F1 2 8 CH3 
2 F2 4 8 H 
3 F3 4 8 CH3 
4 F4 2 10 CH3 
5 F5 4 10 H 
6 F6 4 10 CH3 
7 F7 4 12 H 
8 F8 4 12 CH3 
Table 1. Structures of the most abundant F-acids.19 
 
Unlike the abundant F-acids listed above, some unsaturated F-acids were detected from 
many marine sponges (e.g. Aplysina fistulairs and Strongylophora durissima).13 These 
O (CH2)n(CH2)m
CH3R
COOHH3C
 8 
F-acids were found to be unusual in comparison with the most abundant F-acids, in that 
a highly unsaturated side chain is replaced in one 𝛼-position of the furan ring. In 1991, 
Ciminello et al. found that these F-acid esters from extracts of marine sponge 
Dictyonella incise show a high anti-inflammatory activity in vivo and in vitro 
experiments (Figure 6).13 
 
 
Figure 6. Furan fatty acids isolated from marine sponge Dictyonella incise. 13 
 
At an early stage, F-acids were thought to be produced in animals, such as fish. In 1983, 
research on the metabolism of F-acids in fish by Sand and co-worker proved that fish 
produced neither the furan ring nor the alkyl side chain of furan fatty acids.20 Then it 
was recognized that plants and algae synthesise F-acids, and F-acids accumulate in 
animal tissues after intake of food. 
The generation of F-acids in nature is very complicated and quite different in each case 
of different sources. A variety of studies have indicated that the formation of F-acids is 
Ca2+ dependent.19,21–23 The activation and regulation of some lipoxygenase isoenzymes 
can be controlled by the presence of Ca2+ ion. The enzyme lipoxygenase (LOX) is 
taking part in the initial step of F-acid formation as a source for lipid peroxidation 
(Scheme 1). Linoleic acid 11 is the precursor of the carbon skeleton of F-acids carrying 
a pentyl side chain by formation of a hydroperoxide at C-13 to afford the intermediate 
12. Then the oxygen atom from peroxide group reacts with the conjugated diene by 
elimination of water to generate a five-membered ring 13, which is then converted to a 
furan ring by double bond rearrangement. During F-acids biosynthesis, the 𝛽-methyl 
O
COOH
O
COOH
(9)                                                                                            (10)
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groups derived from periodic incorporation of methylmalonyl coenzyme A 
(methylmalonyl-CoA) into 14. Eventually, methylation of 𝛽-positions in the furan ring 
is able to yield the F-acid F3 15.19,22 
 
 
Scheme 1. Biosynthesis of F-acid F3 from linolenic acid.22 
 
The biosynthetic route demonstrates the generation of F-acids with a pentyl side chain. 
However, it does not explain how those F-acids with a propyl side chain are generated. 
Originally, it was assumed that F-acids with a propyl chain were derived from a 
hydroperoxide in C-12 of Linoleic acid. In 1993, Batna et al. found that propyl F-acid 
F1 17 is synthesised from a different source, 9,12-hexadecadienoic acid 16, in a very 
similar biosynthetic route (Scheme 2).21  
 
 
Scheme 2. Biosynthesis of F1 from 9,12-hexadecadienoic acid.21 
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1.2.2 Anti-inflammatory activity of F-acids  
Ciminiello and co-workers found high inflammatory activity of F-acid sterol esters 
through observing the release of histamine from rat peritoneal cells.13 The ability to 
release histamine from rat peritoneal cells was increased dramatically after the 
administration of F-acids. However, they did not give a detailed mechanism to explain 
the relations among the F-acids, histamine and inflammation.  
A very important breakthrough was achieved in 2011, Wakimoto et al. developed a 
semisynthetic preparation and examined the anti-inflammatory activity of F-acids in a 
rat model of adjuvant-induced arthritis.1 In this research, lipid extracts of the green-
lipped mussel have well-described anti-inflammatory activity due to the presence of F-
acids. 
Lyprinol® is a natural marine extract comprising of a combination of lipid groups, 
which is extracted from the freeze-dried stabilized New Zealand green-lipped mussel 
Perna canaliculus.1,24 It has been confirmed to have great anti-inflammatory activity 
when given to animals and humans, and is being eagerly pursued as an alternative to 
NSAIDs without any known side effects.25 The lipid-rich extract was found to have a 
large number of lipid classes, such as free fatty acids, polar lipids and sterol esters. The 
fatty acid in this mussel mainly consists of 𝜔-3 PUFAs including DHA and EPA. F-
acids were also found in the extract.16 
At first, it was considered that the anti-inflammatory activity of the green-lipped mussel 
was caused by DHA and EPA, via the inhibition of both the COX and 5-lipoxygenase 
arachidonate oxygenation pathways. However, some other mussel species with similar 
concentrations of 𝜔-3 PUFAs did not show the same anti-inflammatory effect. Thus, 
the group hypothesized that other unstable F-acids remained to be identified as the 
potential anti-inflammatory components in the green-lipped mussel.1  
The group examined the F-acids anti-inflammatory effect in a rat model of adjuvant-
 11 
induced arthritis in comparison with that of EPA, Lyprinol® and a commercially 
available NSAID, naproxen. Female Wistar rats were sensitized via injection of 
Mycobacterium butyricum with squalene into the right hind limb. At day 10 after 
arthritis induction, test materials were administered orally for 5 days then the 
suppressive effect was observed via determination of the increase in the volume of the 
rear left paw between the beginning and the end of dosing.1 
The suppression of the rear left paw swelling by the administration of EPA ethyl ester 
did not show a big difference even at a high dose. While the administration of F6 ethyl 
ester inducing significant inhibition proved that F6 is a much more potent anti-
inflammatory component than EPA in green-lipped mussel. Moreover, F6 ethyl ester 
showed a stronger suppression than naproxen at the same dose.1,25 
The mechanisms of F-acids in biological system are not fully understood, but some 
assumptions had been proposed that they are acting as strong scavengers of 
radicals.4,26,27 Such a characteristic of F-acids allow for the suppression of lipid 
peroxidation, the initial event of oxidative stress induced inflammation, thereby leading 
to their anti-inflammatory activity.4,18,27,28 In a recent study, it was considered that 
incorporation of F-acids into cell membrane phospholipids is able to suppress the 
production of inflammatory mediators by affecting key enzymes in the AA metabolic 
pathway.29,30 
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2.0 Furans  
2.1 Furan  
Furans are an important family of heterocyclic compounds containing a five-membered 
aromatic ring structure, of which four are carbon atoms and one is an oxygen atom.31 
The parent compound, furan, is a planar five-membered aromatic ring (Figure 7). Furan 
atoms are numbered from 1 to 5 starting with oxygen atom as number 1 and then 
increasing values counterclockwise.32 Due to the symmetry of the furan ring system, α-position (C2 or C5) and β-position (C3 or C4) are frequently used in furan molecules 
to identify the relative position of carbon atoms to other substituents. 
 
 
Figure 7. Chemical structure of furan. 
 
A general rule proposed by Hückel in 1931 indicates that aromaticity is observed in 
cyclically conjugated systems of 4n + 2 𝜋-electrons, in which n is a positive integer.33 
Furan, consisting of four sp2 hybridized carbon atoms and one sp2 hybridized oxygen 
atom, has an uninterrupted cycle of p-orbitals.32,34,35 The p-orbital of each carbon atom 
contributes one electron to form a 𝜋-bond with an adjacent carbon atom. One of the 
two lone pairs of the oxygen atom lie in the same plane of furan ring, the other being 
orthogonal to the plane of the ring, thereby leading to a delocalized 6 𝜋-electron system 
which gives the furan ring its aromatic character.34  
Due to the oxygen lone pair being tightly held by the highly electronegative oxygen 
atom, the mesomeric representations 19-22 contribute little to the electronic structure 
of furan (Scheme 3). 
2
34
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Scheme 3. Resonance structure of furan.  
 
The highly electronegative oxygen atom in furan holds on to electron density more 
tightly than its nitrogen or sulfur analogues, pyrrole and thiophene, leading to the great 
tendency to electrophilic aromatic substituted products.34 Electrophilic substitutions 
preferentially take place at the	α-position rather than the	β-position, as is evident from 
the resonance structures shown in Scheme 4.34 The intermediate formed by α-position 
attack can be described by three resonance structures 23-25, which is greater than two 
resonance structures 27-28 of the intermediate produced by β -position attack. 
Therefore the α -substitution intermediate is more stable, and so by Hammond’s 
Postulate the rate determining transition state is also lower in energy leading to the 
observed kinetic preference in these reactions.   
 
 
Scheme 4. The regioselectivity of substitutions in furan.34 
 
As an important family of heterocyclic compounds, furans are widely distributed 
throughout nature and synthetic materials alike. A brief literature search yields 
numerous compounds containing the furan ring system possessing an enormous range 
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of pharmacological activities (Figure 8).36–40 Natural products containing the furan ring, 
such as furoscrobiculin B 30 and rubifolide 31 were isolated from soft corals and 
basidiomycetes of mushrooms, respectively.38,39 Nitrofurantoin 32 is an antibiotic and 
is used in treating urinary tract infection.36 Prazosin 33 is a sympatholytic drug used for 
treatment of posttraumatic stress disorder and high blood pressure.35 Cefuroxime 34, as 
a second-generation cephalosporin antibiotic, has provided a remarkable therapeutic 
effect for treatment of Lyme’s disease.40 
 
 
Figure 8. Structures of several natural and pharmaceutical products containing furan framework.36–40 
 
2.2 Syntheses of Furans  
There are a vast number of furan containing compounds, varying from simple mono-
substituted furans such as furfural 35 which is an important industrial raw material and 
synthetic precursor to dozens of compounds, to the more complex tetrasubstituted 
furans such as galerucella pheromone 38 (a natural product isolated from leaf beetle) 
(Figure 9).34,41,42 
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Figure 9. The configuration differences of furans.34,41,42 
 
The difference in the substitution patterns of furans leads to the diversity in the 
synthesis strategy. Generally, there are two main strategies to the synthesis of the furan 
nucleus in organic chemistry. The first strategy is the construction of the furan ring 
itself, and the second involves the functionalization of related furan nuclei to access 
target compounds.43 Some fundamentally and characteristically different approaches 
are reviewed as follows.  
 
2.2.1 Construction of furan rings 
There are numerous synthetic mythologies and strategies reported to form the 
substituted furan ring by cyclisation in the literature, starting from a variety of 
substrates, and being mediated by different catalysts (Figure 10).44–50 Typical core 
components of these substrates include 1,4-diketones, 1,4-alkynediols, enals, enyne 
acetates, 3-alkyne-1,2-diols, alk-1-ynyl oxiranes, etc. 
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Figure 10. A selection of typical substrates.44–50 
 
One of the classical and most important approaches for the preparation of furans is the 
Paal-Knorr reaction (Scheme 5).45,51 The target furan ring is formed by the cyclisation 
of 1,4-diketones 39 mediated by acids. The reaction is proposed to proceed by 
protonation of one carbonyl by acid, followed by cyclisation via attack of the carbonyl 
with formation of the enol to give intermediate 41. Subsequent dehydration results in 
the formation of furan 43. This reaction is limited by the availability of the appropriate 
1,4-diketones and the use of harshly acidic conditions and high temperatures.51  
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Scheme 5. Paal-Knorr furan synthesis.45,51 
 
Knight and his group have produced two approaches to F-acids from alkyne containing 
substrates (e.g. 3-alkyne-1,2-diols). The corresponding 𝛽-iodofurans were delivered 
through 5-endo-dig cyclisation of 3-alkyne-1,2-diols 44 using iodine (Scheme 6).49,50 
The reaction was proposed to proceed by coordination of the alkyne by iodine, followed 
by cyclisation via attack of a hydroxyl group to deliver 47. Subsequently protonolysis 
and dehydration yielded the 𝛽-iodofuran 45. One key factor of this reaction was to 
introduce the halogen atom to the furan ring, which made it possible for further 
modifications at this position by various reactions (e.g. halogen-metal exchange and 
coupling reaction). This reaction generally proceeded smoothly; however, the synthesis 
of 3-alkyne-1,2-diols is lengthy and by-products such as the corresponding 2,4-
diiodofuran were obtained in some cases. 
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Scheme 6. Reagents: (a) I2, NaHCO3, CH2Cl2, 0	℃-r.t., 1 h.49,50 
 
The Knight group also reported the silver-catalysed cyclodehyhydration of 3-alkyne-
1,2-diols 44 into trisubstituted furans 49 (Scheme 7).52,53 The reaction was proposed to 
proceed by activation of the alkyne by Ag(I), followed by cyclisation, protonolysis and 
dehydration to yield the target furan. This reaction can also be catalysed by some other 
metal catalysts such as Pd,54 Au,55 Cu,43 etc. 
 
 
Scheme 7. Reagents: (a) AgNO3-SiO2, CH2Cl2, r.t., 4 h.52,53 
 
Tsuji et al. described a palladium-catalysed cyclisation of 2-alkynyl carbonates 50 with 𝛽-keto esters 51 (Scheme 8).56 In this report, various tetra-substituted furans were 
formed via this successive nucleophilic cyclisation under neutral conditions. In addition, 
the authors demonstrated that 2-(1-alkynyl)oxiranes undergo the same reaction with 𝛽-
keto esters to give highly substituted furans in good yields. More recently, Yoshida and 
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co-workers also reported work on palladium-catalysed cyclisation, using the same 
conditions to form a range of heterocycles including pyrroles,57 benzofurans58 and 
chromans.59 
 
 
Scheme 8. Reagents: (a) Pd2(dba)3∙CHCl3, dppe, THF, 65	℃, 2 h; (b) aqueous HCl, THF, 1 h.56 
 
The mechanism of the furan annelation was proposed by the authors (Scheme 9).56 The 
2-alkynyl carbonate 50 is tansformed to the 𝜋-propargylpalladium complex 53 by 
raection with the palladium catalyst. Subsequently nucleophilic attack of the 𝛽-keto 
ester 51 gives the 𝜋 -allylpalladium intermediate 54. Subsequent intramolecular 
nucleophilic attack of the oxygen ion to the 𝜋 -allylpalladium species proceed 
regioselectively at the substituted carbon to form compound 55. A final isomerisation 
step forms tetrasubstituted furan 52.57 
 
 
Scheme 9. Proposed mechanism of the palladium-catalysed cyclisation.56,57 
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Recently, Moran and co-workers developed a similar trisubstituted furan formation by 
gold-catalysed cyclisation of 𝛽-alkynyl 𝛽-ketoesters (Scheme 10).60 The reaction is 
proposed to be alkyne activation by Au(III) and subsequent intramolecular attack by 
the ketone to form the intermediate 59. Protodemetallation regenerates the catalyst and 
forms the heterocycle 60, which isomerises to the trisubstituted furan 57. The reaction 
generally works quite well achieving good yields (68%-93%) and was shown to have a 
wide substrate scope.  
 
 
Scheme 10. Reagents: (a) AuCl3, MeOH, 65	℃, 12 h.60 
 
Interestingly, compared with Moran’s method, Zheng and Gujarathi reported a silver-
catalysed one pot tetrasubstituted furan synthesis directly from propargylic alcohols 61 
and 1,3-dicarbonyl compounds 62 (Scheme 11).61 The reaction involves two steps, 
propargylation and cycloisomerisation. The reaction starts by silver-catalysed 
dehydroxylation of propargylic alcohol 61 to give a propargylic cation, which is 
subsequently trapped by 62 to deliver intermediate 63. Then it undergoes a similar path 
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as Moran’s method, through alkyne activation by Ag(I) and subsequent 5-exo-dig 
intramolecular attack by the ketone carbonyl to form a heterocycle. After protonolysis 
and isomerisation, the furan 64 is formed. The authors also proved the mechanism by 
the successive isolation of the intermediate 63 in the report. 
 
 
Scheme 11. Reagents: (a) AgSbF6, toluene, 90	℃; Cs2CO3, toulene, 0	℃, 12 h.61  
 
2.2.2 Functionalisation of related furan nuclei 
Reactions with existing furan ring systems are able to eliminate the need for the step of 
forming the heterocycle nucleus and therefore improve the synthesis efficiency. 
Reactions including halogenation, nitration, acylation, alkenylation, metallation, etc. 
are commonly applied in this strategy.62,63 
Among these reactions, metal-catalysed cross coupling reactions between furan C-H 
bonds and unsaturated hydrocarbons constitute an attractive methodology in furan 
synthesis.64,65 A key feature of this methodology is that it avoids the otherwise 
necessary prefunctionalisation by means of aromatic halogenation.66,67  
In 1981, Fujiwara and co-workers reported palladium-catalysed alkenyation of furans 
with various olefins to produce mono-alkenylated products (Scheme 12).67 The 
reaction is regioselective and stereoselective, giving the α-substituted E isomers 66 as 
major products. The reaction is able to give alkenylated products in just one step, 
thereby eliminating the need to convert the heterocycles into their aldehyde derivatives 
or halides before alkenylation.68 However, this reaction always gave Z isomers (1%-
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7%) under the reaction condition and achieved desired products in poor yields (3%-
39%). 
 
 
Scheme 12. Reagents: (a) Pd(OAc)2, Cu(OAc)2, dioxane, acetic acid, 100	℃, 8 h.67 
 
Recently, Zhang et al. have developed an optimized palladium-catalysed coupling 
reaction in the presence of AgOAc and pyridine (Scheme 13).68 This method gave high 
regioselectivity and stereoselectivity, and delivered the desired α -substituted E 
products in good yields (76%-90%). 
 
 
Scheme 13. Reagents: (a) Pd(OAc)2, AgOAc, pyridine, 120	℃, 12 h.68 
 
Alternatively, Reetz and Sommer reported gold-catalysed hydroarylation of electron-
rich and –poor alkynes with various furans (Scheme 14).65 Reactions were carried out 
under mild conditions resulting in high degrees of Z-selectivity. The mechanism of this 
reaction was believed to involve activation of the alkyne by the cationic gold complex, 
and nucleophilic attack of the furan from the opposite side, leading to the generation of 
a vinylgold intermediate 73. Subsequent specific protonation forms the desired Z-
double bond and give the product 71. The authors demonstrated that several gold 
complexes and different co-catalysts can also mediate the reaction. Although other 
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metal catalysts (e.g. Pt, Zr and Pd salts) have been reported to be active in such 
reactions,44 the low catalyst loading (1 mol% Au) in this method is highly favourable. 
 
 
Scheme 14. Reagents: (a) Ph3PAuCl, AgSbF6, CH3NO2, r.t., 3 h.65 
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3.0 Previous Synthetic Routes to F-acids 
The chemical synthesis of F-acids has been studied since their identification in the 
1970s. However, reports of F-acids synthesis are rather scarce, and most of them are 
multiple steps and low efficiency. Hence, isolation of F-acids from natural source is 
still the most important and common method in quantitative analysis of F-acids until 
now.69 Therefore, efficient synthesis of F-acids is a very challenging job and has broad 
prospects. 
 
Schlenk’s routes to F-acids F6 and F7 
The first total synthesis of F-acids was reported in 1979 by Schlenk et al. starting from 
two commercial available materials, 3,4-bis(acetoxymethyl)furan 74 and 3-methyl-2-
furoate 80, respectively.70 Schlenk’s approaches to F-acids were simple and 
straightforward , and mainly involved the generation of alkylfuran and the introduction 
of the long side side chain. For the synthesis of F6, acylation of 74 with valeric 
anhydride gave the butyl ketone 75. Subsequent Wolff-Kishner reduction formed 
pentylfuran diol 76, which was converted to di-chloride 77 with phosgene. The 
dimethyl furan 78 was obtained by simple reduction of di-chloride 77. The long side 
chain was introduced by lithiation and reaction with 1-chloro-10-iododecane. The F-
acid F6 8 was achieved by reaction with Li and subsequent carbonation (Scheme 15). 
However, the introduction of the long side chain and subsequent carbonation occurred 
in two steps with a disappointing yield of 18%. 
 25 
 
Scheme 15. Reagents: (a) [H3C(CH3)CO]2O, BF3, benzene, r.t., 5 h; (b) N2H4, KOH, (HOCH2CH2)O, 
190	℃, 4h (60%, 2 steps); (c) COCl2, toluene, r.t., 4 h; (d) LiAlH4, ether, reflux, 1.5 h (76%, 2 steps); 
(e) n-BuLi, THF, 0	℃; 1-chloro-10-iododecane, ether, r.t. 5 h (58%); (f) Li, CO2, MeOH, ether , 0	℃, 2 
h (32%).70 
 
For the synthesis of F5, acylation of 3-methyl-2-furoate 80 followed by reduction gave 
intermediate 82. Subsequent decarboxylation by using copper gave 2,4-alkylfuran 83. 
The desired F-acid F5 7 was then delivered by undergoing same procedures as above 
(Scheme 16).70  
 
 
Scheme 16. Reagents: (a) [H3C(CH3)CO]2O, BF3, benzene, r.t., 5 h (20%); (b) N2H4, KOH, 
(HOCH2CH2)O, 190	℃, 4 h (85%); (c) Cu, 190	℃, 0.5 h (51%); (e) n-BuLi, THF, 0	℃; 1-chloro-10-
iododecane, ether, r.t. 5 h (48%); (f) Li, CO2, MeOH, ether , 0	℃, 2 h (56%).70 
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Bach’s route to F5 
In 1997, Bach et al. demonstrated a short synthesis of F5 using 4,5-dibromofurfural 85 
as starting material (Scheme 17).71 The 𝛼-bromide of the furan was replaced through 
a regioselective Pd(0)-catalysed coupling reaction with alkyne 86 to generate the 
corresponding furan 87. The unsaturated side chain was then introduced by Wittig 
olefination of the 𝛼 -aldehyde, and the methyl group was introduced from the 𝛽 -
bromide by Pd(0)-catalysed coupling with MeZnCl. Subsequent palladium-catalysed 
hydrogenation of the multiple bonds, generated the benzyl ester 89. Eventually, the 
synthesis was completed after prolonged reaction time of the hydrogenolytic 
deprotection to gave F5 7. 
 
 
Scheme 17. Reagents: (a) PdCl2(PPh3)2, CuI in Et2NH, r.t., 24 h (61%); (b) Ph3P=CHC3H7, THF, 
reflux, 3 h; (c) MeZnCl, PdCl2(PPh3)2, THF, reflux, 16 h (66%, 2 steps); (d) H2, Pd(OH)2/C, EtOAc, r.t. 
1 h (84%); (e) H2, Pd(OH)2/C, EtOAc, r.t. (100%).71 
 
Mascal’s route to F4 
In 2015, Mascal et al. describled a total synthesis of F4 starting from 5-
(chloromethyl)furfural 90 in seven steps with a 60% overall yield (Scheme 18).27 
Protection of the aldehyde using 1-butanol and concentrated HCl gave the acetal 91, 
O Br
Br
O CO2Bn+
O
Br
O CO2Bn
O
CO2Bn
a
b,c d
O OBn4 10
O
O OH4 10
O
F5 (7)
e
(85)                                         (86)                                                                            (87)
(88)                                                                               (89)
 27 
followed by Ni-catalysed coupling reaction lead to a 3-C side chian at	𝛼-position. 
Subsequent deprotection and Wittig reaction of compound 92 gave the 11-C side chain 
at the other 	𝛼 -position, which was transformed to furan 93 under hydrogenation 
conditions. Reaction between paraformaldehyde and furan 93 gave corresponding 
methyl ester at both 𝛽-positions. The synthesis of F4 94 was completed hydrolysis of 
the methyl ester with aqueous sodium hydroxide. 
 
 
Scheme 18. Reagents: (a) BuOH, HCl (cat.), 99%; (b) EtMgCl, Ni (acac)2, DAE, THF, -30 °C; (c) 
HCl/H2O, (83%, 2 steps); (d) (9-carboxynonyl)triphenylphosphonium iodide, LiHMDS, THF/DMSO; 
(e) H2, Pd/C, THF, (92%, 2 steps); (f) paraformaldehyde, HBr, AcOH; (g) H2, Pd/C, THF/H2O, (80%, 2 
steps).27 
 
Wakimoto’s semisynthetic preparation of F6 
Despite the development and improvement of chemistry synthesis of F-acids after 
decades, it is still not convenient when large amount of pure F-acids required. 
Catabolism of furan fatty acids to degradation products provides an alternative 
approach for research.37  
Wakimoto et al. developed a semisynthetic preparation of F6-ester starting from a shark 
metabolite 95 (Figure 11), which was highly accumulated in shark (Lamna ditropis) 
bile (ca. 10% dry weight).1 In this case the presence of an electron-withdrawing group 
conjugated to the tetra-substituted furan ring means the metabolite is relatively stable. 
Besides, the olefinic bond is useful for chemical modification.  
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Figure 11. Furan fatty acid metabolite.1 
 
Following a general method, furan fatty acid metabolite 95 was isolated from shark bile. 
Fischer esterification afforded the methyl ester, which was oxidised by a Lemieux-
Johnson oxidation to give corresponding furfural derivative. Wittig olefination 
followed by hydrogenolysis delivered a tetra-substituted furan with a terminal methyl 
ester 96. The methyl ester was transformed to the aldehyde by diisobutylaluminium 
hydride (DIBAL) reduction. Then the 6-C side chain underwent a second Wittig 
olefination, resulting in the desired 11-C side chain. Subsequent hydrogenolysis with 
H2 and Pd/C, generated the target compound F6 ethyl ester 97 (Scheme 19).1 As 
indicated above, F-acids, especially those with two 𝛽-methyl substituents, are quite 
unstable and prone to degradation during analysis, F6 esters are used instead of direct 
using F6 in analysis.  
 
 
Scheme 19. Reagents: (a) H2SO4, MeOH; (b) NaIO4, OsO4, H2O, r.t., 2 d; (c) CH3(CH2)3PPh3+Br-, 
NaN(SiMe3)2, CH2Cl2, -78 °C, 3 h; (d) Pd-C/H2, CH2Cl2, 5 min; (e) DIBAL-H, CH2Cl2, -78 °C, 2 h; (f) 
EtOCO(CH2)5PPh3+Br-, NaN(SiMe3)2, CH2Cl2, 2 h; (g) Pd-C/H2 5 min.1  
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Marson’s route to F5 
The above syntheses are all of the type where an existing furan nucleus is synthetically 
modified to afford the desired F-acids. Marson and Harper demonstrated a total 
synthesis of F5 by using commercially available cycloundecanone 98 (Scheme 20) as 
starting material.72 Addition of lithium acetylide to ketone 98, followed by hydration of 
the acetylene and dehydration of the terminal alcohol initially gave 1-acetyl-1-
cyclododecene 99. Addition of heptynyl lithium and alkene epoxidation afforded 
compound 100 with the tertiary allylic alcohol and epoxide group. The cyclisation of 
furan was then achieved by using catalytic acid and mercury(II) to give 101. After that, 
the aldehydic group was oxidised with pyridinium dichromate to deliver F5 7. 
Eventually, the total synthesis of F5 is thus obtained a total yield of 12% with six steps. 
 
 
Scheme 20. Reagents: (a) Lithium acetylide, THF, r.t. 1.5 h (75%); (b) aq.HCOOH, reflux, 3h (64%); 
(c) heptynyllithium, 20 °C, 4h (68%); (d) aq. tert-butyl hydroperoxide, VO(acac)2, r.t., 4h (69%); (e) 
Hg(II), aq. H2SO4 (88%); (f) PDC, r.t., 6h (65%).72 
 
Knight’s routes to F-acids F5 and F6 
The Knight group published a series of papers about the 5-endo cyclisation mode and 
have defined an approach to form F5 and F6 by using silver- or iodine-catalyse 5-endo-
dig cyclisation of suitably functionalized 3-alkyne-1,2-diols.49,52,69,73 The group 
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succeeded in achieving a total synthesis of F5 and F6 with the same alkyne-diol 
precursor in 2008.73 Mono-TBS 102 was prepared by Baeyer-Villiger oxidation of 
cyclododecanol, hydrolysis of the resulting lactone, silylation and LiAlH4 reduction (60% 
overall yield of 4 steps).73 Oxidation of the terminal hydroxyl group of mono-TBS 
compound 102 generated an aldehyde, which following a Gignard reaction with 
ethynylmagnesium bromide delivered the alkynol 104. After temporary protection of 
the alcohol group with Ac2O, alkyne hydration was followed by treatment with catalytic 
sodium gold(III) chloride and methanol to deliver the hydroxyl ketone 106. Reaction 
with heptynyllithium then afforded the required 1,2-alkyne-diol 107 in excellent yield. 
The synthesis of the 3-alkyne-1,2-diol precursor is thus obtained with five steps 
(Scheme 21).73  
 
 
Scheme 21. Reagents: (a) PCC, Celite, CH2CI2, 20	℃, 2 h (87%); (b) HCCMgBr, THF, (93%); (c) 
Ac2O, DMAP, pyridine, 20	℃, 16 h, (88%); (d) NaAuCI4.2H2O (cat.), aq. MeOH, reflux, 5 h;(79%);(i) 
C5H11CCLi, THF, -78	℃~0	℃ (95%).73 
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With 3-alkyne-1,2-diol precursor 107 in hand, the 2,3,5-trisubstituted furan moiety 108 
was formed by silver-catalysed cyclisation in excellent yield (97%). The total synthesis 
of F5 7 was achieved by TBAF deprotection and PDC oxidation (Scheme 22).73 
 
 
Scheme 22. Reagents: (a) AgNO3-SiO2, CH2Cl2, 20	℃, 5 h (97%); (b) TBAF, THF, 20 ℃, 1.5 h 
(90 %) then 5 PDC, Celite, DMF, 20	℃, 8 h (85%).73 
 
For the synthesis of F6, the tetra-substituted furan 109 was prepared by iodocyclisation 
of 1,3-alkyne-diol precursor 107. Metal-halogen exchange using butyllithium, followed 
by alkylation with methyl iodide gave the dimethyl furan. The total synthesis of F6 8 
was completed by TBAF deprotection and PDC oxidation as above (Scheme 23).73  
 
 
Scheme 23. Reagents: (a) 3NaHCO3, dry EtOAc, then 3I2, 20℃, 1h (87%); (b) BuLi, THF, -78	℃, 5 
min then MeI (90%); (c) TBAF, THF, 20	℃, 1.5 h (90 %) then 5 PDC, Celite, DMF, 20	℃, 8 h (85%).73 
 
Recently, the Knight group reported optimised syntheses of F-acids F5 and F6 in 
contract to their previous approaches, in order to develop approaches that are suitable 
for producing the F-acids on large scale.69 
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The two new approaches to F5 and F6 still use silver- or iodine-catalyse 5-endo-dig 
cyclisation of 3-alkyne-1,2-diols as before. The key intermediate, 3-alkyne-1,2-diol 114, 
was prepared in five steps (Scheme 24).69 Starting from commercially available 
material undec-10-enal 110, addition of ethylmagnesium bromide to aldehyde gave the 
propargylic alcohol. After temporary protection of the alcohol group to generate 
compound 111, alkyne hydration was followed by use of catalytic sodium gold(III) 
chloride and methanol to deliver the hydroxyl ketone 113. Key intermediate 1,3-alkyne-
diol 114 was achieved by reaction with heptyllithium.  
 
 
Scheme 24. Reagents: (a) HCCMgBr, THF; (b) Ac2O, DMAP, pyridine, 0 oC, 1 h, (92%, 2 steps); (c) 
NaAuCI4.2H2O (cat.), aq. MeOH, 0	℃, 1h; (d) K2CO3, aq. MeOH, 1h (77%, 2 steps); (e) C5H11CCLi, 
THF, -78	℃-0	℃ (95%).69 
 
For the synthesis of F5, the trisubstituted furan 115 was formed by silver-catalysed 
cyclisation of 3-alkyne-1,2-diol 110 in excellent yield (100%).69 Through cross 
metathesis of the furan 115 with benzyl acrylate, which was able to introduce the 
additional carbon atom and carboxylate group, unsaturated benzyl ester 116 was formed. 
The total synthesis of F5 7 was completed by hydrogenation (Scheme 25).69 The key 
feature of this new approach was it completely avoided the step of transformation from 
primary alcohol to carboxylic acid. 
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Scheme 25. Reagents: (a) AgNO3-SiO2, CH2Cl2, 20	℃, 4 h (100%); (b) benzyl acrylate, Grubbs II, 
CH2Cl2, reflux, 2 h (89%); (c) H2, Pd/C, MeOH, 1h, (83%).69  
 
For the synthesis of F6, the 𝛽-iodofuran 117 was prepared by iodocyclisation of 1,3-
alkyne-diol precursor 114. Metal-halogen exchange using methyllithium gave the 
dimethyl furan 118. The total synthesis of F6 8 was completed by same procedures as 
above (Scheme 26).69 
 
 
Scheme 26. Reagents: (a) I2, NaHCO3, THF, 20 ℃, 1 h (85%); (b) MeLi.LiBr.OEt, THF, -78	℃, 0.5 h 
(90%); (c) benzyl acrylate, Grubbs II, CH2Cl2, reflux, 2 h (87%); (c) H2, Pd/C, MeOH, 1h, (91%).69 
 
Tsukasa’s route to F2  
Tsukasa reported a total synthesis of F2 by the cyclisation of an acetal (Scheme 33).74 
The acetal 122, which was prepared from hexanal 120 and 1,1-diethoxy-2-methyl-2-
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propene 121 via a radical addition reaction, was heated in the presence of silica-
magnesia beads to give furan 83. Then it was converted to furfural derivative 123 by a 
Vilsmeier-Haack reaction using DMF and POCl3 in a 90% yield, followed by Wittig 
reaction to give compound 124. Eventually, the target F-acid F2 125 was delivered by 
hydrogenation and hydrogenolytic deprotection. 
 
 
Scheme 27. Reagents: (a) Benzoyl peroxide, 90 ℃, 4 h (72%); (b) Silica-magnesia cat., 250	℃, 4 h 
(60%); (c) DMF, POCl3, 0	℃-r.t., 3h (90%); (d) Ph3=CH(CH2)6COOMe, DMF, NaOCH3, r.t. 5 h 
(73%); (e) MeOH, Pd/C, r.t. (f) NaOH (92%, two steps).74 
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4.0 Aims 
As reviewed in introduction, F-acids exhibited potent activity in vivo anti-inflammatory 
test and have been proposed to have a potential therapeutic effect for the treatment of 
inflammatory disorders. However, the limited natural availability of F-acids has 
hindered their research and applications. Also, most of the current synthetic preparation 
of F-acids required too many steps leading to insufficient material for comprehensive 
testing. 
The first aim of this research was to accomplish the first total synthesis of a natural 
product, a structural metabolite of F-acids accumulated in shark bile, which can serve 
as precursor in the semisynthetic preparation of F6 developed by Wakimoto et al.1  
Once the synthesis of F-acids metabolite had been developed, the research will focus 
on the development of a novel synthetic route to the preparation of F-acids. This is to 
be accomplished by splitting the F-acids into easy relatively simple fragments, which 
allow for easy preparation and modification of two fragments to produce a range of 
target F-acids. It is also the intention to develop a route which is capable to produce a 
series of relevant F-acids analogues to allow for biological testing. 
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5.0 First Total Synthesis of F-acids metabolite  
Furan dicaboxylic acid 95, a structure metabolite of F-acids, is highly accumulated in 
shark (Lamna ditropis) bile.1 It was the starting material of Wakimoto et al.’s  
semisynthetic preparation of F-acids.1 However, to the best of our knowledge, no 
synthetic approaches to furan dicaboxylic acid 95 have ever been reported. The initial 
aim of this research was to develop a synthetic route for the chemical synthesis of this 
natural product. With the knowledge gained from previous syntheses of furans and F-
acids, a retrosynthetic plan for this project was developed and investigated (Scheme 
28). 
 
 
Scheme 28. Retrosynthetic plan for the synthesis of F-acids metabolite 95. 
 
The retrosynthetic plan for the synthesis of F-acid metabolite 95 involves several key 
intermediates. As was illustrated in the introduction, 5-endo-dig cyclisations of 3-
alkyne-1,2-diols using iodine as the electrophile proceeded smoothly to deliver the 
corresponding β-iodofurans.49 The 3-alkyne-1,2-diol intermediate 130 was the starting 
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material intended to undergo iodocyclisation to give 𝛽 -iodofuran 129. The 𝛽 -
iodofuran 129 itself was considered as an intermediate to access dimethyl furan 128, 
accessible by halogen-metal exchange or by replacing the iodine using a coupling 
reaction. The introduction of a protected unsaturated acidic side chain to form 
tetrasubstituted furan 126 was highlighted as a potentially challenging step. 
 
5.1 Preparation of the 3-Alkyne-1,2-diol Intermediate 
Research began by firstly aiming towards the formation of 3-alkyne-1,2-diol 
intermediate 130. With the knowledge gained from Knight’s route to 3-alkyne-1,2-
diols,49 the retrosynthetic plan of 130 splits the molecule into two fragments; ketone 
intermediate 131 and alkyne intermediate 132 (Scheme 29).   
 
 
Scheme 29. Retrosynthetic plan for the synthesis of 3-alkyne-1,2-diol 130. 
 
The ketone intermediate 131 was constructed from 3,4-dihydro-2H-pyran 133 and 
hydroxyacetone 134 as there was already a literature precedent for the same compound 
that showed good yields.75 By utilizing PPTS as a catalyst, the reaction proceeded 
smoothly as reported and pure product was obtained as a colourless oil in a good yield 
of 88% after the purification via column chromatography (Scheme 30). Analytical and 
spectroscopic data was in agreement with that reported in literature.75  
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Scheme 30. Reagents: (a) PPTS, dichloromethane, reflux, 20 h, (88%). 
 
The next part in the synthesis of the 3-alkyne-1,2-diol intermediate 130 was the 
preparation of alkyne intermediate 132, starting with the esterification of commercial 
available 6-heptynoic acid 135 to give 136 in an 87% yield (Scheme 31). The Steglich 
esterification is a very effective method for the esterification of carboxylic acids with 
DCC as a coupling reagent and DMAP as a catalyst.76,77 It proceeded smoothly without 
any difficulties and resulted in excellent yields. The product and starting material 
displayed significant different polarities by TLC. Pure compound 136 was obtained as 
a light yellow oil after column chromatography. 1H NMR confirmed the conversion by 
the presence of a new peak at 𝛿	3.68 ppm corresponding to the protons of the methyl 
group. 
 
 
Scheme 31. Reagents: (a) DCC, DMAP, MeOH, CH2Cl2, r.t., 3 h, (87%). 
 
The Steglich esterification however, produced a large amount of by-product along with 
the desired product (Scheme 32).78 The carboxylic acid 135 reacted with DCC to form 
an O-acyl isourea, which was more reactive than the free acid. Subsequent attack by 
the alcohol at the carbonyl carbon of the O-acyl isourea intermediate 142, formed N,N'-
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dicyclohexylurea (DCU) 144 and ester 136 . The by-product was mostly removed by 
filtration, but trace amounts remained and were difficult to remove.  
 
 
Scheme 32. Proposed mechanism of the Steglich esterification.  
 
A sodium borohydride-methanol system was then used to reduce the ester 136 to the 
primary alcohol 145 (Scheme 33). The alcohol product 145 was prepared by heating a 
solution of ester 136 in the presence of NaBH4 and MeOH in THF. The reflux time was 
extended from one hour to three hours. This provided the reaction sufficient time to go 
to completion and increased the yield from 52% to 82%. The alcohol product 145 was 
isolated as a colourless oil after aqueous work-up. The 1H and 13C NMR spectrum show 
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the product to be pure after purification by silica column. Peaks representing the protons 
of the methyl group of 136 were not present in the 1H NMR. IR spectroscopy was used 
to help characterise the product and a peak at 𝜐	3583 cm-1 corresponding to the OH 
group.  
 
 
Scheme 33. Reagents: (a) NaBH4, MeOH, THF, reflux, 3 h, (82%). 
 
Before the coupling reaction between alkyne 132 and ketone 131, the alcohol group of 
145 need to be protected and initially, a t-butydimethylsilyl group (TBS) was used to 
protect the terminal hydroxyl group (Scheme 34). As expected the reaction proceeded 
smoothly in good yield (80%). The product 146 was easily isolated after aqueous work-
up. The 1H and 13C NMR spectra illustrated the product to be pure after purification by 
silica column chromatography. 1H NMR confirmed this by the presence of peaks at 𝛿 
0.07 ppm and 0.91 ppm corresponding to the protons of the methyl and t-butyl groups 
of the silyl ether respectively. 
 
 
Scheme 34. Reagents: (a) TBSCl, imidazole, dichloromethane, 0	℃-r.t., 3 h, (80%). 
 
Therefore, there was now just one step away from synthesising the target alkynediol. 
Protected alcohol 146 was then proposed to be coupled to ketone 131 (Scheme 35). 
Lithiated alkyne was formed by using nBuLi to deprotonate the terminal alkyne. Then 
a
COOCH3 OH
(136)                                                                         (145)
a
OTBS
(145)                                                                         (146)
OH
 42 
ketone 131 was added to the resulting mixture. After aqueous work-up, the residue was 
dissolved in methanol containing p-toluenesulfonic acid monohydrate (pTSA∙H2O) in 
order to remove the tetrahydropyran group. Unfortunately, signals for the desired 
product were not seen in the crude 1H NMR spectrum. This was confirmed by 1H NMR 
spectrum as the expected peaks at 𝛿 0.07 ppm and 0.91 ppm representing the protons 
of two types of methyl groups from TBS group were absent. Hence, the silyl ether 
protecting group (TBS) has been removed by methanol and pTSA monohydrate. 
 
 
Scheme 35. Reagents: (a) nBuLi, THF, 0	℃, 0.5 h; (b) 131, 0	℃, 1 h; (c) pTSA monohydrate, MeOH, 
r.t., 2 h. 
 
Then t-butyldiphenylsilyl (TBDPS) group was selected to protect the OH group of 145 
as it is less prone to the removal under acidic conditions than TBS. Following the 
procedure employed for TBS protection, the reaction proceeded smoothly without any 
difficulties and resulted in excellent yields of the protected alcohol (89%) (Scheme 36). 
1H NMR confirmed this by the presence of peaks at 𝛿  1.08 ppm representing the 
protons of the tert-butyl group and at 𝛿 7.38-7.68 ppm representing the protons of the 
phenyl groups of the TBDPS group. 
 
 
Scheme 36. Reagents: (a) TBDPSCl, imidazole, dichloromethane, 0	℃-r.t., 16 h, (89%). 
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With compound 148 in hand, the next step was attempted to produce the alkynediol 
derivate using nBuLi to deprotonate the terminal alkyne, initiating the reaction. 
However, the initial acetal deprotection conditions (methanol/p-TSA and 
methanol/PPTS) were found to be problematic to deliver the desired product. After 
using ethanol/PPTS as deprotection conditions, the reaction was able to deliver the 
desired product 149 (Scheme 37). This was confirmed via 1H NMR spectroscopy, and 
all the peaks representing the protons of TBDPS group were observed. The singlet at 𝛿 1.45 ppm represents the protons of the methyl group adjacent to the tetra-substituted 
carbon which is connected to the alkyne carbon. The doublet at 𝛿 3.46 ppm in the 
proton spectrum of 149 represents the protons of the carbon adjacent to the terminal 
hydroxyl group. IR spectroscopy was also used to help characterise the product with a 
peak at 𝜐	3583 cm-1 corresponding to the hydroxyl group. 
 
 
Scheme 37. Reagents: (a) nBuLi, THF, 0	℃, 1 h; (b) 131, 0	℃, 4 h; (c) PPTS, EtOH, 55	℃, 3 h, (77%). 
 
In order to improve the yields, optimisation of the reaction conditions was carried out 
(Table 2). The reaction mixture was allowed to stir with nBuLi for one hour prior to the 
addition of 131. This was to allow for complete deprotonation the alkyne moiety of 148, 
leading to the corresponding lithiated species. Eventually, the 3-alkyne-1,2-diol 149 
was obtained a good 77% yield (Table 2, entry 5). 
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Entry Timea (h) Timeb (h) Yieldc 
1 0.5 2 14% 
2 1 2 26% 
3 1 3 55% 
4 1 3.5 67% 
5 1 4 77% 
Table 2. Optimisation conditions for the synthesis of 149. (a) Reaction time after added                                                          
nBuLi; (b) reaction time after added 146; (c) The overall yield. 
 
In summary, the 3-alkyne-1,2-diol intermediate 149 was delivered within five steps (49% 
overall yield) (Scheme 38). 
 
 
Scheme 38. Reagents: (a) DCC, DMAP, MeOH, CH2Cl2, r.t., 3 h, (87%); (b) NaBH4, MeOH, THF, 
reflux, 3 h, (82%); (c) TBDPSCl, imidazole, CH2Cl2, 0	℃-r.t., 16 h, (89%); (d) 133, PPTS, CH2Cl2, r.t., 
16 h, (62%); (e) nBuLi, THF, 0	℃, 1 h; (f) 131, 0	℃, 4 h; (g) PPTS, EtOH, 55	℃, 3 h, (77%, 3 steps). 
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5.2 Optimisation of the Iodocyclisation 
After the success of obtaining alkynediol intermediate 149, the second part of this 
project was continued, which applied 5-endo-dig cyclisations towards to the natural 
product target. 
Using literature conditions for a similar iodocyclisation, the synthesis of 𝛽-iodofuran 
intermediate 150 was attempted (Scheme 39).49 Using acetonitrile as solvent, 3.3 
equivalents of iodine and sodium hydrogen carbonate were used. After aqueous work-
up, crude product was obtained as a brown oil. Several spots, including starting material, 
were observed by TLC. Three singlet peaks at 𝛿 1.04 ppm, 1.06 ppm and 1.08 ppm 
were found in the crude 1H NMR spectrum, thus further purification was required. 
 
 
Scheme 39. Reagents: (a) I2, NaHCO3, MeCN, r.t., 1 h, (3%). 
 
There were challenges when it came to purification of the mixture. It was nearly 
impossible to isolate the desired product due to two major compounds with similarly 
low polarity. Pure compound 150 (3%) was obtained through preparative thin layer 
chromatography. Through analysis of the 1H NMR, peaks due to protons from the 
TBDPS group were observed. A singlet peak at 𝛿  1.94 ppm corresponding to the 
protons of the 𝛽 -methyl group was found. Another singlet peak at 𝛿  7.17 ppm 
corresponding to 𝛼-proton of the furan ring was observed as well. IR spectroscopy was 
also used to help characterise the product; the absence of a broad OH stretch in the 𝜐	3600 cm-1 region indicated that the diol group of starting material was no long present. 
Though the target 𝛽-iodofuran was delivered, this step was found to be problematic. It 
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was not only the low yield of product, but also the presence and properties of the major 
by-product. In this reaction, the 𝛽 -iodofuran 150 contained an unsubstituted 𝛼 
position, meaning that it was more prone to subsequent electrophilic substitution by the 
residual molecular iodine resulting in the by-product diiodofuran. TLC analysis 
indicated that the polarity of 𝛽-iodofuran 150 and diiodofuran are similar. The most 
notable feature in the 1H NMR spectra of 150 is that the singlet peak at 𝛿 7.17 ppm 
corresponding to the proton at the 𝛼 position of the furan ring; this is not present in 
the by-product diiodofuran.  
Due to the low yields and significant quantities of diiodofuran, optimisation of the 
reaction conditions was then investigated (Table 3). 
Entries 1 to 8 were carried out at room temperature, which proved to be an inefficient, 
and often unsuccessful, means of effecting the transformation. Reduction of the 
reaction time to 0.5 hours (Entries 3 and 4) led to unsuccessful iodocyclisation. A 
marked increase in reaction time to 20 hours (Entries 7 and 8) effected the 
iodocyclisation, with almost complete conversion of the starting material, however only 
the undesired diiodofuran by-product was obtained as observed in the crude 1H NMR 
spectrum. 
In order to decrease the tendency of the desired iodofuran to undergo electrophilic 
substitution with the residual molecular iodine, a reduction in temperature to 0 °C was 
implemented (Entries 9-11). Entries 9 to 11 were desired to react at 0 ℃ . 
Iodocyclisation was not favorable when carried out when THF was employed as the 
solvent, with only trace quantities of products being visible in the crude 1H NMR. 
Although entry 11 produced a low yield, it was first to show a relatively small amount 
of the by-product. Comparing entry 1 and entry 11, it can be seen that low temperature 
aids in reducing the quantity of the undesirable by-product. 
Other reaction variables were then considered, such as the reduction in the number of 
 47 
I2 equivalents. The reasoning behind this is that there would be less chance for the 
diiodofuran to form due to limiting the quantity of residual iodine present in the reaction 
to undergo electrophilic substitution. 
A big step forward was gained, as shown in entry 18, when half of the initial equivalents 
of iodine and NaHCO3 were used which resulted in a higher yield (12%) with only trace 
by-product observed after 16 hours. 
Whilst a drastic improvement over previous attempts, the yield was still poor. 
Modification of reagent concentrations led to a dramatic change in reaction yield. A 
dramatic change occurred (Entry 19), when the reaction proceeded at a concentration 
of 1 mL/mmol; it produced a yield of 38% without any by-product being observed. 
Another three experiments (Entries 20, 21 and 22) were attempted whilst modifying 
concentration or reaction time. Eventually, the optimum reaction conditions (1.6 I2; 1.6 
NaHCO3; 1 mL/mmol MeCN; 0	℃; 40 h) was found with an improved yield of 45% 
(Entry 21) (Scheme 40). 
 
 
Scheme 40. Reagents: (a) I2, NaHCO3, MeCN, 0	℃, 40 h, (45%). 
 
Entry Solventa conc. 
(mL/mmol) 
NaHCO3 
equiv. 
I2 
equiv. 
Tem. 
(℃) 
Time 
(h) 
Yield 
150 
Yieldb 
diiodo 
-furan 
1 MeCN 3 3.3 3.3 r.t. 2 3% 8% 
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2 MeCN 6 3.3 3.3 r.t. 2 trace trace 
3 MeCN 3 3.3 3.3 r.t. 0.5 - - 
4 THF 3 3.3 3.3 r.t. 0.5 - - 
5 MeCN 3 6.6 6.6 r.t. 3 3% 10% 
6 THF 3 3.3 3.3 r.t. 3 - - 
7 MeCN 3 3.3 3.3 r.t. 20 trace 13% 
8 THF 3 3.3 3.3 r.t. 20 trace 14% 
9 THF 3 3.3 3.3 0 2 trace trace 
10 THF 3 3.3 3.3 0 3 trace trace 
11 MeCN 3 3.3 3.3 0 3 4% 2% 
12 MeCN 3 3 3 0 3 5% 2% 
13 MeCN 3 3 3 0 8 8% 3% 
14 MeCN 3 2 2 0 12 9% 2% 
15 THF 3 2 2 0 12 8% 3% 
16 THF 5 2 2 0 16 8% 4% 
17 MeCN 3 2 2 0 16 9% 2% 
18 THF 3 1.6 1.6 0 16 12% trace 
19 MeCN 1 1.6 1.6 0 16 38% - 
20 MeCN 0.5 1.6 1.6 0 18 35% - 
 49 
21 MeCN 1 1.6 1.6 0 40 45% - 
22 MeCN 1.5 1.5 1.5 0 25 37% - 
Table 3. Optimisation of iodocyclisations. (a) All of the solvents were used anhydrous; (b) Determined 
by 1H NMR spectroscopy. 
 
Though this reaction obtained a relatively satisfactory result, other approaches were 
attempted to explore alternative routes in this research. Bromine was considered to be 
able to induce the same cyclisation as iodine; herein N-bromosuccinimide (NBS) was 
chose to act as an electrophilic reagent in the cyclisation (Scheme 41). However, it 
failed to yield 151. TLC analysis showed no different products were present in the 
mixture. This was also confirmed by crude 1H NMR spectroscopy, and starting material 
149 was recovered from the reaction. The succinimide route was not pursued further 
because of the lack of success. 
 
 
Scheme 41. Reagents: (a) NBS, NaHCO3, MeCN, r.t., 2 h. 
 
5.3 Synthesis of the Furan Acid Intermediate  
The next part of this project was the introduction of a protected unsaturated acidic side 
chain to the furan ring of 150. Clearly there are a variety of different approaches to 
introduce C-C bond through the cleavage of C-H bond, such as palladium-catalysed 
cross-coupling reactions.64,71,79 In order to ensure that cross coupling reactions of 𝛽-
iodofuran 150 were possible, a series of similar reactions were tested as practice to 
avoid the wastage of raw material.  
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The first intention was to repeat the work initial reported by Tsuji and co-workers 
(Scheme 42); 2-methylfuran was allowed to undergo oxidative cross coupling with 
acrylates in the presence of t-butyl perbenzoate and a catalytic amount of 
Pd(OCOPh)2.44 A key feature of this coupling reaction was that the olefinic bond of the 
product is exclusively trans. Readily available Pd(OAc)2 was selected to replace 
Pd(OCOPh)2 as the catalyst in the coupling reactions. A solution of 2-methyl furan 152, 
ethyl acrylate 153, t-butyl perbenzoate and 5mol% Pd(OAc)2 in glacial acetic acid was 
heated at 100	℃ for 4 hours, TLC analysis showed that new products were present in 
the mixture. The coupled product 154 was isolated in 55% yield, after aqueous work-
up and purification via column chromatography. 1H NMR confirmed this by the 
presence of peaks at 𝛿 7.37-7.34 pm and 6.24-6.21 ppm corresponding to the protons 
of the carbon-carbon double bond. 1H NMR analysis showed that both J coupling values 
of the carbon-carbon double bond were 15.6 Hz, indicating the trans double bond was 
present rather than the cis one. 
 
 
Scheme 42. Reagents: (a) Pd(OAc)2, PhCO3t-Bu, AcOH, reflux, 4 h, (55%). 
 
The olefin hydroarylation between hetercocylic C-H bonds and olefinic C-C bonds is 
an important synthetic methodology for the preparation of alkylated hetercocyles.66 The 
gold-catalysed hydroarylation of ethyl propiolate 155 by 2-methyl furan 152 was also 
investigated as a potential replacement for the aforementioned palladium-catalysed 
oxidative cross coupling as it is quoted as being selective towards the cis product 
(Scheme 43). Readily available reagent AgOTf was selected to replace AgSbF6 as the 
co-catalyst with Ph3PAuCl in the reaction. This reaction proceeded smoothly without 
any difficulties and resulted in acceptable yields (49%). New products were observed 
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on the TLC plate and compound 156 was obtained after purification via silica gel 
column chromatography. 1H NMR spectroscopy confirmed this by the presence of 
peaks at 𝛿  6.75-6.72 ppm and 5.66-5.63 ppm corresponding to the protons of the 
carbon-carbon double bond. Traces of the different isomers were also identified via 1H 
NMR analysis. 
 
 
Scheme 43. Reagents: (a) Ph3PAuCl, AgOTf, CH3NO2, r.t., 4 h, (52%). 
Entry Au cat. 
(mol%) 
Ag cat. 
(mol%) 
Equiv. 155  Time (h)  Yield (%) 
[Z:E]a 
1 1 0 10 3 0 
2 0 1 10 3 0 
3 1 1 1 4 7[>99:1] 
4 1 1 10 4 52[>99:1] 
Table 4. Hydroarylation of 152. (a) Determined by 1H NMR spectroscopy. 
 
Though this reaction mainly produces cis-compounds, the mild reaction conditions and 
simple operations are the most important advantages of the gold-catalysed 
hydroarylation of ethyl propiolate by furans.  
The conversion of cis product 156 to 154 resulted in quantitative yields by utilizing 
iodine to isomerise the double bond (Scheme 44). The reaction process was monitored 
by 1H NMR. Doublet peaks at 𝛿 6.74 ppm and 5.65 ppm representing the protons of 
the carbon-carbon double bond were removed after 5 hours (Figure 12). Spectra data 
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was consistent with that obtained from the palladium-catalysed coupling reaction of 
152. 
 
Scheme 44. Reagents: (a) I2, CDCl3, r.t., 5 h, (100%). 
 
 
Figure 12. 1H NMR spectra of iodine induced isomerisation of 156. 
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With the knowledge gained from these reactions, the project continued to introduce side 
chain to 𝛽-iodofuran 150.  
Initially, synthesis of the target product was attempted through the palladium catalysed 
cross-coupling reaction (Scheme 45). Following the procedure outlined in the 
literature,42 a dark oil was obtained after aqueous work-up. TLC analysis showed many 
products were recovered in the mixture. However, this reaction proved unsuccessful 
with neither starting material nor desired product being observed from the reaction. 
This might be due to the harsh reaction conditions, especially using acetic acid as the 
solvent, decomposing the 𝛽-iodofuran 150. 
 
 
Scheme 45. Reagents: (a) ethyl acrylate 153, Pd(OAc)2, PhCO3t-Bu, AcOH, reflux, 4 h. 
 
Therefore, this research focused on the gold-catalysed reaction between 150 and ethyl 
propiolate 155. Using the same reaction conditions as before (Entry 1), the target furan 
was not obtained. The original conditions utilized an excess of furan, which was 
considered wasteful in this case. A trace amount of product was observed in the crude 
1H NMR when the reaction time was prolonged to 8 hours. Optimisation of the reaction 
conditions was then carried out (Table 5). 
When low quantities of ethyl propiolate were employed (Entries 1-4), conversion was 
unsuccessful. An increase to 10 equivalents of ethyl propiolate (Entry 5) led to the 
desired product being formed, however a yield of 6% was far from desirable. An 
increase in reaction time to 24 hours (Entry 8) saw an increase in the yield to 13%. 
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TLC analysis indicated there was a new compound present. Pure compound 158 was 
then obtained after purification and was confirmed by 1H and 13C NMR. Doublet peaks 
at 𝛿 6.23 ppm and 6.19 ppm representing the proton of the carbon-carbon double bond 
were observed. The singlet peak at 𝛿 7.17 ppm representing the proton of the furan 
ring of starting material was removed. 
 
 
Scheme 46. Reagents: (a) ethyl propiolate 155, Ph3PAuCl, AgOTf, CH3NO2, r.t., 24 h, (13%). 
Entry Equiv of 155 Time (h) Temp. (℃) Yield (%) 
1 0.1 4 r.t. - 
2 0.1 8 r.t. trace 
3 0.1 4 100 - 
4 1 8 r.t. trace 
5 10 8 r.t. 6 
6 10 16 r.t. 8 
7 10 16 r.t. 9 
8 10 24 r.t. 13 
Table 5. Optimisation for conditions. 
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In order to improve the yield of the gold-catalysed reaction, alternative gold catalysts 
were examined. (Acetonitrile) [(2-biphenyl)di-tert-butylphosphine] gold(I) 
hexafluoroantimonate, which is known as JohnPhos Au(MeCN)SbF6 159 (Figure 13), 
was tried to replace Ph3PAuCl/AgOTf. This catalyst was used directly without the need 
for activation by silver salts. This reaction proceeded smoothly with an improved yield 
of 33% under the same conditions as scheme 46. Spectroscopic data was consistent 
with that obtained previously. 
 
 
Figure 13. JohnPhos Au(MeCN)SbF6. 
 
Work was then directed towards optimising the conditions of the Au(I)-catalysed 
hydroarylation of the iodofuran (Scheme 47). Table 6 shows some trends by different 
reaction conditions. When the concentration was increased to 6 mL/mol, the yield was 
decreased to 23% as shown in entry 3. Excess gold(I) catalyst had a negative effect on 
the reaction (Entries 4, 5 and 6). For example, neither starting material nor the desired 
product was isolated when using 50 mol % gold(I) catalyst (Entry 6).  
Further optimisation showed that lower amounts of catalyst can be used, e.g., only 3 
mol % of gold catalyst (Entry 7 and 8). Interestingly, the order of addition of iodofuran 
and ethyl propiolate slightly affected the yield of the reaction (Entry 7 and 8). Under 
the same conditions (3 mol % gold(I) catalyst, 10 equiv. of ethyl propiolate, r.t., 24 h), 
adding iodofuran first resulted in 37% yield of 158 (Entry 7).  
Further experiments addressed the temperature issue but the results did not improve 
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(Entry 9 and 10). When the reaction temperature was increased to 100 	℃ neither 
starting material nor the desired product was isolated (Entry 11).   
The last modification to the method was a change in reaction time. With the knowledge 
gained from previous experiments, the reaction proceeded with low amounts of the 
catalyst (1-3 mol %) and low solvent concentration (1-3 mL/mol) (Entries 12-15). 
Finally, in an experiment using 3 mol % of gold(I) catalyst at r.t. (48 h), product 158 
was obtained in 58% yield as a 25:75 Z/E mixture (Entry 15). Subsequent isomerization 
gave the desired compound 157 as a yellow oil.  
The opposite E/Z-selectivity is not caused by a change in mechanism. Rather, it is likely 
that the primary products are in fact Z-configured but undergo isomerisation to the E-
form under the reaction conditions. This was supported by the observation that the E/Z 
ratio of product 158 changed from 66:34 to 75:25 upon subjecting the isolated product 
mixture to the increased reaction time 36-48 h (Entries 14 and 15). 
Pure product 157 and its E-isomer 158 were isolated after very careful purification via 
column chromatography. This was confirmed via 1H, and 13C NMR spectroscopy and 
mass spectrometry. However, it was much easier to collect the Z/E mixture directly. 
Pure product 157 was then obtained, without any difficulties and resulted in quantitative 
yields, by using iodine in CH2Cl2. The reaction process was monitored by 1H NMR 
spectroscopy. Doublet peaks at 𝛿 6.52 pm and 5.71 ppm representing the two protons 
of the carbon-carbon double bond of 158 were absent after a reaction time of 3 hours. 
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Scheme 47. Reagents: (a)155, Au(MeCN)SbF6, CH3NO2, r.t., 48 h, (58%); (b) I2, CDCl3, r.t., 3 h, 
(99%). 
Entry Au cat. 
[mol%] 
Equiv. of 
155 
Temp. 
[℃] Time [h] Conc. [mL/mmol] Yield (%) 157  
1 5 10 r.t. 24 3 33  
2 5 10 r.t. 24 5 27  
3 5 10 r.t. 24 6 23  
4 8 10 r.t. 24 3 18  
5 10 10 r.t. 24 3 7  
6 50 10 r.t. 24 5 - 
7 3 10 r.t. 24 3 37  
8 3 10 r.t. 24 3 33  
9 3 10 40 4 3 22  
10 3 10 40 24 3 36  
11 3 5 100 4 3 - 
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12 2 5 r.t. 24 2 29  
13 1 5 r.t. 24 2 18  
14 3 5 r.t. 36 1 42  
15 3 5 r.t. 48 1 58  
Table 6. Optimisation of conditions for preparation of 157. 
 
With iodofuran 157 in hand, work could begin on the methylation of the aryl halide. 
Scheme 48 shows the methylation of iodofuran 157 to give product 160 by the Suzuki-
Miyaura coupling.79 The reaction was carried out in refluxing dioxane, employing 
potassium carbonate as base, Pd(PPh3)4 as a catalyst, and trimethylboroxine as the 
coupling partner and source of the methyl group. TLC analysis showed that a new 
product was present in the mixture. Column chromatography was used to separate the 
mixture and the new product was confirmed to be the desired product 160 (9%) by 1H 
NMR and MS analysis. A singlet at 𝛿 1.84 ppm corresponding to the protons of the 
new methyl group was observed.  
 
 
Scheme 48. Reagents: (a) Pd(PPh3)4, trimethylboroxine, K2CO3, dioxane, reflux, 28 h, (9%). 
 
In order to develop the optimum conditions for this reaction as shown in Table 7, three 
experiments were carried out by increasing the reaction time from 8 h to 28 h (Entries 
1-3). However, the Suzuki-Miyaura coupling only gave a disappointing 9% yield and 
O
I
O OTBDPS
O
 (157)
O
O OTBDPS
O
 (160)
a
 59 
trace of starting material was recovered from each case. 
 
Entry Time [h] Yield of 160 [%] 
1 8 5 
2 16 8 
3 28 9 
Table 7. Optimisation of conditions for preparation of 160. 
 
The inefficient methylation step proved problematic due to the precursor iodofuran 
being a valuable, and difficult to prepare, starting material. In addition, due to the 
presence of olefinic bonds and ester groups, harsh reagents and conditions (e.g. 
organolithium reagents) could not be employed. Due to a large mass of product being 
required to support the further synthetic route, alternative synthetic routes and methods 
were then considered to form desired product 160 instead of using Suzuki-Miyaura 
coupling. Herein a seconded synthetic route was developed and followed (Figure 14). 
An obvious advantage is that the direct methylation of iodofuran 150 allows the 
application of multiple methylation methods.      
 
 60 
 
Figure 14. Two synthetic routes from iodofuran 150 to furan 160. 
 
It was decided that a halogen-metal exchange could be used to convert iodofuran 150 
into dimethylfuran 161 prior to the hydroarylation step. A standard procedure 
developed by Knight group,69 nBuLi at low temperature followed by iodomethane, was 
used to generate dimethylfuran 161 (Scheme 49). After aqueous work-up, TLC analysis 
indicated that both a new compound and starting material were present in the mixture. 
After careful purification via column chromatography, dimethylfuran 161 was obtained 
in an acceptable yield of 67%. 1H NMR spectra confirmed this by the presence of 
singlet peak at 𝛿  1.84 ppm corresponding to the protons of the newly introduced 
methyl group. 
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Scheme 49. Reagents: (a) nBuLi, THF, -78 ℃, 5 min; (b) MeI, -78	℃, 5 min, then r.t., 10 min, (67%).  
 
Dimethyl furan 161 was also obtained in excellent yield of 88% when methyl lithium 
was used for the iodine-methyl exchange step (Scheme 55).69,80 A solution of methyl 
lithium in diethyl ether, complexed with LiBr was added to a stirred solution of 150 in 
THF at -78	℃. This was allowed to stir for 3 hours before warming to r.t and stiring for 
a further 1 hour. After aqueous work-up, pure 161 was isolated by column 
chromatography. This was confirmed by 1H and 13C NMR. 
 
 
Scheme 50. Reagents: (a) MeLi∙LiBr, THF, -78	℃, 3 h, then r.t., 1 h, (88%). 
 
Of course, it could be possible to introduce a newly methyl group using Suzuki-Miyaura 
coupling as well (Scheme 51). Under the same conditions used before (Table 7, entry 
3), it produced a yield of 52% in this case. However, compared to the other two methods 
(using nBuLi/MeI and MeLi), there were no obvious advantages to using this method. 
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Scheme 51. Reagents: (a) Pd(PPh3)4, trimethylboroxine, K2CO3, dioxane, reflux, 28 h, (52%). 
 
The next step was to introduce the unsaturated ester side chain to 161; a series of 
experiments trialing different conditions is shown in Table 8. As expected the reaction 
proceeded smoothly and resulted in a good yield of 85%. At the end of the reaction, a 
mixture of Z/E isomers of 160 was collected directly by column chromatography.  
The isomerisation was carried out under the same conditions (I2, CH2Cl2). Surprisingly, 
signals for the olefinic bond were notably absent in the 1H NMR spectrum in the first 
attempt (200 mg scale). TLC analysis showed that many compounds was showed in the 
mixture. It was hypothesised that the unsuccessful reaction was due to the iodine being 
present in visible light as well as an excess amount was used, leading to the 
decomposition of olefinic bond.  
After modification, pure 160 was generated after isomerisation by using a catalytic 
amount iodine in the dark. 1H NMR spectroscopy can be used to confirm the completion 
of the isomerisation. Two doublets at 6.46 ppm and 5.57 ppm are observed and only 
doublets at 6.13 ppm remained confirming that all Z-isomer had been converted to the 
corresponding E-isomer after 4 hours reaction (Scheme 52). Remarkably, a good yield 
of 85% was achieved by using a small volume of nitromethane (Table 8, Entry 4, 1 
mL/mmol). Spectral data was the same as that obtained from the Suzuki-Miyaura 
coupling reaction of 157. 
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Scheme 52. Reagents: (a) 155, Au(MeCN)SbF6, CH3NO2, r.t.; then I2, CH2Cl2, r.t., 4 h. 
Entry Au cat. 
[mol%] 
Equiv. 
of 155 
Temp. 
[℃] Time [h]   Conc. [mL/mmol] Yield 160 [%] 
1 3 10 r.t. 48 3.3 33 
2 4 10 r.t. 64 3 57 
3 3 10 r.t. 64 3 54 
4 3 5 r.t. 64 1 85 
Table 8. Optimisation of conditions. 
 
5.4 Synthesis of the F-acids Metabolite 
Alcohol 162 was subsequently prepared by selective removal of TBDPS ether with 
tetrabutylammonium fluoride (TBAF) (Scheme 53). A solution of TBAF in THF was 
added to a stirred solution of 160 in THF at 0 ℃ and allowed to stir for 5 minutes 
before warming to r.t. over 4 hours. At the end of reaction, two new spots were observed 
by TLC. Pure compound 162 (99%) was obtained after purification via column 
chromatography. This was confirmed via 1H NMR spectroscopy, as all the peaks 
representing the protons of TBDPS group were absent. IR spectroscopy was also used 
to help characterise the product and a peak at 𝜐	3431 cm-1 corresponding to the 
hydroxyl group was present. 
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Scheme 53. Reagents: (a) TBAF, THF, 0	℃, 5 min, then r.t., 4 h, (99%). 
 
With primary alcohol 162 synthesised, a final step to introduce the carboxylic acid 
functionality was required (Figure 15). 
 
 
Figure 15. The chemical structure of acid 163. 
 
Originally, the reaction was attempted with several common oxidation methods on a 
small scale. For example, oxidants like Jones reagent, Dess-Martin periodinane, 
RuCl3/NaIO4 and ceric ammonium nitrate were tested in each experiment,81-85 however 
these all proved to be ineffective for the desired product, however no starting material 
was also observed from these reactions. This might be due to the harsh reaction 
conditions decomposing the olefinic bond of alcohol 162.  
Pyridinium dichromate (PDC) was then used and investigated as an alternative 
oxidising agent to form the desired product.85 The addition of PDC to alcohol 162 
dissolved in DMF result in the formation of the corresponding carboxylic acid 163. 
TLC analysis showed that a different product was present in the mixture with a higher 
polarity compared with starting material. 13C NMR spectroscopy confirmed this by the 
presence of peak at 𝛿 178.74 ppm representing the carbon of the newly carboxylic 
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acid. This was also be confirmed by 1H NMR spectroscopy as the multiplet at 𝛿 1.34-
1.44 ppm representing the two protons of the terminal alcohol carbon shown in the 
starting material was absent. 
In order to develop the optimum conditions, a series of experiments was carried out as 
shown in Table 9. The initial conditions used (Entry 1) were taken from a similar 
reaction in the literature but only gave trace yield after purification. Several modified 
procedures have been employed to enhance the rate and the efficacy of PDC. As is 
shown in the table, the only improvement in yield came when the solvent system was 
changed to DMF/MeOH opposed to DMF, and this only increased the yield to 6% 
(Entry 5). 
 
 
Scheme 54. Reagents: (a) PDC, DMF/MeOH, r.t., (6%). 
Entry Equiv. of 
PDC 
Time [h] Solvent   Conc. 
[mL/mmol]  
 Yield [%] 
1 5 8 DMF 15 Trace  
2 5 16 DMF 15 Trace  
3 3.5 8 DMF/MeOH 2 Trace 
4 5 8 DMF/H2O 2 2 
5 5 16 DMF/MeOH 2 6 
Table 9. Optimisation of conditions for preparation of carboxylic acid 163. 
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Due to the lack of success and low yields from the initial methods, an alternative was 
found. Tetrapropylammonium perruthenate (TPAP)-catalysed oxidation86 was then 
employed to produce desired product. TPAP serves as the oxidation catalyst, and 
NMO∙H2O is acting as the co-oxidant in the reaction.86 Unlike PDC oxidation, the 
reaction proceeded smoothly, and after work-up the carboxylic acid 163 was formed in 
a moderate yield of 20%. An increase in reaction time from one hour to 16 hours led to 
an improved yield of 50% (Scheme 55). Spectral data is the same as that obtained 
previously.  
 
 
Scheme 55. Reagents: (a) TPAP, NMO∙H2O, MeCN, r.t., 16 h, (50%). 
 
In comparison with PDC oxidation, TPAP/NMO.H2O proved to be a simple, clean, mild 
and effective method for the formation of 163. This is not only because of the higher 
yield of the reaction, but also due to the low catalyst loadings and a much easier work-
up involved. 
With carboxylic acid 163 in hand, the next step was to convert the carboxylic acid group 
to its corresponding methyl ester.87 It was mainly considered in order to be convenient 
for the purification in further synthesis. To a solution of acid 163 in MeOH, thionyl 
chloride (SOCl2) was added slowly at 0	℃ over a period of 30 minutes and allowed to 
stir a further 16 hours at r.t. (Scheme 56). However a lot of new spots were visible on 
the TLC plate and purification by column chromatography was unsuccessful. 1H NMR 
confirmed neither starting material nor desired product was present in the mixture. 
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Scheme 56. Reagents: (a) SOCl2, MeOH, 0	℃, 0.5 h, then r.t., 16 h. 
 
An alternative reaction also proved incapable of generating product 164. The acid 
chloride was supposed to be generated by using SOCl2 reacted with 163 in CH2Cl2 
overnight, then it was isolated after solvent removal. Acid chloride was then stirred 
with excess MeOH overnight to produce 164. Crude 1H NMR confirmed this procedure 
also failed to yield the desired product.  
After two failed esterification experiments, it was decided to deprotect the ethyl group 
directly to gain finally product 95 (Scheme 57). Ester 163 was hydrolysed under mild 
conditions with lithium hydroxide (LiOH) in 2:1:2 THF:H2O:MeOH mixture at r.t. for 
32 h.88 TLC analysis indicated a new product was made with higher polarity than the 
starting material. Pure product 95 was isolated after careful purification via column 
chromatography in a yield of 45%. 1H NMR spectra confirmed this by the absence of 
the triplet and quartet at	𝛿 1.30 ppm and 4.20 ppm representing the protons of the ethyl 
group of 163.  
 
 
Scheme 57. Reagents: (a) LiOH, THF:H2O:MeOH, r.t., 32 h (45%). 
 
Consequently, natural product 95 was prepared from 3-alkyne-1,2-diols 149 in 7 steps 
(7.5% overall yield) (Scheme 58). 
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Scheme 58. Reagents: (a) I2, NaHCO3, MeCN, 0	℃, 40 h, (45%); (b) MeLi∙LiBr, THF, -78	℃, 3 h, 
then r.t., 1 h, (88%); (c) 155, Au(MeCN)SbF6, CH3NO2, r.t., 48 h; (d) I2, CH2Cl2, r.t., 4 h, (85%, 2 
steps); (e) TBAF, THF, 0	℃, 5 min, then r.t., 4 h, (99%); (f) TPAP, NMO∙H2O, MeCN, r.t., 16 h, (50%); 
(g) LiOH, THF:H2O:MeOH, r.t., 32 h (45%). 
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6.0 Synthesis of F-acids and Their Analogues  
Naturally occurring F-acids have received significant attention among organic chemists, 
resulting in extensive studies being devoted towards developing synthetic routes to 
these highly substituted furans.19,27,69,70 Whilst various approaches exist, such as those 
documented in the introduction to chapter 3.0, synthesis of F-acids remains challenging 
in terms of synthetic efficiency. 
For this reason, a versatile and flexible approach to the chemical synthesis of F-acids 
was the focus of this research. Research began by studying and developing the 
palladium catalysed cyclisation to functionalised furans, and then utilised the 
cyclisation to construct the furan nuclei of F-acids and their modified analogues.      
        
6.1 Palladium Catalysed Cyclisation to Furans 
There have been various methods for the synthesis of functionalised furans. The method 
used in the research to achieve functionalised furans involves the modification of a 
approach reported by Tsuji et al.56  
In their work on the palladium-catalysed reaction of propargylic carbonates with 𝛽-
keto esters, a series of simple exomethylene furans have been synthesised in moderate 
to good yields by the catalysis of Pd(0)-phosphine complexes. In this reaction, 
propargylic carbonate reacts with palladium catalyst to generate the 𝜋-allypalladium 
complex, which is attacked by the soft nucleophile on the central sp-carbon. Subsequent 
nucleophilic attack on the resulting species by the second nucleophilic moiety of the 𝛽-keto ester led to the formation of the exomethylene (Scheme 59).57  
The work also produced several functionalised furans from the corresponding 
exomethylene furans through isomerisation. For example, isomerisation of methylene 
furan 167 yielded the trisubstituted furan 168 quantitatively under slightly acidic 
conditions (Scheme 59).56   
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Scheme 59. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 20-25	℃, 4 h, (88%); (b) HCl, THF, r.t., 10 
min, (100%).56 
 
More recently, similar palladium-catalysed reaction of propargylic carbonates with bis-
nucleophiles to highly substituted heterocyclic compounds have been extensively 
studied by Yoshida et al.57-59,89 For example, the substituted pyrrole 171 is 
regioselectively generated in excellent yield of 96% through the nucleophilic 
cyclisation of the carbonate 169 with the 𝛽-enamino ester 170 (Scheme 60).57      
 
 
Scheme 60. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 3 h; (b) HCl, r.t., 1 h, (96%, 2 steps).92 
 
Unlike methods for furan formation starting from complex molecules, such as 3-alkyne-
1,2-diols used in iodine or silver catalysed cyclisation, the palladium catalysed 
cyclisation allows the formation of the furan nuclei of F-acids and their analogues from 
two relatively simple and easier prepared compounds, propargylic carbonates and 𝛽-
keto esters. As a further advantage in versatility, by modifying the carbon chain length 
of either propargylic carbonates or 𝛽-keto esters could achieve corresponding F-acids 
framework.  
In order to verify the feasibility and versatility of the palladium catalysed cyclisation, 
the reaction was pursued, practiced and tested using commercially available or easily 
prepared propargylic carbonates and 𝛽-keto esters prior to the application to the total 
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synthesis of F-acids and their analogues. 
Work began on the preparation of propargylic substrates by esterification of propargylic 
alcohol 172 with chloroformate 173 in the presence of pyridine in dichloromethane at 
0	℃ for 3 hours, as described by Yoshida et al.93 The desired propargylic carbonate 
169 was obtained in good yields of 80% after purification by column chromatography 
(Scheme 61).    
 
 
Scheme 61. Reagents: (a) Pyridine, CH2Cl2, 0	℃, 3 h, (80%). 
 
Subsequent cyclisation of 169 and methyl acetoacetate 166 was carried out by treatment 
with 5 mol% Pd2(dba)3∙CHCl3 and 10 mol% DPPE in THF (Scheme 62). As expected 
the reaction proceeded smoothly and the desired product was obtained in a 72% yield 
as a yellow oil after purification by column chromatography.  
 
 
Scheme 62. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 3 h; (b) HCl, r.t., 1 h, (72%, 2 steps). 
 
A simple optimisation of conditions for preparation of 174 was carried out. The reaction 
was trialled by stirring the resulting mixture at room temperature (Tsuji’s conditions), 
but this gave a very disappointing 35% yield. The reaction was also repeated by 
doubling the catalyst loading to 10 mol% Pd2(dba)3 ∙CHCl3 and 20 mol% DPPE, 
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however higher catalyst loadings inhibited product formation, with the isolated yield 
dropping to 54% after purification. 
Alternative methyl carbonate 176 was trialled and proved to be a more efficient 
propargylic carbonate substrate for the cyclisation. The methyl carbonate 176 was 
prepared under the same conditions as the preparation of 169 (Scheme 63). Treatment 
of 172 with methyl chloroformate and pyridine gave propargylic methyl carbonate 176 
as a colourless oil in an 85% yield after purification by column chromatography. 
 
 
Scheme 63. Reagents: (a) Pyridine, dichloromethane, 0	℃, 3 h, (85%). 
 
The preparation of desired furan 174 from 176 and 166 proceeded smoothly and 
resulted in an 85% isolated yield (Scheme 64). 
  
 
Scheme 64. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 3 h; (b) HCl, r.t., 1 h, (85%, 2 steps). 
 
The cyclisation of alternative carbonucleophile 177 with propargylic carbonate was 
also found to be successful. Formation of furan 178 was carried out using the same 
conditions employed for the preparation of 174 (Scheme 65). After treatment with mild 
acid for one hour, TLC and 1H NMR analysis of the crude reaction mixture indicated 
furan 178 to be the only detected product. Three singlet peaks at 𝛿	2.61 ppm, 2.47 ppm 
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and 2.38 ppm were found on the 1H NMR spectrum of 178, corresponding to the 
protons of three different methyl groups.  
 
 
Scheme 65. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 4 h; (b) HCl, r.t., 1 h, (81%, 2 steps). 
 
In an attempt to improve the scope of the reaction as well as to test the feasibility of 
palladium catalysed cyclisation, an aliphatic propargylic carbonate was required. 
Carbonate 180 was chosen, and it would be able to introduce the pentyl side chain to 
expected furan products. Propargylic alcohol 179 is commercially available, but is too 
expensive for a cost-effective synthesis. 
For this reason, as well as a practice for further attempts to synthesise F-acids, a 
synthetic route was developed and followed starting from commercial hexanal 120 to 
carbonate 180. Initial attempts in the addition of acetylene to hexanal 120 used lithium 
acetylide or lithium (trimethylsilyl)acetylide however these both proved inefficient and 
the presence of many by-products made it impossible to purify.  
Finally, commercial ethynylmagnesium bromide was employed and gave the clean 
product with much improved yield. Propargylic alcohol 179 was prepared via the 
Grignard addition of commercial ethynylmagnesium bromide to a solution of hexanal 
120 in THF at 0	℃. After aqueous work-up and purification by column chromatography, 
179 was obtained as a colourless oil (89%). Preparation of 180 was carried out by the 
esterification of 179 with methyl chloroformate in the presence of pyridine in THF 
(88%) (Scheme 66).        
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Scheme 66. Reagents: (a) HCCMgBr, THF, 0	℃, 3.5 h, (89%); (b) methyl chloroformate, pyridine, 
CH2Cl2, 0	℃, 3 h, (88%). 
 
The palladium catalysed cyclisation of 180 and 166 proceeded smoothly as expected, 
and after work-up the tetrasubstituted furan 181 was isolated in an 81% yield (Scheme 
67).  
 
 
Scheme 67. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 4 h; (b) HCl, r.t., 1 h, (81%, 2 steps). 
 
Subsequent coupling of carbonate 180 and commercial ethyl 3-oxohexanoate 182 was 
carried out following the same procedure illustrated preciously. The reaction proceeded 
smoothly, and resulted in an 87% isolated yield of 183 after purification by column 
chromatography (Scheme 68). 1H NMR confirmed this by the presence of three triplet 
peaks at 𝛿 1.31 ppm, 0.92 ppm and 0.85 ppm, and one singlet peak at 𝛿 2.04 ppm 
representing the protons of four different methyl groups. It was a pleasing to introduce 
propyl and pentyl side chains to the furan product, and proved it possible for the 
application of palladium catalysed reaction to the total synthesis of F-acids.     
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Scheme 68. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 4 h; (b) HCl, r.t., 1 h, (87%, 2 steps). 
 
 
6.2 Initial Synthetic Route to F-acids F4 and F6 
With successful conditions for furan formation to hand, it was reasoned that the 
palladium catalysed cyclisation methodology would be able to generate the furan nuclei 
of F-acids. Several total syntheses of F-acids demonstrated in the introduction to 
chapter 3.6 and the previous work on F-acid metabolite were considered in the 
development of a novel retrosynthetic plan for the total synthesis of F-acids.  
With these in mind, an initial retrosynthetic plan was developed and followed (Scheme 
69). The initial approach to the synthesis of F6 8 involved the coupling of 𝛽-keto ester 
188 and propargylic carbonate 189, leading to the generation of tetrasubstituted furan 
187 bearing a 𝛽-ester functionality. Subsequent reduction of the 𝛽-ester group would 
deliver furan 186 possessing a hydroxyl group, then a second reduction of the hydroxyl 
would yield dimethyl furan 185. Finally, F6 8 would be prepared by introduction of the 
terminal carboxylic acid group in the synthesis through deprotection followed by 
oxidation.   
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Scheme 69. Proposed initial retrosynthetic plan for the synthesis of F6 8. 
 
The retrosynthetic plan splits the F-acid molecule into two key substrates, a propargylic 
carbonate, and a 𝛽-keto ester. These can be modified to yield corresponding F-acids. 
Due to the fact that there is a propyl or pentyl side chain in most F-acids, ethyl 3-
oxohexanoate 182 and ester 188 were used in the synthesis of F-acids (Figure 16). 
 
 
Figure 16. Two 𝛽-keto esters used in the synthesis of F-acids. 
 
Ester 188 was prepared following the procedure published by Thomson et al.90 
Commercial hexanoyl chloride 191 was added dropwise to a cool solution of 
Meldrum’s acid 190 and pyridine in dichloromethane (Scheme 70). After complete 
acylation, an acid work-up afforded a crude mixture as an orange oil. Heating the crude 
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mixture in methanol leaded to ester exchange and decarboxylation. After purification 
by column chromatography, ester 188 was isolated as a colourless oil (93%).   
 
 
Scheme 70. Reagents (a) Pyridine, CH2Cl2, 0	℃, 1 h; (b) MeOH, reflux, 2 h (93%, 2 steps). 
 
6.2.1 Preparation of the Propargylic Carbonate  
With the knowledge gained from the preparation of propargylic carbonate 180, the 
retrosynthetic plan of compound 189 was developed and followed (Scheme 71). This 
involved the conversion of commercial cyclododecanone 196 to lactone 195, using 
Bayer-Villiger oxidation conditions. Subsequent selective reduction of lactone 195 to 
afford 194, which after protection of the alcohol functionality followed by addition of 
an acetylenic Grignard reagent to the aldehyde, will deliver the desired propargylic 
alcohol 207. Eventually, esterification of the hydroxyl group of propargylic alcohol 192 
would yield propargylic carbonate 189. 
 
 
Scheme 71. Retrosynthetic plan for the synthesis of carbonate substrate 189. 
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The first step in the synthesis of this propargylic carbonate substrate is shown in 
Scheme 79. Follow a similar procedure reported by Luu et al,91 The Bayer-Villiger 
oxidation of cyclic ketone 196 with mCPBA and trifluoroacetic acid (TFA) in 
dichloromethane to afford lactone 195 proceeded smoothly and resulted in a good yield 
of 87% (Scheme 72).  
 
 
Scheme 72. Reagents (a) mCPBA, TFA, CH2Cl2, reflux at dark, 72 h, (87%).  
 
Subsequent conversion of lactone 195 to the aldehyde 194 was carried out by a 
selectively reduction. Reaction with diisobutylaluminium hydride (DIBAL-H) at -78	℃ 
for 2 h, followed by an acidic work-up and column chromatography afforded 194 as a 
colourless solid in good yield (82%) (Scheme 73). Initially, purification proved difficult 
as a result of both the lactone and the reduced product displaying similar polarities, as 
seen by overlapping spots when conducting TLC; and several impurities were always 
found in the product after purification. Eventually, by switching the elution solvents 
from light petroleum/ethyl acetate to dichloromethane/ethyl acetate, pure 194 was 
obtained. 1H NMR confirmed this by the presence of triplet peaks at 𝛿  9.78 ppm 
corresponding to the adjacent proton of the aldehyde group. IR spectroscopy was used 
to help characterise the product and a peak at 𝜐	3425 cm-1 corresponding to the 
hydroxyl group. 
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Scheme 73. Reagents: (a) DIBAL-H, THF, -78	℃, 2 h, (82%). 
 
Following the same procedure as for the preparation of 148, the terminal primary 
alcohol group of aldehyde 194 was protected with a bulky silyl ether to generate 
aldehyde 197 in an excellent yield of 94% as a yellow liquid. Subsequent Grignard 
addition of the aldehyde group using ethynylmagnesium bromide, followed by an 
aqueous work-up and purification by column chromatography afforded the desired 
propargylic alcohol 198 as a colourless oil in a good yield of 83% (Scheme 74).  
 
 
Scheme 74. Reagents: (a) TBDPSCl, imidazole, CH2Cl2, r.t., 16 h, (94%); (b) HCCMgBr, THF, 0	℃, 3 
h, (83%). 
 
Consequently, the preparation of desired compound 199 from propargylic alcohol 198 
proceeded smoothly as expected and resulted in a good yield of 81% (Scheme 75).   
 
 
Scheme 75. Reagents: (a) methyl chloroformate, pyridine, CH2Cl2, 0	℃, 3 h, (81%). 
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6.2.2 Synthesis towards to F6  
Due to the successful synthesis of required 𝛽-keto ester 188 and propargylic carbonate 
199, work began on the construction of the furan nuclus of F6. Generation of furan 200 
was carried out using the conditions employed for the preparation of 183. After aqueous 
work-up and purification by column chromatography, pure furan 200 was obtained as 
a yellow oil in an 87% yield (Scheme 76).  
 
 
Scheme 76. Reagents: (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 4 h; (b) HCl, r.t., 1 h, (87%, 2 steps). 
 
With the desired furan 200 in hand, an unavoidable synthetic challenge in the total 
synthesis of F6 was encountered, which is the transformation from 𝛽-ester group to a 
methyl group. Furthermore, problems were likely to be encountered in future work on 
the synthesis of F-acids bearing only one 𝛽-methyl substituent, as transformation of 
the 𝛽-ester group to a proton would be required. 
In order to accomplish the target dimethyl furan, a three-step approach was developed. 
First by the reducing the 𝛽-ester group to the corresponding hydroxyl functionality, 
subsequent undergoing tosylation of the functional group to the formation of tosylate 
ester. Finally, with a good leaving group in position, the resulting tosylate would yield 
the desired dimethyl furan through nucleophilic attack by metal hydrides.  
Formation of 201 was achieved using the commercial lithium aluminium hydride 
(LiAlH4) solution as reducing agent. The reaction proceeded well and gave the desired 
compound as colourless liquid in a yield of 92% after work-up and purification by 
column chromatography (Scheme 77).     
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Scheme 77. Reagents: (a) LiAlH4, THF, 0	℃, 2 h, (92%). 
 
Initially the preparation of 202 was attempted using a method reported by Kabalka et 
al.92 Furan 201 in dichloromethane was cooled to 0 	℃ , pyridine was then added, 
followed by the careful addition of p-toluenesulfonyl chloride (TsCl) (Scheme 78). The 
reaction was monitored by TLC, and gave a crude mixture as a brown oil after work-
up. Neither desired product nor starting material were isolated after purification by 
column chromatography. It was hypothesised that the tosylate-bearing furan product 
was thermally and/or air sensitive, leading to decomposition. 
      
 
Scheme 78. Reagents: (a) TsCl, pyridine, CH2Cl2, 0	℃, 3 h. 
 
In order to overcome this problem and test the hypothesis, the reaction was repeated, 
and the crude reaction mixture was diluted with THF and immediately treated with 
LiAlH4 at 0	℃. After work-up and careful purification by column chromatography, pure 
dimethyl furan 203 was isolated as a colourless oil in a disappointing yield of 4% 
(Scheme 79). The 1H and 13C NMR spectra both show the furan to be pure after 
purification by column chromatography.  
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Scheme 79. Reagents: (a) TsCl, pyridine, CH2Cl2, 0	℃, 3 h; (b) LiAlH4, THF, 0	℃, 2 h, (4%) 
 
Work was then undertaken to optimise the preparation of dimethyl furan 203 via 
tosylation (Table 10). 
 
 
Scheme 80. Reagents: (a) CH2Cl2; (b) LiAlH4, THF, 0	℃, 2 h 
Entry Reagents (a) Temperature Time Yield of 203 
1 TsCl/pyridine 0	℃ 16 h 11% 
2 TsCl/pyridine r.t. 16 h - 
3 TsCl/ pyridine /DMAP 0	℃ 24 h 17% 
4 TsCl/ TEA 0	℃ 24 h 24% 
5 TsCl/ TEA /DMAP 0	℃ 24 h 30% 
6 MsCl/TEA/DMAP 0	℃ 24 h 28% 
7 Ts2O/ Yb(III)(OTf)3 r.t. 3 h SM 
Table 10. Optimisation of conditions for preparation of 203, all reactions carried out on a 50 mg (0.085 
mmol) scale in CH2Cl2. 
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Initially, prolonging the reaction time from 3 to 16 hours was attempted, and it was 
found to provide positive results with a higher yield (11%) isolated (entry 1, Table 10). 
A subsequent attempt, carried out at room temperature, failed to yield any desired 
products despite the observation that starting materials had been consumed. This 
confirmed the previous suspicion that increasing the temperature had a detrimental 
effect on the yield (entry 2, Table 10). 
In order to enhance the stability of the sulfonate intermediate, mesylate was attempted 
to form instead of tosylate. Treatment of 201 in dicholomethane with methanesulfonyl 
chloride, and triethylamine (TEA) in the presence of a catalytic amount of DMAP, 
followed by a work-up and subsequent reduction with LiAlH4 gave the desired product 
as colourless oil in a disappointing yield of 28% (entry 6, Table 10).  
To avoid the use of TsCl in the tosylation step, another set of conditions were explored. 
The reaction was attempted using the ytterbium-catalysed conditions reported by 
Schirrmacher,93 through the use of p-toluenesulfonic anhydride (Ts2O), and a catalytic 
amount of ytterbium trifluoro-methansulfonate (Yb(III)(OTf)3), with the alcohol 
suspended in dichloromethane. After work-up, the crude product was used immediately 
by reducing with LiAlH4 in THF. Unfortunately, most of the starting material furan 201 
was recovered after purification via column chromatography (entry 7, Table 10).   
The two-step method proved difficult and inefficient in forming the target dimethyl 
furan by tosylation and reduction, but it did give the compound, even in a very 
disappointing yield of 30%. With only two steps remaining to form the final natural 
product, it was then decided to continue to the next step work and resolve this problem 
in the future.    
After treatment of 203 with TBAF in THF, 184 was obtained after the smooth 
deprotection of the terminal silyl ether, with the desired product being obtained in an 
excellent 95% yield, the deprotection of the terminal bulky silyl group proceeded 
smoothly and resulted in excellent yields (95%) (Scheme 81).  
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Scheme 81. Reagents: (a) TBAF, THF, r.t., 3 h, (95%). 
 
With furan 184 in hand, work moved to the oxidation of the primary hydroxyl group to 
the corresponding carboxylic acid. Actually, compound 184 was exactly the same 
substrate used in Knight’s total synthesis of F6, which was oxidised to F6 by using PDC 
(85%) (Scheme 82).73  
 
 
Scheme 82. Reagents: (a) PDC, celite, DMF, r.t., 8 h, 85%.73  
 
Treatment of 184 with PDC in DMF at room temperature on a 15 mg (0.044 mmol) 
scale, to form the desired furan fatty acid 8 was attempted. Unfortunately, signals for 
the desired product were not observed in the 1H and 13C NMR spectra of the crude 
product. Moreover, the starting material was absent in the NMR spectra. 
The reaction was attempted again in the same scale by employing the TPAP/NMO∙H2O 
oxidation conditions. After stirring overnight at room temperature, TLC monitoring 
indicated the formation of a new polar compound. The 13C NMR spectrum of the crude 
product also gave a positive signal by the presence of a peak at 𝛿	179.9 ppm. 
Disappointingly, approximately 90% starting material was recovered after purification 
by column chromatography, with no F-acid obtained.  
As a result of the unsuccessful oxidation of 184 and poor yield of dimethyl furan 203, 
the route to the total synthesis of F-acids was reconsidered. It was really disappointing 
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that two key steps limited the development of the synthetic approach and made it 
completely inefficient. Consequently, the last two steps of initial approach were not 
pursed further due to the lack of success.       
In conclusion, the formal synthesis to F6 ended with the isolation of furan 184 in 10 
steps from commercial cyclododecanone 196 (10% overall yield) (Scheme 83).  
 
 
Scheme 83. Reagents: (a) mCPBA, TFA, CH2Cl2, reflux at dark, 72 h, (87%); (b) DIBAL-H, THF, -
78	℃, 2 h, (82%); (c) TBDPSCl, imidazole, CH2Cl2, r.t., 16 h, (94%); (d) HCCMgBr, THF, 0	℃, 3 h, 
(83%); (e) methyl chloroformate, pyridine, CH2Cl2, 0	℃, 3 h, (81%); (f) 188, Pd2(dba)3∙CHCl3, DPPE, 
THF, 50	℃, 4 h, then HCl, r.t., 1 h, (87%); (g) LiAlH4, THF, 0	℃, 2 h, (92%); (h) TsCl, TEA, DMAP, 
CH2Cl2, 0	℃, 24 h; (i) LiAlH4, THF, 0	℃, 2 h, (30%); (j) TBAF, THF, r.t., 3 h, (95%). 
 
In the course of the initial work towards the synthesis of F6 8, work was also undertaken 
alongside this on the total synthesis towards F4 94. Due to the fact that both F-acids 
have similar structures (Figure 17), the synthesis of F4 underwent the same procedures 
and conditions as outlined above.   
 
 
Figure 17. F-acids F4 and F6. 
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The construction of the furan framework of F4 94 was carried out following a general 
procedure for the preparation of furans above, from commercial ethyl 3-oxohexanoate 
182 and propargylic carbonate 199. Furan 204 was isolated as a yellow oil (93%) after 
purification by column chromatography, subsequent reduction delivered compound 205 
as a pale yellow oil (75%) (Scheme 84).  
 
 
Scheme 84. (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 4 h; (b) HCl, r.t., 1 h, (93%, 2 steps); (c) LiAlH4, 
THF, 0	℃, 2 h, (75%). 
 
 
6.3 Second Synthetic Route of F-acids F4 and F6 
Looking back to the previous synthesis of F-acids metabolite 95 and F6 8, it was found 
that the conversion of the terminal hydroxyl functionality to a carboxylic acid 
functionality is an obvious shortcoming in both synthetic routes. Problems in the step 
became apparent when the oxidations were attempted, such as the instability of the 
furans, low average yields and unpleasant work-up. These negative factors have greatly 
limited the efficiency and versatility of synthesis approaches.         
As outlined in the introduction to chapter 3.6, a literature report by the Knight group 
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proposed a perfect solution to address this problem by using alkene cross metathesis 
with benzyl acrylate and hydrogenation to introduce the terminal carboxylic acid 
functionality (Scheme 85).69 The cross metathesis method was capable of avoiding the 
oxidation step in the synthesis.  
 
 
Scheme 85. (a) benzyl acrylate, Hoveyda-Grubbs MK II, CH2Cl2, reflux, 2 h (87%); (b) H2, Pd/C, 
MeOH, 1h, (91%).69 
 
It was therefore considered in the development of a new retrosynthetic plan for target 
F-acids. With this in mind, the second retrosynthetic plan was developed and followed 
(Scheme 86). 
 
 
Scheme 86. Second retrosynthetic plan for the synthesis of F6. 
 
Unlike the preparation of propargylic carbonate 199, the corresponding aldehyde 
precursor 110 for the required carbonate is commercially available. Treatment of 10-
undecenal 110 with commercial ethynylmagnesium bromide gave an 95% yield of 
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propargylic alcohol 208 as colourless oil. Subsequent esterification with methyl 
chloroformate affored the carbonate 207 in an 87% yield as a pale yellow liquid 
(Scheme 87).  
 
 
Scheme 87. (a) HCCMgBr, THF, 0	℃, 3 h, (95%); (b) methyl chloroformate, pyridine, CH2Cl2, 0	℃, 3 
h, (87%). 
 
Following the same procedures and conditions as before, starting from ester 188 and 
carbonate 207, furan 206 was afforded in an 89% yield as a yellow oil. Subsequent 
reduction of the ester functionality using LiAlH4, gave alcohol 209 in a 90% yield as 
pale yellow oil.    
 
 
Scheme 88. (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 4 h; (b) HCl, r.t., 1 h, (89%, 2 steps); (c) LiAlH4, 
THF, 0	℃, 2 h, (84%). 
 
Originally, formation of dimethyl furan 118 was carried out using the same conditions 
O 8
(110)
8
OH
(208)
8
OCO2Me
(207)
a b
O
O
O
(188)
8
OCO2Me
(207)
+
O4 8
MeO2C
(206)
a,b
O4 8
(209)
HO
c
 89 
employed for the preparation of 203. As expected, an unsatisfactory yield (24%) of the 
dimethyl furan was isolated (Scheme 89). 
 
 
Scheme 89. (a) TsCl, TEA, DMAP, CH2Cl2, 0	℃, 24 h; (b) LiAlH4, THF, 0	℃, 3 h, (24%). 
 
Fortunately, the breakthrough came when the reaction was attempted following the 
procedure published by MaGee et al, via the conversion of the hydroxyl functionality 
to the corresponding iodide; with the desired methyl group being generated after 
reduction with a metal hydride reagent.94 Portionwise addition of iodine to a solution 
of alcohol 209 in the presence of PPh3 and imidazole gave the iodide, which after an 
aqueous work-up followed by reduction by LiAlH4, gave pure 118 was isolated in a 
much more acceptable yield of 85% (Scheme 90).  
 
 
Scheme 90. (a) PPh3, I2, imidazole, CH3CN, Et2O, 0	℃, 1 h; (b) LiAlH4, THF, 0	℃, 4 h, (85%, 2 steps).  
  
With alkene 118 in hand, the final step in the synthesis approach was to introduce the 
carboxylic acid group. By using Knight group’s method,69 the reaction was repeated 
and resulted in an 86% yield (Scheme 91). The required carboxylate group and 
additional carbon atom were introduced to the molecule by treating 118 with benzyl 
acrylate, and a catalytic amount of Hoveyda-Grubbs 2nd generation catalyst in 
dichloromethane at reflux, subsequent hydrogenation to deprotect the carboxylic acid 
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functionality and saturate the olefinic bond gave the natural product F6 as a colourless 
oil.       
 
 
Scheme 91. (a) benzyl acrylate, Hoveyda-Grubbs MK II, CH2Cl2, reflux, 2 h; (b) H2, Pd/C, MeOH, 2h, 
(86%, 2 steps). 
 
Consequently, natural product F6 8 (Figure 18 and 19) was prepared from commercial 
10-undecenal 110 in 7 steps (55% overall yield) 
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Figure 18. 1H NMR of F6 8. 
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Figure 19. 13C NMR of F6 8. 
 93 
Preparation of F4 was carried out under the same conditions as for the preparation of 
F6 (Scheme 92). These reactions proceeded smoothly without any difficult and finally 
provided natural product F4 94 (Figure 20 and 21) as a colourless oil in an overall 
46% yield.  
 
 
Scheme 92. (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50	℃, 4 h; HCl, r.t., 1 h, (82%, 2 steps); (b) LiAlH4, 
THF, 0	℃, 2 h, (78%); (c) PPh3, I2, imidazole, CH3CN, Et2O, 0	℃, 1 h; (d) LiAlH4, THF, 0	℃, 4 h, 
(80%, 2 steps); (e) benzyl acrylate, Hoveyda-Grubbs MK II, CH2Cl2, reflux, 2 h; (f) H2, Pd/C, MeOH, 
2h, (90%, 2 steps), (46% overall yield). 
 
It was found that both F4 and F6 are unstable when exposed to silica gel or air at room 
temperature for a long time during work-up and purification. Hence a rapid processing 
was required, and they were stored at very low temperature under argon atmosphere. 
However, there were some impurities observed in later biological testing.  
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Figure 20. 1H NMR of F4 94. 
 95 
 
Figure 21. 13C NMR of F4 94. 
 96 
6.4 Synthesis of F-acids Modified Analogues 
A range of furans prepared in the Pritchard Group were subjected to biological testing 
to examine their anti-inflammatory activity. Furan 183 was found to exhibit more potent 
anti-inflammatory activity than other furans.  
 
 
Figure 20. Furan 183. 
 
Originally, it was hypothesised that the 𝛽-ester functionality contributes to its anti-
inflammatory activity. Yet other furans containing same 𝛽 -ester group were not 
performing similar anti-inflammatory activity. It was then proposed that the aliphatic 
side chains might have a positive effect to increase its anti-inflammatory activity.   
In order to confirm the hypothesis, F4 and F6 analogues (Figure 21) were required to 
be prepared and subjected to biological testing. Eventually, it was hoped to determine 
which aspects of the chemical structure of F-acids are integral to its anti-inflammatory 
activity, through testing a series of furans formed from each step in the total synthesis 
of 213 and 214. 
 
 
Figure 21. F4 and F6 analogues. 
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Starting from commercial dodecanal 215, propargylic alcohol 216 was obtained as a 
colourless oil in a yield of 91%. The desired carbonate substrate 217 was successful 
formed by esterification, and resulted in a good yield of 83% (Scheme 93).   
 
 
Scheme 93. (a) HCCMgBr, THF, 0℃, 3 h, (91%); (b) methyl chloroformate, pyridine, CH2Cl2, 0℃, 3 
h, (83%). 
 
Preparation of F4 analogue 213 was carried out by using standard procedure from ester 
182 and carbonate 217 (Scheme 94). Due to its non-polar nature, it was very easy to 
purify by column chromatography. Pure 213 was isolated as a colourless oil in an 
overall 55% yield. 
 
 
Scheme 94. (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50℃, 4 h; HCl, r.t., 1 h, (85%, 2 steps); (b) LiAlH4, 
THF, 0℃, 2 h, (80%); (c) PPh3, I2, imidazole, CH3CN, Et2O, 0℃, 1 h; (d) LiAlH4, THF, 0℃, 4 h, (81%, 
2 steps) (55% overall yield). 
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In conclusion, following the same procedure as above, pure 214 was obtained as a 
colourless oil starting from ester 188 and carbonate 217 (44% overall yield) (Scheme 
95). 
 
 
Scheme 95. (a) Pd2(dba)3∙CHCl3, DPPE, THF, 50℃, 4 h; HCl, r.t., 1 h; (b) LiAlH4, THF, 0℃, 2 h, 
(55%, 2 steps); (c) PPH3, I2, imidazole, CH3CN, Et2O, 0℃, 1 h; (d) LiAlH4, THF, 0℃, 4 h, (80%, 2 
steps) (44% overall yield). 
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7.0 Conclusions and Future Work  
The first total synthesis of a natural product, F-acids metabolite 95, has been achieved 
(12 steps, 3.5% overall yield) in this thesis. However, it was found that the final step, 
the conversion of the terminal hydroxyl functionality to a carboxylic acid functionality, 
is an obvious shortcoming in this synthetic route.  
Using palladium catalysed cyclisation methodology, a novel synthetic route has been 
developed and applied to the total syntheses of F-acids F4, F6 and their analogues. It has 
been proved to be a versatile and flexible approach to the chemical synthesis of different 
F-acids.  
Due to the success of this novel synthetic route, a number of different avenues of 
research could be continued in the future.  
The most important aspect of future work associated with this synthetic could be 
focussed on expanding the scope of the novel synthetic approach to form tri-substituted 
F-acids precursor 224 (Scheme 96). The transformation is proposed to be produced by 
an approach involving reduction followed by decarboxylation of the ester group of 223. 
 
 
Scheme 96. Proposed synthesis route to 224. 
 
A variety of important compounds such as fluorinated F-acids and aromatic substituted 
F-acids could also be generated by modifications of the 𝛽-ester functionality of 223 
(Sccheme 97). In term of the ability to enhance the metabolic stability, binding 
selectively, and lipophilicity of F-acids by the presence of the trifluoromethylated 
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moiety,95,96 the formation of fluorinated F-acids is a valuable area to investigate.    
 
 
Scheme 97. Different avenues of future work. 
 
Instead of the reaction of the 𝛽-ester functionality, another area of future work could 
be focussed on the development of novel methodology for the direct preparation of 
fluorinated F-acids (Scheme 98).  
 
 
Scheme 98. Second proposed synthetic plan for the preparation of trifluoromethylated F-acids. 
 
The trifluoromethyl moiety is intended to be introduced by palladium catalysed 
cyclisation of propargylic carbonate 222 and 𝛼-triflluoromethyl ketone 227. Due to the 
high electronegativity of fluorine, and the consequently the powerful electron 
withdrawing nature of the trifluoromethyl group,96 it was proposed to stabilise the 
generation of enolate intermediate 230 and promote the palladium catalysed cyclisation 
process (Scheme 99).   
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Scheme 99. Proposed synthesis of 226. 
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8.0 Experimental  
8.1 General experimental  
Anhydrous conditions were obtained by performing reactions under a nitrogen or argon 
atmosphere in oven-dried or flame-dried glassware.  
All commercially available reagents were used without further purification. The gold 
catalysts and palladium catalysts were obtained from Sigma-Aldrich○R  and were 
handled under argon.  
All the solvents used were obtained commercially except tetrahydrofuran (THF), 
acetonitrile (MeCN) and dichloromethane. THF was freshly distilled as required from 
sodium and benzophenone prior to use, MeCN and dichloromethane were both distilled 
from calcium hydride. Petroleum ether refers to the fractions with a boiling point 
between 40-60	℃.  
1H and 13C NMR spectra were recorded at 400 MHz and 100 MHz respectively using 
either a Bruker Avance 400 MHz NMR spectrometer or a JEOL ECS-400 400 MHz 
NMR spectrometer as solutions in deuterated CDCl3. Coupling constants are measured 
in hertz (Hz) and chemical shifts are quoted as parts per million (ppm). 
High resolution mass spectra were recorded using a Thermo Fisher Exactive mass 
spectrometer, with ESI as the ionisation mode.   
Flash column chromatography was carried out using Apollo Scientific ZEOprep-60 
silica under pressure. The eluent is specified with the applicable methods.  
TLC analysis was performed on pre-coated aluminium backed silica plates and were 
visualised under Ultra Violet light, or with vanillin stain and heating.     
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8.2 Synthetic Procedures 
8.2.1 First Total Synthesis of F-acid metabolite (Chapter 5.0) 
Preparation of (±)-1-((tetrahydro-2H-pyran-2-yl)oxy)propan-2-one97 
 
(9) 
A solution of hydroxyacetone (0.574 g, 7.36 mmol), 3,4-dihydro-2H-pyran (1.243 g, 
14.80 mmol), PPTS (180 mg, 0.74 mmol) and anhydrous CH2Cl2 (20 mL) were stirred 
together at reflux for 20 h. The excess CH2Cl2 was removed by evaporation under 
reduced pressure yielding a yellow liquid. The title compound was isolated by column 
chromatography (10:1, light petroleum: ethyl acetate) yielding a colourless liquid (985 
mg, 6.47 mmol, 88%). νmax(neat) /cm-1: 2927, 2855, 1730, 1428. NMR δH (400 MHz, 
CDCl3): 4.66 (1H, bt, J = 3.6 Hz), 4.27 and 4.13 (2H, ABq, J = 15.6 Hz), 3.85-3.82 (1H, 
m), 3.54-3.51 (1H, m), 2.20 (3H, s), 1.78-1.69 (2H, m), 1.61-1.54 (4H, m). NMR δC 
(100MHz, CDCl3): 206.8, 98.7, 72.3, 62.3, 30.2, 26.5, 25.2, 19.1. HRMS, m/z found 
(159.1015, C8H15O3+ requires 159.1016). Data was in agreement with that reported in 
the literature.97 
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Preparation of 6-heptynoic acid methyl ester41 
 
(136) 
To a stirred solution of 6-heptynoic acid (3.60 g, 28.5 mmol) in CH2Cl2 (30 mL) was 
added methanol (5.2 mL, 114 mmol) and DMAP (0.35 g, 2.9 mmol) at room 
temperature. Then DCC (7.20 g, 34.3 mmol) was added to the reaction mixture at 0℃, 
which was then stirred for 5 min at 0 	℃  and then 3 h at room temperature. The 
precipitated urea was then filtered off and the filtrate evaporated down in vacuo. The 
residue was taken in dichloromethane (30 mL) which was washed with 0.5 M HCl (30 
mL) and then with saturated NaHCO3 solution (30 mL), and dried over MgSO4. The 
organics were concentrated in vacuo to give a light yellow oil which was further 
purified via column chromatography (4:1, light petroleum: ethyl acetate) to isolate the 
title compound as a pale yellow oil (4.04 g, 24.7 mmol, 87%). νmax(neat) /cm-1: 3293, 
2117, 1738, 1149. NMR δH (400 MHz, CDCl3): 3.68 (3H, s), 2.35 (2H, t, J = 7.6 Hz), 
2.24-2.20 (2H, m), 1.96 (1H, t, J = 2.8 Hz), 1.80-1.72 (2H, m), 1.61-1.55 (2H, m). NMR 
δC (100 MHz, CDCl3): 172.8, 82.9, 67.5, 50.5, 32.5, 26.8, 22.9, 17.1. HRMS, m/z found 
(163.0732, C8H12O2Na+ requires 163.0730). Data was in agreement with that reported 
in the literature.41 
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Preparation of 6-heptyn-1-ol98 
 
(145) 
To a stirred solution of 6-heptynoic acid methyl ester (3.32 g, 23.7 mmol) in THF (22 
mL), finely powdered NaBH4 (5.38 g, 142 mmol) was added. The mixture was heated 
at reflux, and then methanol (37 mL) was added dropwise over 15 min to the resulting 
mixture with effervescence being observed. After 3 h at reflux, the resulting mixture 
was cooled to room temperature, quenched with saturated NH4Cl solution (45 mL) and 
stirred for a further period of 1.5 h. The organic layer was separated and the aqueous 
layer phase extracted twice with ethyl acetate (2 × 30 mL). The combined organic 
layers were then dried over MgSO4 and concentrated in vacuo to give the crude product 
as light yellow oil. The residue was purified via column chromatography (4:1, light 
petroleum: ethyl acetate) to afford the alcohol as a colourless oil (2.15 g, 17.7 mmol, 
75%). νmax(neat) /cm-1: 3583, 3298, 2116, 1050. NMR δH (400 MHz, CDCl3): 3.63 (2H, 
t, J = 5.6 Hz), 2.19-2.17 (2H, m), 2.02 (1H, OH), 1.93 (1H, t, J = 1.2 Hz), 1.57-1.47 
(6H, m). NMR δC (100 MHz, CDCl3): 84.4, 68.3, 62.8, 32.2, 28.2, 24.9, 18.4. HRMS, 
m/z found (113.0963, C7H13O+ requires 113.0961). Data was in agreement with that 
reported in the literature.98 
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Preparation of tert-butyl(hept-6-yn-1-yloxy)dimethylsilane99 
 
(146) 
TBSCl (0.746 g, 4.95 mmol) was added portionwise over 1 min to a stirred solution of 
6-heptyn-1-ol (0.400 g, 3.38 mmol) and imidazole (0.674 g, 9.90 mmol) in anhydrous 
CH2Cl2 (20 mL) at 0 ℃ under nitrogen. The resulting mixture was allowed to stir for 
a further 16 h at room temperature. The mixture was then diluted with CH2Cl2 (20 mL) 
and washed with H2O (3 ×  15 mL), brine (15 mL), dried over MgSO4 and 
concentrated in vacuo giving a residue which was then purified by column 
chromatography. Elution with 45:1, light petroleum/ethyl acetate gave the title 
compound as a light yellow liquid (0.621 g, 2.64 mmol, 78%). νmax(neat) /cm-1: 3314, 
2119, 1433, 1361, 1338. NMR δH (400 MHz, CDCl3): 3.63 (2H, t, J = 7.2 Hz), 2.22-
2.19 (2H, m), 1.96 (1H, t, J = 2.8 Hz), 1.60-1.57 (2H, m), 1.57-1.55 (2H, m), 1.55-1.53 
(2H, m), 0.91 (9H, s), 0.07 (6H, s). NMR δC (100 MHz, CDCl3): 83.6, 75.6, 67.1, 62.0, 
31.2, 27.2, 24.6, 24.0, 17.4, 17.3. HRMS, m/z found (227.1814, C13H27O+ requires 
227.1826). Data was in agreement with that reported in the literature.99 
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Preparation of tert-butyl(hept-6-yn-1-yloxy)diphenylsilane100 
 
(148) 
TBDPSCl (1.37 g, 5.00 mmol) was added dropwise over 1 min to a stirred solution of 
6-heptyn-1-ol (0.401 g, 3.39 mmol) and imidazole (0.698 g, 9.99 mmol) in anhydrous 
dichloromethane (25 mL) at 0	℃ under nitrogen. The resulting mixture was allowed to 
stir overnight at room temperature. The mixture was then diluted with dichloromethane 
(25 mL) and washed with H2O (3 × 20 mL), brine (20 mL), dried over MgSO4 and 
concentrated in vacuo giving a residue as a brown oil. The title compound was isolated 
by column chromatography (45:1, light petroleum: ethyl acetate) yielding a yellow 
liquid (1.06 g, 3.02 mmol, 89%). νmax(neat)/cm-1: 3305, 3030, 2118, 1389, 1361, 702. 
NMR δH (400 MHz, CDCl3): 7.69-7.68 (4H, m), 7.45-7.38 (6H, m), 3.69 (2H, t, J = 2.4 
Hz), 2.20-2.19 (2H, m), 1.95 (1H, t, J = 2.8 Hz), 1.60-1.58 (2H, m), 1.56-1.54 (2H, m), 
1.53-1.51 (2H, m), 1.08 (9H, s). NMR δC (100 MHz, CDCl3): 134.5, 133.0, 128.5, 126.5, 
87.0, 67.1, 62.6, 31.0, 27.7, 25.8, 23.9, 18.2, 17.3. HRMS, m/z found (351.2138, 
C23H31OSi+ requires 351.2139). Data was in agreement with that reported in the 
literature.100 
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Preparation of (±)-9-((tert-butyldiphenylsilyl)oxy)-2-methylnon-3-yne-1,2-diol 
 
(149) 
Butyllithium (1.3 mL of a 2.45 M solution in hexanes, 3.25 mmol) was added dropwise 
to a stirred solution of alkynediol (1.08 g, 2.96 mmol) in anhydrous THF (15 mL) at 
0	℃. After 1 h, 1-((tetrahydro-2H-pyran-2-yl)oxy)propan-2-one (0.562 g, 3.55 mmol) 
was slowly added and the resulting mixture stirred for a further 4 h, then quenched by 
the careful addition of water (4 mL). The organic layer was separated and the aqueous 
layer was extracted with ethyl acetate (3 × 10 mL). The combined organics were 
washed with water (10 mL), brine (15 mL), dried over MgSO4 and concentrated in 
vacuo giving a residue as a pale yellow oil. The residue was dissolved in ethanol (28 
mL) containing PPTS (0.086 g, 0.34 mmol) and stirred at 55	℃ for a further 3 h. The 
resulting solution was cooled to room temperature and the solvents evaporated. The 
title compound was isolated by column chromatography (4:1, light petroleum: ethyl 
acetate) yielding a colourless liquid (1.02 g, 2.28 mmol, 77%). νmax(neat) /cm-1: 3583, 
3390, 2242, 1389, 1361, 1110, 702. NMR δH (400 MHz, CDCl3): 7.70-7.68 (4H, m), 
7.45-7.38 (6H, m), 3.68 (2H, t, J = 6.4 Hz), 3.61 (1H, d, J = 10.8 Hz), 3.46 (1H, d, J = 
10.8 Hz), 2.21 (2H, t, J = 7.2 Hz), 1.59-1.57 (2H, m), 1.52-1.50 (2H, m), 1.49-1.48 (2H, 
m), 1.45 (3H, s), 1.08 (9H, s). NMR δC (100 MHz, CDCl3): 135.5, 134.0, 129.5, 127.6, 
85.2, 81.7, 70.9, 68.6, 63.7, 32.0, 28.4, 26.9, 25.6, 25.1, 18.6, 18.3. HRMS, m/z found 
OTBDPSHO
HO
 110 
(447.2326, C26H36OSiNa+ requires 447.2326). 
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Preparation of tert-butyl-[5-(3-iodo-4-methylfuran-2-yl)-pentyloxy]-
diphenylsilane 
 
(150) 
Sodium hydrogen carbonate (0.065 g, 0.47 mmol) was added to dry acetonitrile (0.4 
mL), stirred under dry nitrogen and cooled at 0	℃, followed by the alkynediol 149 
(0.200 g, 0.472 mmol). After stirring for 30 min, solid iodine (0.201 g, 0.778 mmol) 
was added in one portion. The resulting mixture was allowed to stir at 0	℃ for a further 
40 h. At the end of the reaction, aqueous 10% sodium sulfite solution was then added 
dropwise until excess iodine colour was completely discharged. The mixture was 
diluting with ethyl acetate (10 mL). The organic layer was separated and the aqueous 
layer was washed with ethyl acetate (3 × 5 mL). The combined organics were washed 
with H2O (10 mL), brine (10 mL), dried over MgSO4 and concentrated in vacuo to give 
a yellow oil. The title compound was isolated via column chromatography (50:1, light 
petroleum: ethyl acetate) yielding a colourless oil (0.11 g, 0.21 mmol, 45%). νmax(neat) 
/cm-1: 2931, 2858, 1589, 1555, 1462, 1388, 1108, 1022, 908, 733. NMR δH (400 MHz, 
CDCl3): 7.70-7.68 (4H, m), 7.44-7.38 (6H, m), 7.17 (1H, s), 3.67 (2H, t, J = 6.4 Hz), 
2.66 (2H, t, J = 7.2 Hz), 1.94 (3H, s), 1.65-1.63 (2H, m), 1.61-1.59 (2H, m), 1.42-1.41 
(2H, m), 1.07 (9H, s). NMR δC (100 MHz, CDCl3): 156.2, 137.2, 135.6, 134.1, 129.5, 
127.6, 123.3, 69.8, 63.7, 32.2, 27.79, 27.71, 26.8, 25.1, 19.2, 11.3. HRMS, m/z found 
(533.1373, C26H34O2ISi+ requires 533.1367). 
O
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Preparation of ethyl (Z)-3-2[2-(5-methylfuryl)]propenoate66	
 
(156) 
To a solution of triphenylphosphinegold(I) chloride (0.005 g, 0.01 mmol) in 
nitromethane (2 mL), AgOTf (1.0 mL of a 0.01 M solution in nitromethane) was added 
under nitrogen. The mixture was allowed to stir at room temperature for 30 min. 2-
Methyl furan (0.822 g, 10.1 mmol) and ethyl propiolate (0.099 g, 1.01 mmol) were 
added dropwise to the mixture. The resulting mixture was kept stirring at room 
temperature for 4 h. After which, the solvent was removed in vacuo giving a residue 
which was then purified via column chromatography (100:1, light petroleum: ethyl 
acetate) to afford the title compound as a yellow oil (0.091 g, 0.52 mmol, 52%). 
νmax(neat) /cm-1: 1715, 1622, 1522, 1175, 1028, 975, 813. NMR δH (400 MHz, CDCl3):  
7.64 (1H, d, J = 3.6 Hz), 6.74 (1H, d, J = 12.8 Hz), 6.14 (1H, d, J = 0.8 Hz), 5.65 (2H, 
d, J = 12.8 Hz), 4.22 (2H, q, J = 7.2 Hz), 2.34 (3H, s), 1.31 (3H, t, J = 7.2 Hz). NMR δC 
(100 MHz, CDCl3): 165.2, 153.4, 148.5, 130.0, 117.7, 113.0, 108.3, 59.2, 13.3, 13.1. 
HRMS, m/z found (181.0857, C10H13O3+ requires 181.0859). Data was in agreement 
with that reported in the literature.66 
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Preparation of ethyl (E)-3-2[2-(5-methylfuryl)]propenoate101 
  
(154) 
Method 1:  
A mixture of palladium(II) acetate (0.01 g, 0.05 mmol), tert-butyl perbenzoate (0.194 
g, 1.01 mmol), 2- methylfuran (0.082 g, 1.0 mmol) and ethyl acrylate (0.1 g, 1 mmol) 
in acetic acid (5 mL) was heated at 100	℃ for 3 h. After 3 h, the mixture was poured 
into cold water (20 mL), and extracted with ethyl acetate (2 × 10 mL). The combined 
extracts were washed with 10% NaOH solution (15 mL), brine (15 mL), dried over 
MgSO4 and solvent removed in vacuo giving crude product as a brown oil. The title 
compound was isolated by column chromatography (100:1, light petroleum: ethyl 
acetate) yielding a yellow oil (0.098 g, 0.55 mmol, 55%). νmax(neat) /cm-1: 1709, 1637, 
1527, 1159, 1022, 970, 788. NMR δH (400 MHz, CDCl3): 7.36 (1H, d, J = 15.6 Hz), 
6.50 (1H, d, J = 3.2 Hz), 6.23 (1H, d, J = 15.6 Hz), 6.07 (2H, d, J = 3.2 Hz), 4.23 (2H, 
q, J = 7.2 Hz), 2.33 (3H, s), 1.32 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 167.3, 
155.3, 149.5, 131.0, 116.3, 113.9, 108.7, 60.2, 14.6, 14.3. HRMS, m/z found (181.0848, 
C10H13O3+ requires 181.0859). Data was in agreement with that reported in the 
literature.101 
Method 2:  
O
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Ethyl (Z)-3-2[2-(5-methylfuryl)]propenoate (0.020 g, 0.12mmol) was dissolved in 
deuterated chloroform (0.7 mL) in a NMR tube, one small crystal of iodine was added 
to the NMR tube. The progress of the reaction was monitored by 1H NMR spectroscopy. 
After 5 h, the conversion was completed. Data as above. 
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Preparation of 3(Z)-{5-[5-(tert-butyldiphenylsilanyloxy)-pentyl]-4-iodo-3-
methylfuran-2-yl}-acrylic acid ethyl ester 
  
(158) 
Method 1:  
Triphenylphosphinegold(I) chloride (0.002 g, 0.004 mmol) was weighed into a flame 
dried flask, the flask was then evacuated for several minutes and charged with argon. 
Nitromethane (1.2 mL) and AgOTf (0.4 mL of a 0.01 M solution in nitromethane) were 
added dropwise to the flask and stirred at room temperature for 30 min. After iodofuran 
150 (0.100 g, 0.19 mmol) and ethyl propiolate (0.021 g, 0.19 mmol) were added and 
the mixture was allowed to stir at room temperature for a further 24 h. After which, the 
solvent was removed in vacuo giving a residue which was then purified via column 
chromatography (100:1, light petroleum: ethyl acetate) to afford the title compound as 
a yellow oil (0.015 g, 0.025 mmol, 13%). νmax(neat) /cm-1: 3070, 3049, 2930, 2857, 
1707, 1633, 701. NMR δH (400 MHz, CDCl3): 7.69-7.67 (4H, m), 7.44-7.38 (6H, m) , 
6.52 (1H, d, J = 12.8 Hz), 5.71 (1H, d, J = 12.8 Hz), 4.25 (2H, q, J = 7.2 Hz), 3.68 (2H, 
t, J = 6.4 Hz), 2.69 (2H, t, J = 7.2 Hz), 2.02 (3H, s), 1.69-1.60 (4H, m), 1.45-1.43 (2H, 
m), 1.34 (3H, t, J = 7.2 Hz), 1.06 (9H, s). NMR δC (100 MHz, CDCl3): 166.8, 157.6, 
145.0, 135.5, 134.0, 129.5, 127.9, 127.6, 123.4, 114.8, 71.9, 63.7, 60.4, 32.2, 30.3, 27.6, 
26.8, 25.2, 19.2, 14.2, 12.4. HRMS, m/z found (653.1550, C31H39O4INaSi+ requires 
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653.1555). 
Method 2:  
To a stirred solution of (acetonitrile)[(2-biphenyl)di-tert-butylphosphine]gold(I) 
hexafluoroantimonate (0.01 g, 0.005 mmol) in nitromethane (2.5 mL) was added ethyl 
propiolate (0.750 g, 7.65 mmol) under argon. The mixture was stirred for 10 min then 
added iodofuran 150 (0.250 g, 0.476 mmol) and continued stirring for 20 h. The solvent 
was removed in vacuo to yield a brown oil and purified through column 
chromatography (95:1, light petroleum: ethyl acetate) to obtain the title compound as a 
yellow oil (0.172 g, 0.300 mmol, 58%). Data as above. 
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Preparation of 3(E)-{5-[5-(tert-butyldiphenylsilanyloxy)pentyl]-4-iodo-3-
methylfuran-2-yl}-acrylic acid ethyl ester 
  
(157) 
To a solution of tetrasubstituted furan 158 (0.098 g, 0.15 mmol) in dichloromethane (10 
mL) in a flask surrounded with aluminium foil. A solution of I2 (0.1 mL of a 0.04 M 
solution in CH2Cl2) was added dropwise to the solution. After 5 h, aqueous 10% sodium 
sulphite (0.5 mL) was then added dropwise until excess iodine colour was completely 
discharged. The organic layer was separated and the aqueous layer was washed with 
ethyl acetate (3 × 5 mL). The combined organics were washed with H2O (15 mL), brine 
(15 mL), dried over MgSO4 and concentrated in vacuo to yield the title compound as a 
yellow oil (0.097 g, 0.16 mmol, 99%). νmax(neat) /cm-1: 3070, 3049, 2930, 2857, 1707, 
1633, 701. NMR δH (400 MHz, CDCl3): 7.69-7.67 (4H, m), 7.47-7.38 (7H, m), 6.21 
(1H, d, J = 15.6 Hz), 4.26 (2H, q, J = 7.2 Hz), 3.68 (2H, t, J = 6.4 Hz), 2.70 (2H, t, J = 
7.2 Hz), 2.08 (3H, s), 1.69-1.60 (4H, m), 1.45-1.43 (2H, m), 1.34 (3H, t, J = 7.2 Hz), 
1.06 (9H, s). NMR δC (100 MHz, CDCl3): 167.4, 158.5, 145.8, 135.5, 134.0, 129.5, 
128.9, 128.8, 127.6, 113.6, 72.6, 63.6, 60.3, 32.1, 28.0, 27.5, 26.8, 25.2, 19.2, 14.3, 12.0. 
HRMS, m/z found (653.1545, C31H39O4INaSi+ requires 653.1555). 
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Preparation of tert-butyl((5-(3,4-dimethylfuran-2-yl)pentyl)oxy)diphenylsilane 
  
(161) 
Method 1: 
Potassium carbonate (0.036 g, 0.20 mmol), trimethylboroxine (0.027 g, 0.12 mmol), 
iodofuran 150 (0.047 g, 0.089 mmol), Pd(PPh3)4 (0.010 g, 0.090 mmol) and 10% aq. 
1,4-dioxane (0.5 mL) were charged to a flask and the contents heated to 105	℃ under 
nitrogen for 28 h. The reaction mixture was filtered through a pad of Celite®, washed 
with THF and concentrated in vacuo. The residue was purified via column 
chromatography (100:1, light petroleum: ethyl acetate) to afford the title compound as 
a colourless oil (0.019 g, 0.045 mmol, 52%). νmax(neat) /cm-1: 1642, 1472, 1428, 1383, 
1110, 908, 735. NMR δH (400 MHz, CDCl3): 7.66-7.64 (4H, m), 7.46-7.38 (6H, m), 
7.07 (1H, s,), 3.63 (2H, t, J = 6.4 Hz), 2.52 (2H, t, J = 7.2Hz), 1.90 (3H, s), 1.84 (3H, 
s), 1.59-1.52 (4H, m), 1.41-1.31 (2H, m), 1.00 (9H, s). NMR δC (100 MHz, CDCl3): 
151.3, 136.3, 135.6, 134.2, 129.5, 127.6, 120.9, 115.5, 63.3, 32.4, 28.3, 26.9, 26.2, 25.4, 
19.2, 8.4, 8.0. HRMS, m/z found (421.2584, C27H37O2Si+ requires 421.2557). 
Method 2: 
A solution of iodofuran 150 (0.050 g, 0.095 mmol) dissolved in THF (2 mL) was cooled 
to -78 °C and stirred for 10 min. nBuLi (0.1 mL of a 1 M solution in THF, 0.1 mmol) 
O
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was added dropwise and stirred for 10 min before iodomethane (0.020 g, 0.14 mmol) 
was added in one portion. The resulting mixture was allowed to stir for a further 10 min 
before warming to room temperature and stirring for an additional 10 min. The reaction 
mixture was quenched by the addition of aqueous ammonium chloride (2 mL). THF 
was removed under reduced pressure and the product extracted with diethyl ether (3 × 
5 mL). The combined organic extracts were dried, filtered and evaporated and the 
product purified by column chromatography (100:1, light petroleum: ethyl acetate) to 
yield the title compound as a colourless oil (0.026 g, 0.063, 67%). Data as above. 
Method 3: 
A solution of iodofuran 150 (0.51 g, 0.97 mmol) in THF (3.2 mL) was cooled to -78	℃. 
Methyl lithium (2.3 mL of a 1.4 M solution in diethyl ether complex with LiBr, 3.2 
mmol) was added dropwise to the stirred solution and stirred for 3 h. Then the resulting 
mixture was allowed to warm to room temperature and stir for a further 1 h. The 
reaction mixture was quenched by the addition of aqueous ammonium chloride (2 mL). 
THF was carefully removed under reduced pressure and the residue extracted into ethyl 
acetate (3 × 5 mL). The combined organics were dried over MgSO4, filtered and 
evaporated. The residue was purified via column chromatography (l00:1, light 
petroleum: ethyl acetate) to afford the dimethyl furan as a colourless oil (0.358 g, 0.854 
mmol, 88%). Data as above. 
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Preparation of (E)-ethyl-3-(5-(5-((tert-butyldiphenylsilyl)oxy)pentyl)-3,4-
dimethylfuran-2-yl)acrylate 
  
(160) 
Method 1: 
Potassium carbonate (0.018 g, 0.13 mmol), trimethylboroxine (0.011 g, 0.091 mmol), 
iodofuran 157 (0.028 g, 0.045mmol), Pd(PPh3)4 (0.005 g, 0.004 mmol) and 10% aq. 
1,4-dioxane (0.2 mL) were charged to a flask and the contents heated to 105	℃ under 
nitrogen for 28 hours. The reaction mixture was filtered through a pad of Celite®, 
washed with THF and concentrated in vacuo. The residue was purified via column 
chromatography (l10:1, light petroleum: ethyl acetate) to afford the title compound as 
a pale yellow oil (0.002 g, 0.004 mmol, 9%). νmax(neat) /cm-1: 3434, 3055, 2987, 2685, 
1637, 1265, 734. NMR δH (400 MHz, CDCl3): 7.65-7.63 (4H, m), 7.43-7.34 (7H, m), 
6.13 (1H, d, J = 15.6 Hz), 4.20 (2H, q, J = 7.2 Hz), 3.63 (2H, t, J = 8.4 Hz), 2.53 (2H, 
t, J = 7.2 Hz), 2.01 (3H, s), 1.84 (3H, s), 1.62-1.53 (4H, m), 1.41-1.31 (2H, m), 1.29 
(3H, t, J = 7.2 Hz), 1.02 (9H, s). NMR δC (100 MHz, CDCl3): 168.0, 154.4, 144.8, 135.6, 
134.1, 129.5, 129.3, 127.7, 127.6, 117.7, 111.6, 63.8, 60.1, 32.3, 28.0, 26.9, 26.4, 25.5, 
19.2, 14.4, 8.9, 8.1. HRMS, m/z found (519.2915, C32H42O4Si+ requires 519.2925). 
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Method 2: 
Dimethyl furan 161 (0.330 g, 0.797 mmol), Au(MeCN)SbF6 (0.017 g, 0.024 mmol) and 
nitromethane (0.8 mL) were added to a flask. The flask was charged with argon for 
several minutes. Ethyl propiolate (0.392 g, 4.00 mmol) was added dropwise to the 
stirred solution during 10 min. The mixture was stirred for a further 64 h at room 
temperature under argon. After this period, the solvent was removed in vacuo to yield 
a brown oil and purified via column chromatography (95:1, light petroleum: ethyl 
acetate) to yield a crude oil (0.291 g, 0.678 mmol, 85%). The mixture was then 
dissolved in CH2Cl2 (9 mL) in a flask surrounded with aluminium foil. I2 (0.1 mL of a 
0.04 M solution in CH2Cl2) was added dropwise to the solution. After 5 h, aqueous 10% 
sodium sulphite (0.4 mL) was added dropwise until excess iodine colour was 
completely discharged. The organic layer was separated and the aqueous layer was 
washed with ethyl acetate (3 × 5 mL), the combined organics were then washed with 
H2O (15 mL), brine (15 mL), dried over MgSO4 and concentrated in vacuo yielding the 
title compound as a pale yellow oil (0.291 g, 0.677 mmol, 80%). Data as above. 
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Preparation of (E)-ethyl 3-(5-(5-hydroxypentyl)-3,4-dimethylfuran-2-yl)acrylate 
  
(162) 
To a solution of silyl ester 160 (0.085 g, 0.17 mmol) in THF (3 mL) was slowly added 
TBAF (0.33 mL of a 1 M solution in THF, 0.33 mmol) at 0	℃. After 5 min stirring, the 
resultant mixture was warmed to room temperature and left to stir for a further 4 h. 
After this period, the mixture was diluted with ethyl acetate (10 mL) and washed with 
brine (2 × 10 mL), dried with MgSO4, filtered and the solvent removed under reduced 
pressure yielding a yellow oil. The mixture was purified by column chromatography 
(1:1 light petroleum: ethyl acetate) yielding the title compound as a colourless oil (0.046 
g, 0.17 mmol, 99%). νmax(neat) /cm-1: 3431, 2977, 2685, 1702, 1604. NMR δH (400 
MHz, CDCl3): 7.40 (1H, d, J = 15.6 Hz), 6.12 (1H, d, J = 15.6 Hz), 4.19 (2H, q, J = 7.2 
Hz), 3.62 (2H, t, J = 8.4 Hz), 2.55 (2H, t, J = 7.2 Hz), 2.00 (3H, s), 1.84 (3H, s), 1.68-
1.53 (4H, m), 1.44-1.34 (2H, m), 1.31 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 
168.0, 154.2, 144.8, 129.3, 127.8, 117.7, 111.6, 62.8, 60.2, 32.5, 28.0, 26.3, 25.4, 14.4, 
8.9, 8.1. HRMS, m/z found (281.1743, C16H25O4+ requires 281.1747; 303.1562, 
C16H24O4Na+ requires 303.1567). 
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Preparation of (E)-5-(5-(3-ethoxy-3-oxoprop-1-en-1-yl)-3,4-dimethylfuran-2-
yl)pentanoic acid 
 
(163) 
To a solution of alcohol 162 (0.042 g, 0.15 mmol) and NMO.H2O (0.208 g, 1.50 mmol) 
in acetonitrile (0.6 mL) was added TPAP (0.005g, 0.02 mmol) at 0	℃. After stirring for 
5 min, the resultant mixture was warmed to room temperature and then allowed to stir 
a further 4 h. The reaction mixture was diluted with ethyl acetate (5 mL) and washed 
with distilled water (5 mL). The aqueous layer was further extracted with ethyl acetate 
(3 × 5 mL). The combined organic layers were washed with brine (15 mL), dried with 
MgSO4, filtered and the solvent removed under reduced pressure yielding a crude oil. 
The mixture purified via column chromatography (8:2, 7:3, 6:4, 1:1, light petroleum: 
ethyl acetate) yielding the title compound as a yellow oil (0.022 g, 0.074 mmol, 50%). 
νmax(neat) /cm-1: 3583, 3054, 2986, 2685, 1708, 1637, 1605, 1265. NMR δH (400 MHz, 
CDCl3): 7.40 (1H, d, J = 15.6 Hz), 6.12 (1H, d, J = 15.6 Hz), 4.20 (2H, q, J = 7.2 Hz), 
2.57-2.55 (2H, m), 2.37-2.36 (2H, m), 2.00 (3H, s), 1.84 (3H, s), 1.66-1.64 (4H, m), 
1.30 (3H, t, J=3.6 Hz). NMR δC (100 MHz, CDCl3): 178.7, 168.0, 153.6, 144.9, 129.3, 
127.7, 117.9, 111.8, 60.2, 33.6, 27.6, 26.0, 24.2, 14.4, 8.9, 8.1. HRMS, m/z found 
(295.1537, C16H23O5+ requires 295.1540). 
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Preparation of (E)-5-(5-(2-carboxyvinyl)-3,4-dimethylfuran-2-yl)pentanoic acid 
  
(95) 
To a solution of furan acid ester 163 (0.014 g, 0.048 mmol) in THF: methanol: water 
(1.4 mL, 2:2:1) was added LiOH (0.004 g, 0.2 mmol) and the resultant mixture stirred 
at room temperature for 32 h. After this period the reaction was diluted with ethyl 
acetate (5 mL) and washed with hydrochloric acid (1 M; 5 mL). The aqueous layer was 
further extracted with ethyl acetate (5 mL). The combined organic layers were washed 
with brine (10 mL), dried over MgSO4, filtered and the solvent removed under reduced 
pressure yielding the crude acid as yellow oil. The mixture was then purified via column 
chromatography (1:1, light petroleum: ethyl acetate) yielding the title compound as a 
white solid (0.005 g, 0.02 mmol, 40%). νmax(neat) /cm-1: 3583, 3400, 3054, 2987, 1603, 
1265. NMR δH (400 MHz, CDCl3): 7.41 (1H, d, J = 15.2 Hz), 6.12 (1H, d, J = 15.2 Hz), 
2.56-2.58 (2H, m), 2.38-2.37 (2H, m), 2.01 (3H, s), 1.85 (3H, s), 1.67-1.65 (4H, m). 
NMR δC (100 MHz, CDCl3): 177.4, 168.4, 153.7, 144.9, 129.5, 127.9, 118.0, 111.3, 
33.3, 27.6, 26.0, 24.2, 8.9, 8.1. HRMS, m/z found (267.1201, C14H19O5+ requires 
267.1227; 289.1043, C14H18O5Na+ requires 289.1046). 
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8.2.2 Pd-Catalysed Cyclisation to Furans (Chapter 6.1) 
Preparation of (±)-oct-1-yn-3-ol102 
  
(179) 
To a solution of ethynylmagnesium bromide (7.8 mL, 3.9 mmol, 0.5 M in THF) was 
added hexanal (0.3 g, 3.0 mmol) at 0	℃. Then the resulting mixture was allowed to stir 
at room temperature for 3.5 h. The reaction mixture was quenched with saturated aq. 
NH4Cl (10 mL), extracted with diethyl ether (3 × 10 mL). The combined organics 
were washed with brine (30 mL), dried over MgSO4, filtered and the solvent removed 
by evaporation under reduced pressure. The residue was purified by column 
chromatography on silica gel (20:1, pentane: ethyl acetate) to afford propargylic alcohol 
179 as a colourless oil (0.336 g, 2.67 mmol, 89%). νmax(neat) /cm-1: 3583, 3309, 2930, 
2861, 2249. NMR δH (400 MHz, CDCl3): 4.35 (1H, d, J = 4.8 Hz), 2.44 (1H, d, J = 2.0 
Hz), 2.02 (1 H, OH), 1.72-1.67 (2H, m), 1.47-1.40 (2H, m), 1.33-1.27 (4H, m), 0.87 
(3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 85.1, 72.8, 62.4, 37.6, 31.4, 24.7, 22.6, 
14.2. HRMS, m/z found (127.1116, C8H15O+ requires 127.1115). Data was in agreement 
with that reported in the literature.102 
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Preparation of (±)-benzyl (1-phenylprop-2-yn-1-yl) carbonate90 
 
(169) 
To a stirred solution of 1-phenyl-2-propyn-1-ol (0.520 g, 3.95 mmol) and pyridine (2.5 
mL, 32 mmol) in dichloromethane (50 mL) was added dropwise benzyl chloroformate 
(2.0 g, 12 mmol) at 0	℃, and stirring was continued for 2.5 h at the same temperature. 
The reaction mixture was diluted with saturated aq NH4Cl (30 mL) and extracted with 
ethyl acetate (3 × 50 mL). The combined organics were washed with brine (100 mL), 
dried over MgSO4 and the solvent removed by reduced pressure. The title compound 
was isolated by column chromatography (19:1, light petroleum: ethyl acetate) yielding 
a colourless liquid (0.841 g, 3.16 mmol, 80%). νmax(neat) /cm-1: 3289, 3090, 3066, 3035, 
2127, 1748, 1650. NMR δH (400 MHz, CDCl3): 7.57-7.24 (10H, m), 6.31 (1H, d, J = 
2.0 Hz), 5.21 (1H, d, J =11.6 Hz), 5.18 (1H, d, J = 11.6 Hz), 2.73 (1H, d, J = 2.0 Hz). 
NMR δC (100 MHz, CDCl3): 154.2, 135.8, 134.9, 129.4, 128.8, 128.7, 128.4, 128.4, 
127.8, 79.6, 76.6, 70.2, 69.5. HRMS, m/z found (289.0829, C17H14O3Na+ requires 
289.0835). Data was in agreement with that reported in the literature.90 
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Preparation of (±)-methyl (1-phenylprop-2-yn-1-yl) carbonate103 
 
(176) 
Using the general procedure from 1-phenyl-2-propyn-1-ol (0.270 g, 2.05 mmol), the 
title compound was isolated by column chromatography (25:1, hexane: ethyl acetate) 
yielding a colourless liquid (0.331 g, 1.74 mmol, 85%). νmax(neat) /cm-1: 3303, 3036, 
2255, 1747, 1322, 1257. NMR δH (400 MHz, CDCl3): 7.55-7.53 (2H, m), 7.40-7.36 
(3H, m), 6.28 (1H, d, J = 2.0 Hz), 3.80 (3H, s), 2.71 (1H, d, J = 2.4 Hz). NMR δC (100 
MHz, CDCl3): 154.9, 135.8, 129.4, 128.8, 127.7, 79.6, 76.7, 76.5, 55.2. HRMS, m/z 
found (191.0701, C11H11O3+ requires 191.0703). Data was in agreement with that 
reported in the literature. 
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Preparation of (±)-methyl oct-1-yn-3-yl carbonate104 
  
(180) 
Followed general procedure from oct-1-yn-3-ol 179 (0.352 g, 2.79 mmol), the title 
compound was isolated by column chromatography (25:1, hexane: ethyl acetate) 
yielding a colourless liquid (0.418 g, 2.46 mmol, 88%). νmax(neat) /cm-1: 3295, 2957, 
2937, 2862, 2124, 1752, 1443. NMR δH (400 MHz, CDCl3): 5.18 (1H, td, J = 4.8 Hz 
and 2.4 Hz), 3.79 (3H, s), 2.50 (1H, d, J = 2.4 Hz), 1.83-1.77 (2H, m), 1.55-1.27 (6H, 
m), 0.88 (3H, t, J = 6.8 Hz). NMR δC (100 MHz, CDCl3): 155.5, 80.6, 77.4, 76.2, 55.05, 
34.6, 31.2, 24.5, 22.5, 14.02. HRMS, m/z found (185.1171, C10H17O3+ requires 
185.1172). Data was in agreement with that reported in the literature. 
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Preparation of methyl 2,4-dimethyl-5-phenylfuran-3-carboxylate56 
 
(174) 
To a stirred solution of methyl (1-phenylprop-2-yn-1-yl) carbonate 176 (0.474 g, 1.78 
mmol) in THF (10 mL) were added methyl acetoacetate (0.196 g, 1.69 mmol), 
Pd2(dba)3∙CHCl3 (0.087 g, 0.084 mmol) and DPPE (0.067 g, 0.17 mmol) at room 
temperature, and stirring was continued for 3 h at 50	℃ under argon atmosphere. The 
reaction mixture was then added 1M HCl (2 mL), and further stirring was continued for 
2 h at room temperature. After filtration of the reaction mixture using small amount of 
silica gel followed by concentration, the residue was chromatographed on silica gel (9:1, 
light petroleum: ethyl acetate) to give the title compound a yellow oil (0.341 g, 1.44 
mmol, 85%). νmax(neat) /cm-1: 2955, 1740, 1441. NMR δH (400 MHz, CDCl3): 7.58-
7.56 (2H, m), 7.42-7.24 (3H, m), 3.84 (3H, s), 2.59 (3H, s), 2.38 (3H, s). NMR δC (100 
MHz, CDCl3): 165.3, 158.3, 147.8, 131.0, 128.5, 128.4, 127.2, 126.1, 116.9, 115.2, 51.1, 
14.5, 10.9. HRMS, m/z found (231.1014, C14H15O3+ requires 231.1016). Data was in 
agreement with that reported in the literature. 
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Preparation of 1-(2,4-dimethyl-5-phenylfuran-3-yl)ethan-1-one56 
 
(178) 
Starting from propargylic carbonate 176 (0.074 g, 0.28 mmol) and acetylacetone (0.028 
g, 0.28 mmol) in THF (2 mL), the above procedure led to the title compound as a yellow 
oil (0.049 g, 0.23 mmol, 81%). νmax(neat) /cm-1: 3058, 2962, 1955, 1666, 1072, 765. 
NMR δH (400 MHz, CDCl3): 7.60-7.54 (2H, m), 7.43-7.27 (3H, m), 2.61 (3H, s), 2.47 
(3H, s), 2.38 (3H, s). NMR δC (100 MHz, CDCl3): 195.2, 157.3, 148.0, 130.7, 129.0, 
128.6, 127.4, 124.5, 116.2, 31.1, 15.4, 11.5. HRMS, m/z found (215.1063, C14H15O2+ 
requires 215.1067). Data was in agreement with that reported in the literature. 
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Preparation of methyl 2,4-dimethyl-5-pentylfuran-3-carboxylate 
 
(181) 
Followed general procedure of from methyl oct-1-yn-3-yl carbonate 180 (0.10 g, 0.54 
mmol) and methyl acetoacetate (0.063 g, 0.54 mmol), the title compound was isolated 
by column chromatography (19:1, hexane: ethyl acetate) yielding a pale yellow oil 
(0.098 g, 0.44 mmol, 81%). νmax(neat) /cm-1: 2954, 2859, 1749, 1583, 1090. NMR δH 
(400 MHz, CDCl3): 3.78 (3H, s), 2.48 (2H, t, J = 8.0 Hz), 2.04 (3H, s), 1.56-1.52 (2H, 
m), 1.29-1.23 (4H, m), 0.86 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 165.8, 
157.5, 150.1, 114.4, 113.8, 51.0, 31.3, 28.2, 25.5, 22.4, 14.3, 14.1, 9.9. HRMS, m/z 
found (225.1484, C13H21O3+ requires 225.1485). 
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Preparation of ethyl 4-methyl-5-pentyl-2-propylfuran-3-carboxylate 
 
(183) 
Followed general procedure from methyl oct-1-yn-3-yl carbonate 180 (0.092 g, 0.50 
mmol) and ethyl 3-oxohexanoate 182 (0.079 g, 0.50 mmol), the title compound was 
isolated by column chromatography (19:1, hexane: ethyl acetate) yielding a pale yellow 
oil (0.116 g, 0.435 mmol, 87%). νmax(neat) /cm-1: 2960, 2862, 1712, 1576, 1080. NMR 
δH (400 MHz, CDCl3): 4.24 (2H, q, J = 7.2 Hz), 2.86 (2H, t, J = 7.6 Hz), 2.48 (2H, t, J 
= 7.6 Hz), 2.04 (3H, s), 1.65-1.63 (2H, m), 1.60-1.54 (2H, m), 1.31 (3H, t, J = 7.2 Hz), 
1.30-1.25 (4H, m), 0.92 (3H, t, J = 7.2 Hz), 0.85 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, 
CDCl3): 165.1, 161.2, 150.0, 114.3, 113.3, 59.6, 31.2, 30.6, 28.2, 25.5, 22.4, 21.7, 14.3, 
14.0, 13.8, 9.9. HRMS, m/z found (267.1952, C16H27O3+ requires 267.1955). 
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Preparation of methyl 3-oxooctanoate90 
 
(188) 
Hexanoyl chloride (1.6 g, 12 mmol) was added dropwise to a solution of Meldrum’s 
acid (1.4 g, 10 mmol) and pyridine (1.6 mL, 20 mmol) in dichloromethane (20 mL) at 
0	℃. The mixture was then allowed to warm to room temperature and left stirring for 1 
h. The mixture was washed with 1 M HCl, followed by H2O (20 mL). The organic 
extract was dried over MgSO4, filtered, and the solvent removed by evaporation under 
reduced pressure. The residue was refluxed in methanol (30 mL) under nitrogen for 2 
h. The solution was cooled to room temperature and the solvent removed under reduced 
pressure to give the crude product as a brown oil. The title compound was isolated by 
column chromatography (9:1, light petroleum: ethyl acetate) yielding a colourless 
liquid (1.60 g, 9.32 mmol, 93%). νmax(neat) /cm-1: 2956, 2933, 1748, 1716, 1651, 1241. 
NMR δH (400 MHz, CDCl3): 3.76 (3H, s), 3.47 (2H, s), 2.55 (2H, t, J = 7.2 Hz), 1.65-
1.57 (2H, m), 1.36-1.25 (4H, m), 0.91 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 
202.9, 167.7, 52.3, 49.0, 43.0, 31.1, 23.1, 22.4, 13.9. HRMS, m/z found (173.1175, 
C9H17O3+ requires 173.1172; 195.0989, C9H16O3Na+ requires 195.0992). Data was in 
agreement with that reported in the literature.90 
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8.2.3 Initial Synthetic Route to F-acids F4 and F6 (Chapter 6.2) 
Preparation of oxacyclotridecan-2-one95 
 
(195) 
Cyclododecanone (3.30 g, 16.5 mmol), trifluoroacetic acid (1.39 mL) and m-CPBA 
(7.67 g, 44.0 mmol) were mixed in dichloromethane (38 mL). The suspension was 
heated under reflux in the dark for 72 h. After cooling to room temperature, a saturated 
solution of Na2CO3 (100 mL) was added to the reaction mixture and the aqueous layer 
was extracted with ethyl acetate (3 × 50 mL). The combined organics were washed 
with brine, dried over MgSO4 and concentrated in vacuo to give the crude product as 
light yellow oil. The residue was purified via column chromatography (19:1, light 
petroleum: ethyl acetate) to afford the lactone 195 as a colourless oil (2.774 g, 14.01 
mmol, 85%). νmax(neat) /cm-1: 2931, 2862, 2677, 1735, 1458. NMR δH (400 MHz, 
CDCl3): 4.19-4.16 (2H, m), 2.39-2.36 (2H, m), 1.73-1.65 (4H, m), 1.47-1.44 (2H, m), 
1.36-1.33 (12H, m). NMR δC (100 MHz, CDCl3): 174.2, 64.6, 34.7, 27.4, 26.6, 26.4, 
26.3, 25.3, 24.9, 24.59, 24.52, 24.1. HRMS, m/z found (199.1692, C12H23O2+ requires 
199.1693). Data was in agreement with that reported in the literature.95 
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Preparation of 12-hydroxydodecanal105 
 
(194) 
Diisobutylaluminium hydride (2.24 mL, 2.24 mmol, 1 M solution in THF) was added 
dropwise to a solution of the lactone 195 (0.400 g, 2.02 mmol) in dichloromethane (10 
mL) at -78 ℃. After stirring at -78	℃ for 2 h, methanol (2.8 mL) was added and the 
mixture poured into 0.5 M HCl (50 mL). After stirring at room temperature for a further 
1 h, the organic phrase was separated. The aqueous layer was extracted with 
dichloromethane (3 × 15 mL), and the combined organics were washed with brine, 
dried over MgSO4 and evaporated. The crude material was purified by column 
chromatography (3:2, dichloromethane: ethyl acetate) to afford the title compound as a 
white solid (0.332 mg, 1.66 mmol, 82%). mp: 76-79	℃. νmax(neat) /cm-1: 3425, 3155, 
2924, 1797, 1465. NMR δH (400 MHz, CDCl3): 9.78 (1H, t, J = 2.0 Hz), 3.66 (2H, t, J 
= 6.8 Hz), 2.46-2.42 (2H, m), 1.68-1.58 (4H, m), 1.55-1.53 (2H, m), 1.50-1.30 (12H, 
m). NMR δC (100 MHz, CDCl3): 203.1, 63.1, 43.3, 32.8, 29.5, 29.48, 29.41, 29.3, 29.1, 
25.7, 23.2, 22.0. HRMS, m/z found (201.1848, C12H25O2+ requires 201.1849). Data was 
in agreement with that reported in the literature.105 
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Preparation of 12-((tert-butyldiphenylsilyl)oxy)dodecanal 
 
(197) 
A cooled (0	℃) solution of 12-hydroxydodecanal (1.8 g, 9.0 mmol), TBDPSCl (3.70 g, 
13.5 mmol) and imidazole (1.84 g, 27.0 mmol) in dichloromethane (27 mL) was stirred 
for 16 h. Water (15 mL) was added to the mixture, which was extracted with 
dichloromethane (3 × 20 mL). The combined organic extracts were washed with brine, 
dried over MgSO4 and concentrated in vacuo giving a residue as a brown oil. The title 
compound was isolated by column chromatography (19:1, light petroleum: ethyl 
acetate) yielding a yellow liquid (3.71 g, 8.46 mmol, 94%). νmax(neat) /cm-1: 3070, 2931, 
2854, 2708, 1712, 1589. NMR δH (400 MHz, CDCl3): 9.78 (1H, t, J = 2.0 Hz), 7.70-
7.68 (4H, m), 7.44-7.37 (6H, m), 3.67 (2H, t, J = 6.4 Hz), 2.39-2.35 (2H, m), 1.65-1.55 
(4H, m), 1.36-1.27 (14H, m), 1.06 (9H, s). NMR δC (100 MHz, CDCl3): 203.1, 135.6, 
134.1, 129.4, 127.8, 64.0, 43.9, 33.8, 32.5, 29.58, 29.52, 29.4, 29.3, 29.3, 29.1, 29.0, 
26.8, 25.7. HRMS, m/z found (439.3021, C28H43O2Si+ requires 439.3027). 
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Preparation of (±)-14-((tert-butyldiphenylsilyl)oxy)tetradec-1-yn-3-ol 
 
(198) 
Ethynylmagnesium bromide (3.6 mL, 1.8 mmol, 0.5 M in THF) was added to a solution 
of aldehyde 197 (0.610 g, 1.39 mmol) in THF (3 mL) at 0	℃. The reaction was allowed 
to warm to room temperature and stirred for 3 h. After addition of saturated aq. NH4Cl 
(10 mL), the organic phrase was separated and the aqueous phrase was washed with 
diethyl ether (3 × 10 mL). The combined organics were washed with brine, dried over 
MgSO4, filtered and the solvent removed under reduced pressure. The residue was then 
purified via column chromatography (15:1, light petroleum: ethyl acetate) yielding the 
title compound as a colourless oil (0.561 g, 1.15 mmol, 83%). νmax(neat) /cm-1: 3402, 
3302, 3155, 2931, 2252, 1103. NMR δH (400 MHz, CDCl3): 7.68-7.67 (4H, m), 7.46-
7.37 (6H, m), 4.39 (1H, td, J = 2 Hz and 6.4 Hz), 3.67 (2H, t, J = 6.4 Hz), 2.48 (1H, s), 
1.77-1.70 (2H, m), 1.61-1.54 (4H, m), 1.36-1.27 (14H, m), 1.06 (9H, s). NMR δC (100 
MHz, CDCl3): 135.6, 134.2, 129.4, 127.5, 85.0, 72.8, 64.0, 62.3, 37.6, 32.6, 29.6, 29.58, 
29.55, 29.54, 29.3, 29.2, 26.8, 25.7, 25.0, 19.2. HRMS, m/z found (465.3177, 
C30H45O2Si+ requires 465.3183; 487.2994, C30H44O2SiNa+ requires 487.3003). 
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Preparation of (±)-14-((tert-butyldiphenylsilyl)oxy)tetradec-1-yn-3-yl methyl 
carbonate 
 
(199) 
Methyl chloroformate (0.305 g, 3.23 mmol) was added to a cooled (0	℃) solution of 
propargylic alcohol 198 (0.500 g, 1.08 mmol) and pyridine (0.8 mL, 8 mmol) in 
dichloromethane (13 mL). The reaction was allowed to stir at the same temperature for 
3 h. The reaction mixture was diluted with saturated aq NH4Cl (10 mL) and extracted 
with ethyl acetate (3 × 15 mL). The combined organics were washed with brine (50 
mL), dried over MgSO4 and the solvent removed by reduced pressure. The title 
compound was isolated by column chromatography (19:1, light petroleum: ethyl 
acetate) yielding a colourless liquid (0.464 g, 0.889 mmol, 81%). νmax(neat) /cm-1: 2931, 
2854, 2252, 1751, 1273. NMR δH (400 MHz, CDCl3): 7.71-7.68 (4H, m), 7.46-7.37 
(6H, m), 5.22 (1H, td, J = 2 Hz and 6.8 Hz), 3.83 (3H, s), 3.67 (2H, t, J = 6.4 Hz), 2.53 
(1H, s), 1.87-1.81 (2H, m), 1.61-1.47 (4H, m), 1.36-1.27 (14H, m), 1.07 (9H, s). NMR 
δC (100 MHz, CDCl3): 155.0, 135.6, 134.2, 129.4, 127.5, 80.6, 74.4, 67.9, 64.0, 55.0, 
34.6, 32.6, 29.6, 29.56, 29.51, 29.4, 29.3, 29.0, 26.8, 25.7, 24.7, 19.2. HRMS, m/z found 
(523.3232, C32H47O2Si+ requires 523.3238; 545.3049, C32H46O2SiNa+ requires 
545.3058). 
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Preparation of methyl 5-(11-((tert-butyldiphenylsilyl)oxy)undecyl)-4-methyl-2-
pentylfuran-3-carboxylate 
 
(200) 
Following general procedure for the synthesis of tetrasubstituted furans above, from 𝛽-keto 188 (0.080 g, 0.47 mmol) and propargylic carbonate 199 (0.238 g, 0.455 mmol) 
was obtained the title compound by column chromatography (20:1, light petroleum: 
ethyl acetate) as a yellow oil (0.217 g, 0.350 mmol, 77%). νmax(neat) /cm-1: 3071, 3049, 
2924, 2854, 1715, 1576. NMR δH (400 MHz, CDCl3): 7.72-7.68 (4H, m), 7.46-7.35 
(6H, m), 3.89 (3H, s), 3.66 (2H, t, J = 6.4 Hz), 2.91 (2H, t, J = 6.4 Hz), 2.52 (2H, t, J = 
7.6 Hz), 2.07 (3H, s), 1.66-1.53 (6H, m), 1.40-1.27 (18H, m), 1.06 (9H, s), 0.95 (3H, t, 
J = 6.0 Hz). NMR δC (100 MHz, CDCl3): 161.6, 150.0, 135.5, 134.1, 129.4, 127.5, 
114.2, 64.0, 50.8, 32.6, 31.4, 29.62, 29.60, 29.3, 29.0, 28.5, 27.99, 27.90, 26.8, 25.7, 
25.5, 22.3, 19.2, 14.0, 9.9. HRMS, m/z found (641.3985, C39H58O4SiNa+ requires 
641.3997). 
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Preparation of (5-(11-((tert-butyldiphenylsilyl)oxy)undecyl)-4-methyl-2-
pentylfuran-3-yl)methanol 
 
(201) 
To a cooled (0	℃) solution of ester 200 (0.544 g, 0.880 mmol) in THF (3.5 mL) was 
added LiAlH4 (1.76 mL, 1.76 mmol, 1 M in THF). After being stirring at the same 
temperature for 2h, the reaction was quenched by the carefully addition of methanol 
(0.5 mL) and water (0.5 mL). After 30 min at room temperature, the reaction mixture 
was then poured into diethyl ether (10 mL), dried over MgSO4 and filtered. The 
unfiltered residue was extracted with diethyl ether (4 × 5 mL) and all extracts were 
combined and evaporated under reduced pressure. The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate) yielding a colourless 
liquid (0.478 g, 0.810 mmol, 92%). NMR δH (400 MHz, CDCl3): 7.74-7.71 (4H, m), 
7.47-7.39 (6H, m), 4.45 (2H, s), 3.70 (2H, t, J = 6.4 Hz), 2.61 (2H, t, J = 7.2 Hz), 2.54 
(2H, t, J = 7.2 Hz), 1.99 (3H, s), 1.67-1.55 (6H, m), 1.40-1.27 (18H, m), 1.09 (9H, s), 
0.93 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 151.2, 149.5, 135.6, 134.2, 129.5, 
127.5, 119.1, 113.6, 64.0, 55.4, 32.6, 31.4, 29.65, 29.64, 29.46, 29.42, 29.2, 28.75, 
28.70, 26.9, 26.0, 25.9, 25.8, 22.4, 19.2, 14.0, 8.1. HRMS, m/z found (591.4221, 
C38H59O3Si+ requires 591.4228)  
O
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Preparation of tert-butyl((11-(3,4-dimethyl-5-pentylfuran-2-
yl)undecyl)oxy)diphenylsilane 
 
(203) 
To a stirred, cooled (0	℃) solution of alcohol 201 (0.04 g, 0.07 mmol), TEA (0.021 g, 
0.21 mmol) and DMAP (0.002 g, 0.02 mmol) in dichloromethane (2 mL) was added 4-
toluenesulfonyl chloride (0.027 g, 0.14 mmol). The reaction mixture was stirred at 0	℃ 
for 24 h. Water (4 mL) was added, and then the organic phrase was washed with 
saturated aq. NaHCO3 (4 mL) followed by brine. The organic phrase was collected and 
dried over MgSO4, and the solvent evaporated under reduced pressure. The residue was 
dissolved in THF (3.5 mL), and then a solution of LiAlH4 (0.2 mL, 0.2 mmol, 1 M in 
THF) was added dropwise at 0	℃. After being stirring at the same temperature for 2 h, 
the reaction was quenched by the careful addition of methanol (0.5 mL) and water (0.5 
mL). After 30 min at room temperature, the reaction mixture was then poured into 
diethyl ether (5 mL), dried over MgSO4 and filtered. The solid residue was extracted 
with diethyl ether (4 × 5 mL) and all extracts were combined and evaporated under 
reduced pressure. The title compound was isolated by column chromatography (90:1, 
light petroleum: ethyl acetate) yielding a colourless oil (0.012 g, 0.021 mmol, 30%). 
NMR δH (400 MHz, CDCl3): 7.69-7.68 (4H, m), 7.44-7.28 (6H, m), 3.67 (2H, t, J = 6.4 
Hz), 2.51 (4H, t, J = 7.2 Hz), 1.86 (6H, s), 1.62-1.54 (6H, m), 1.40-1.27 (18H, m), 1.07 
O
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(9H, s), 0.91 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 148.44, 148.42, 135.7, 
134.2, 129.4, 127.8, 114.4, 64.0, 32.6, 31.9, 29.6, 29.5, 29.46, 29.40, 29.2, 28.9, 28.8, 
26.8, 26.8, 26.1, 26.0, 25.7, 22.4, 19.2, 14.1, 8.39, 8.38. HRMS, m/z found (575.4286, 
C38H59O2Si+ requires 575.4284). 
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Preparation of 11-(3,4-dimethyl-5-pentylfuran-2-yl)undecan-1-ol73 
 
(184) 
To a stirred, cooled (0	℃) solution of the furan 203 (0.030 g, 0.058 mmol) in THF (1.2 
mL) was added TBAF (0.12 mL, 0.12 mmol, 1 M in THF). After stirring at room 
temperature for 3 h, the solvent was evaporated and the residue was taken up in diethyl 
ether and H2O (1:1, 5 mL). the organic layer was separated and the aqueous layer was 
washed with diethyl ether (3 × 5 mL). The combined organic layers were washed with 
brine, dried over MgSO4, and the solvent evaporated under reduced pressure. The title 
compound was isolated by column chromatography (4:1, light petroleum: ethyl acetate) 
yielding a colourless oil (0.019 g, 0.055 mmol, 95%). NMR δH (400 MHz, CDCl3): 
3.66 (2H, t, J = 6.8 Hz), 2.50 (4H, t, J = 7.2 Hz), 1.80 (6H, s), 1.61-1.54 (6H, m), 1.39-
1.28 (18H, m), 0.90 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 148.4, 114.4, 63.1, 
32.8, 31.4, 29.7, 29.5, 29.4, 29.2, 28.8, 28.5, 26.09, 26.07, 25.7, 22.4, 14.1, 8.38, 8.37. 
HRMS, m/z found (337.3107, C22H41O2+ requires 337.3101). Data was in agreement 
with that reported in the literature. 
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Preparation of ethyl 5-(11-((tert-butyldiphenylsilyl)oxy)undecyl)-4-methyl-2-
propylfuran-3-carboxylate 
 
(204) 
Following general procedure for the synthesis of tetrasubstituted furans above, from 
ethyl 3-oxohexanoate (0.041 g, 0.26 mmol) and propargylic carbonate 199 (0.133 g, 
0.254 mmol) was obtained the title compound by column chromatography (19:1, light 
petroleum: ethyl acetate) as yellow oil (0.142 g, 0.236 mmol, 93%). νmax(neat) /cm-1: 
3050, 2958, 2855, 1712, 1576. NMR δH (400 MHz, CDCl3): 7.68-7.64 (4H, m), 7.43-
7.35 (6H, m), 4.26 (2H, q, J = 7.2 Hz), 3.65 (2H, t, J = 6.4 Hz), 2.88 (2H, t, J = 8.0 Hz), 
2.50 (2H, t, J = 7.2 Hz), 2.07 (3H, s), 1.70-1.60 (2H, m), 1.57-1.53 (4H, m), 1.33 (3H, 
t, J = 7.2 Hz), 1.38-1.27 (14H, m), 1.05 (9H, s), 0.93 (3H, t, J = 7.2 Hz). NMR δC (100 
MHz, CDCl3): 165.1, 161.3, 150.1, 135.6, 134.2, 129.5, 127.6, 114.3, 113.4, 64.1, 59.6, 
32.6, 30.1, 29.7, 29.6, 29.4, 29.1, 28.5, 26.9, 25.8, 25.5, 21.7, 19.3, 14.2, 13.9, 10.0. 
HRMS, m/z found (605.4016, C38H57O4Si+ requires 605.4021; 627.3833, 
C38H56O4SiNa+ requires 627.3840). 
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Preparation of (5-(11-((tert-butyldiphenylsilyl)oxy)undecyl)-4-methyl-2-
propylfuran-3-yl)methanol 
 
(205) 
Following general procedure for the reduction of ester above, from tetrasubstituted 
furan 204 (0.225 g, 0.371 mmol) was obtained the title compound by column 
chromatography (19:1, light petroleum: ethyl acetate) as pale yellow oil (0.118 g, 0.195 
mmol, 75%). νmax(neat) /cm-1: 3425, 3070, 2931, 2854, 2214. NMR δH (400 MHz, 
CDCl3): 7.71-7.69 (4H, m), 7.45-7.39 (6H, m), 4.44 (2H, s), 3.68 (2H, t, J = 6.4 Hz), 
2.59 (2H, t, J = 7.2 Hz), 2.53 (2H, t, J = 7.2 Hz), 1.98 (3H, s), 1.65-1.55 (6H, m), 1.38-
1.27 (12H, m), 1.08 (9H, s), 0.94 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 151.0, 
149.6, 135.6, 134.2, 129.7, 127.5, 119.3, 113.5, 64.0, 55.4, 32.6, 29.7, 29.64, 29.62, 
29.43, 29.41, 29.2, 28.6, 28.0, 26.8, 25.9, 25.8, 22.3, 19.2, 13.7, 8.1. HRMS, m/z found 
(563.3918, C36H55O3Si+ requires 563.3915). 
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8.2.4 Second Synthetic Route to F-acids F4 and F6 (Chapter 6.3) 
Preparation of (±)-tridec-12-en-1-yn-3-ol 
 
(208) 
Following general procedure for the preparation of propargylic alcohol above, from 10-
undecenal (1.682 g, 10.00 mmol) was obtained the title compound by column 
chromatography (5:1, light petroleum: ethyl acetate) as a colourless liquid (1.842 g, 
9.494 mmol, 95%). νmax(neat) /cm-1: 3548, 3309, 3077, 2926, 2854, 1640, 1033, 909. 
NMR δH (400 MHz, CDCl3): 5.83 (1H, ddt, J = 16.8, 10.4 and 6.8 Hz), 5.03-4.96 (2H, 
m), 4.39 (1H, td, J = 6.4 and 2.0 Hz), 2.49 (3H, s), 2.08-2.03 (2H, m), 1.74-1.68 (2H, 
m), 1.41-1.24 (10H, m). NMR δC (100 MHz, CDCl3): 139.2, 114.1, 85.0, 72.8, 62.3, 
37.6, 33.8, 29.4, 29.3, 29.2, 29.1, 28.9, 25.0. HRMS, m/z found (195.1762, C13H22O+ 
requires 195.1743). Data was in agreement with that reported in the literature. 
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Preparation of (±)-methyl tridec-12-en-1-yn-3-yl carbonate 
 
(207) 
Following general procedure for the preparation of propargylic carbonate above, from 
propargylic alcohol 208 (0.676 g, 3.50 mmol) was obtained the title compound by 
column chromatography (19:1, light petroleum: ethyl acetate) as a pale yellow liquid 
(0.634 g, 2.76 mmol, 79%). νmax(neat) /cm-1: 3295, 3077, 2927, 2855, 1753, 1640, 1442, 
1265, 910. NMR δH (400 MHz, CDCl3): 5.83 (1H, ddt, J = 17.6, 8.0 and 6.8 Hz), 5.21 
(1H, td, J = 6.4 and 2.0 Hz), 5.04-4.93 (2H, m), 3.83 (3H, s), 2.53 (1H, s), 2.08-2.03 
(2H, m), 1.89-1.77 (2H, m), 1.48-1.41 (2H, m), 1.41-1.24 (10H, m). NMR δC (100 MHz, 
CDCl3): 155.0, 139.2, 114.1, 80.1, 74.9, 67.9, 54.9, 34.5, 33.8, 29.3, 29.07, 29.03, 28.9, 
24.7. HRMS, m/z found (275.1617, C15H24O3Na+ requires 275.1618). 
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Preparation of ethyl 5-(dec-9-en-1-yl)-4-methyl-2-propylfuran-3-carboxylate 
 
(210) 
Following general procedure for the synthesis of tetrasubstituted furans above, from 
ethyl 3-oxohexanoate (0.252 g, 1.43 mmol) and propargylic carbonate 207 (0.360 g, 
1.43 mmol) was obtained the title compound by column chromatography (19:1, light 
petroleum: ethyl acetate) as yellow oil (0.383 g, 1.15 mmol, 82%). NMR δH (400 MHz, 
CDCl3): 5.83 (1H, ddt, J = 17.6, 8.0 and 4.4 Hz), 4.99-4.90 (2H, m), 4.25 (2H, t, J = 7.2 
Hz), 2.86 (2H, t, J = 7.2 Hz), 2.48 (2H, t, J = 7.2 Hz), 2.48 (2H, t, J = 7.2 Hz), 2.04 (3H, 
s), 2.04-2.01 (2H, m), 1.67-1.52 (2H, m), 1.40-1.22 (13H, m), 0.91 (3H, t, J = 7.2 Hz). 
NMR δC (100 MHz, CDCl3): 165.1, 161.3, 150.0, 139.3, 114.3, 114.1, 59.6, 33.8, 30.8, 
29.4, 29.3, 29.1, 29.0, 28.9, 28.5, 25.5, 21.7, 14.4, 13.8, 9.9. HRMS, m/z found 
(335.2587, C21H35O3+ requires 335.2581). 
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Preparation of (5-(dec-9-en-1-yl)-4-methyl-2-propylfuran-3-yl)methanol 
 
(211) 
Following general procedure for the reduction of ester above, from tetrasubstituted 
furan 210 (0.740 g, 2.22 mmol) was obtained the title compound by column 
chromatography (8:1, light petroleum: ethyl acetate) as pale yellow oil (0.584 g, 1.86 
mmol, 84%). NMR δH (400 MHz, CDCl3): 5.83 (1H, ddt, J = 17.6, 8.0 and 4.4 Hz), 
5.04-4.93 (2H, m), 4.43 (2H, s), 2.57 (2H, t, J = 7.2 Hz), 2.51 (2H, t, J = 7.2 Hz), 2.06 
(2H, t, J = 7.2 Hz), 1.97 (3H, s), 1.68-1.58 (4H, m), 1.37-1.26 (10H, m), 0.94 (3H, t, J 
= 7.2 Hz). NMR δC (100 MHz, CDCl3): 151.0, 149.6, 139.2, 119.3, 114.1, 113.5, 55.9, 
33.8, 29.4, 29.3, 29.2, 29.1, 28.9, 28.6, 28.0, 25.9, 22.3, 13.7, 8.1. HRMS, m/z found 
(315.2289, C19H33O2+ requires 315.2295). 
O
HO
 150 
Preparation of 2-(dec-9-en-1-yl)-3,4-dimethyl-5-propylfuran 
 
(212) 
To a stirred, cooled (0 	℃ ) solution of furan alcohol 211 (0.505 g, 1.73 mmol), 
recrystallized triphenylphosphine (0.590 g, 2.249 mmol), and imidazole (0.153 g, 2.246 
mmol) in acetonitrile and diethyl ether (1:1.6, 3.6 mL) was slowly added iodine (0.609 
g, 2.422 mmol) resulting a yellow suspension. After stirring at the same temperature 
for 1 h, the reaction mixture was diluted with diethyl ether (5 mL) and sequentially 
washed with saturated aqueous Na2S2O3, saturated aqueous CuSO4, and H2O. The 
organic layer was dried over MgSO4, filtered, and concentrated to afford the crude 
product as a brown oil. The residue was taken up in THF (3.5 mL) and treated with 
LiAlH4 (3.5 ml, 3.5 mmol, 1 M in THF) at 0 ℃ for 4 h. The reaction was quenched by 
the carefully addition of methanol (1 mL) and water (1 mL). After 1 h at room 
temperature, the reaction mixture was then poured into diethyl ether (20 mL), dried 
over MgSO4 and filtered. The unfiltered residue was extracted with diethyl ether (4 × 
10 mL) and all extracts were combined and evaporated under reduced pressure. The 
title compound was isolated by column chromatography (19:1, light petroleum: ethyl 
acetate) yielding a colourless liquid (0.406 g, 1.47 mmol, 85%). νmax(neat) /cm-1: 3077, 
2926, 2855, 1641, 1455, 1380. NMR δH (400 MHz, CDCl3): 5.80 (1H, ddt, J = 17.6, 
8.0 and 4.4 Hz), 5.00-4.89 (2H, m), 2.48-2.43 (4H, m), 2.04-1.99 (2H, m), 1.81 (6H, s), 
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1.61-1.51 (4H, m), 1.37-1.26 (10H, m), 0.89 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, 
CDCl3): 148.5, 148.3, 139.3, 114.7, 114.5, 114.1, 33.8, 29.5, 29.4, 29.2, 29.1, 29.0, 28.8, 
28.1, 26.1, 22.2, 13.8, 8.4. HRMS, m/z found (276.2403, C19H32O requires 276.2448).  
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Preparation of 11-(3,4-dimethyl-5-propylfuran-2-yl)undecanoic acid27 
 
(94) 
Hoveyda-Grubbs Catalyst 2nd (0.04 g, 0.05 mmol) was added to a stirred solution of 
furan 212 (0.260 g, 0.942 mmol) in dichloromethane (15 mL). Benzyl acrylate (0.210 
g, 1.30 mmol) was added and the solution refluxed under argon for 3 h. The solution 
was filtered through a plug of silica and the solvent evaporated to yield a brown oil. 
The residue was taken up in methanol (10 mL) and treated with 10% palladium on 
carbon (0.150 g). The reaction was stirred under an atmosphere of hydrogen for 2 h 
then the catalyst removed by filtration. The solvent was removed under reduced 
pressure. The title compound was isolated by column chromatography (8:1, 4:1, 2:1, 
1:1, light petroleum: ethyl acetate) yielding a colourless oil (0.272 g, 0.848 mmol, 90%). 
νmax(neat) /cm-1: 3583, 3400, 2927, 2855, 2087, 1709, 1651. NMR δH (400 MHz, 
CDCl3): 2.52-2.47 (4H, m), 2.37 (2H, t, J = 7.6 Hz), 1.85 (6H, s), 1.69-1.55 (6H, m), 
1.41-1.23 (12H, m), 0.98 (3H, t, J = 6.8 Hz). NMR δC (100 MHz, CDCl3): 179.9, 148.4, 
148.2, 114.6, 114.4, 34.0, 30.3, 29.5, 29.4, 29.3, 29.25, 29.24, 29.0, 28.8, 28.1, 26.0, 
24.6, 22.1, 13.8, 8.3. HRMS, m/z found (323.2582, C20H35O3+ requires 323.2581). Data 
was in agreement with that reported in the literature.27  
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Preparation of methyl 5-(dec-9-en-1-yl)-4-methyl-2-pentylfuran-3-carboxylate 
 
(206) 
Following general procedure for the synthesis of tetrasubstituted furans above, from 𝛽-keto 188 (0.265 g, 1.54 mmol) and propargylic carbonate 207 (0.581 g, 2.32 mmol) 
was obtained the title compound by column chromatography (19:1, light petroleum: 
ethyl acetate) as yellow oil (0.480 g, 1.38 mmol, 89%). NMR δH (400 MHz, CDCl3): 
5.83 (1H, ddt, J = 17.6 Hz, 8.0 Hz and 4.4 Hz), 5.32-4.93 (2H, m), 3.82 (3H, s), 2.91 
(2H, t, J = 7.2 Hz), 2.52 (2H, t, J = 7.2 Hz), 2.07 (3H, s), 2.06-2.02 (2H, m), 1.68-1.55 
(4H, m), 1.49-1.20 (14H, m), 0.89 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 
165.6, 161.6, 150.1, 139.3, 114.2, 114.1, 113.0, 50.9, 33.8, 31.4, 29.4, 29.3, 29.1, 29.0, 
28.9, 28.5, 28.0, 27.9, 25.5, 22.4, 14.0, 8.9. HRMS, m/z found (349.2738, C22H37O3+ 
requires 349.2737).  
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Preparation of (5-(dec-9-en-1-yl)-4-methyl-2-pentylfuran-3-yl)methanol 
 
(209) 
Following general procedure for the reduction of ester above, from tetrasubstituted 
furan 206 (0.452 g, 1.29 mmol) was obtained the title compound by column 
chromatography (9:1, light petroleum: ethyl acetate) as colourless oil (0.347 g, 1.08 
mmol, 84%). νmax(neat) /cm-1: 3325, 3073, 2925, 1641, 1465, 993. NMR δH (400 MHz, 
CDCl3): 5.83 (1H, ddt, J = 17.6 Hz, 8.0 Hz and 4.4 Hz), 4.99-4.90 (2H, m), 4.33 (2H, 
s), 2.54 (2H, t, J = 7.2 Hz), 2.47 (2H, t, J = 7.2 Hz), 2.01 (2H, t, J = 7.2 Hz), 1.97 (3H, 
s), 1.57-1.55 (4H, m), 1.49-1.20 (14H, m), 0.87 (3H, t, J = 7.2 Hz). NMR δC (100 MHz, 
CDCl3): 151.3, 149.6, 139.3, 119.2, 114.1, 113.6, 55.5, 33.8, 31.4, 29.5, 29.4, 29.2, 29.1, 
28.9, 28.79, 28.71, 26.1, 25.9, 22.4, 14.0, 8.2. HRMS, m/z found (343.2606, 
C21H36O2Na+ requires 343.2608). 
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Preparation of 2-(dec-9-en-1-yl)-3,4-dimethyl-5-pentylfuran69 
 
(118) 
Following general procedure for the preparation of dimethyl furans above, from furan 
209 (0.452 g, 1.292 mmol) was obtained the title compound by column chromatography 
(19:1, light petroleum: ethyl acetate) as colourless oil (0.328 g, 1.08 mmol, 84%). 
νmax(neat) /cm-1: 3033, 2928, 2856, 1654, 1428. NMR δH (400 MHz, CDCl3): 5.82 (1H, 
ddt, J = 17.6 Hz, 8.0 Hz and 4.4 Hz), 4.99-4.89 (2H, m), 2.48-2.44 (4H, m), 2.01 (2H, 
q, J = 7.2 Hz), 1.97 (3H, s), 1.57-1.55 (4H, m), 1.49-1.20 (14H, m), 0.87 (3H, t, J = 7.2 
Hz). NMR δC (100 MHz, CDCl3): 148.49, 148.47, 139.3, 114.5, 114.1, 33.8, 31.5, 29.5, 
29.4, 29.37, 29.30, 29.2, 29.0, 28.8, 28.5, 26.1, 22.5, 14.1, 8.4. HRMS, m/z found 
(305.2836, C21H37O+ requires 305.2839). Data was in agreement with that reported in 
the literature.69 
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Preparation of 11-(3,4-dimethyl-5-pentylfuran-2-yl)undecanoic acid73 
 
(8) 
Following general procedure for the preparation of furan fatty acid above, from furan 
118 (0.106 g, 0.349 mmol) was obtained the title compound by column chromatography 
(8:1, 4:1, 2:1, 1:1, light petroleum: ethyl acetate) as colourless oil (0.105 g, 0.300 mmol, 
86%). νmax(neat) /cm-1: 3584, 3400, 2926, 2855, 1710, 1456, 1329. NMR δH (400 MHz, 
CDCl3): 2.52-2.47 (4H, m), 2.37 (2H, t, J = 7.6 Hz), 1.85 (6H, s), 1.69-1.63 (2H, m), 
1.58-1.56 (4H, m), 1.36-1.29 (18H, m), 0.90 (3H, t, J = 6.8 Hz). NMR δC (100 MHz, 
CDCl3): 179.7, 148.43, 148.41, 114.4, 34.2, 31.4, 30.3, 29.5, 29.43, 29.40, 29.25, 29.24, 
29.0, 28.8, 28.5, 26.09, 26.07, 24.7, 22.4, 14.0, 8.4, 8.3. HRMS, m/z found (351.2896, 
C22H39O3+ requires 351.2894). Data was in agreement with that reported in the 
literature.73 
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8.2.5 Synthesis of F-acids modified analogues (Chapter 6.4)  
Preparation of (±)-tetradec-1-yn-3-ol106 
 
(216) 
Following general procedure for the preparation of propargylic alcohol above, from 
dodecanal (1.84 g, 10.0 mmol) was obtained the title compound by column 
chromatography (4:1, light petroleum: ethyl acetate) as colourless liquid (2.317 g, 9.093 
mmol, 91%). νmax(neat) /cm-1: 3689, 3603, 3302, 3155, 2931, 2677. NMR δH (400 MHz, 
CDCl3): 4.38-4.32 (1H, m), 2.45 (1H, d, J = 3.2 Hz), 1.72-1.65 (2H, m), 1.50-1.40 (2H, 
m), 1.28-1.24 (16H, m), 0.86 (3H, t, J = 7.2Hz). NMR δC (100 MHz, CDCl3): 85.0, 
72.9, 62.4, 37.7, 36.9, 29.7, 29.64, 29.60, 29.4, 29.3, 25.0, 22.7, 14.2. HRMS, m/z found 
(233.1881, C14H26ONa+ requires 233.1876). Data was in agreement with that reported 
in the literature.106 
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Preparation of (±)-methyl tetradec-1-yn-3-yl carbonate 
 
(217) 
Following general procedure for the preparation of propargylic carbonate above, from 
propargylic alcohol 216 (1.796 g, 8.323 mmol) was obtained the title compound by 
column chromatography (19:1, light petroleum: ethyl acetate) as colourless liquid 
(1.851 g, 6.906 mmol, 83%). νmax(neat) /cm-1: 3309, 3155, 2924, 2854, 1751, 1273. 
NMR δH (400 MHz, CDCl3): 5.18 (1H, td, J = 6.4 and 2 Hz), 3.79 (3H, s), 2.49 (1H, d, 
J = 2.0 Hz), 1.81-1.78 (2H, m), 1.50-1.40 (2H, m), 1.28-1.24 (16H, m), 0.86 (3H, t, J = 
7.2 Hz). NMR δC (100 MHz, CDCl3): 155.0, 80.6, 74.4, 68.0, 55.0, 34.6, 31.9, 29.6, 
29.6, 29.5, 29.48, 29.42, 29.1, 24.8, 22.7, 14.2. HRMS, m/z found (269.2110, C16H28O3+ 
requires 269.2111). 
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Preparation of ethyl 4-methyl-2-propyl-5-undecylfuran-3-carboxylate 
 
(218) 
Following general procedure for the synthesis of tetrasubstituted furans above, from 
ethyl 3-oxohexanoate (0.749 g, 4.74 mmol) and propargylic carbonate 217 (0.847 g, 
3.16 mmol) was obtained the title compound by column chromatography (20:1, light 
petroleum: ethyl acetate) as yellow oil (0.940 g, 2.69 mmol, 85%). νmax(neat) /cm-1: 
3055, 2854, 2685, 1705, 1265. NMR δH (400 MHz, CDCl3): 4.25 (2H, q, J = 7.2 Hz), 
2.86 (2H, t, J = 7.6 Hz), 2.48 (2H, t, J = 7.6 Hz), 2.04 (3H, s), 1.69-1.59 (2H, m), 1.56-
1.51 (2H, m), 1.32 (3H, t, J = 7.2 Hz), 1.30-1.23 (16H, m), 0.91 (3H, t, J = 7.6 Hz), 0.86 
(3H, t, J = 7.6 Hz). NMR δC (100 MHz, CDCl3): 165.1, 161.3, 150.1, 114.3, 113.3, 59.6, 
31.9, 30.0, 29.7, 29.6, , 29.4, 29.1, 28.5, 25.5, 22.7, 21.7, 14.4, 14.2, 13.8, 9.9. HRMS, 
m/z found (351.2893, C22H28O3+ requires 351.2894). 
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Preparation of (4-methyl-2-propyl-5-undecylfuran-3-yl)methanol 
 
(219) 
Following general procedure for the reduction of ester above, from tetrasubstituted 
furan 218 (0.845 g, 2.414 mmol) was obtained the title compound by column 
chromatography (10:1, light petroleum: ethyl acetate) as colourless oil (0.595 g, 1.93 
mmol, 80%). νmax(neat) /cm-1: 3410, 3155, 2924, 2854, 1465. NMR δH (400 MHz, 
CDCl3): 4.40 (2H, s), 2.53 (2H, t, J = 7.6 Hz), 2.47 (2H, t, J = 7.2Hz), 1.93 (3H, s), 
1.62-1.52 (4H, m), 1.30-1.27 (16H, m), 0.89 (3H, t, J = 7.2 Hz), 0.84 (3H, t, J = 7.2 Hz). 
NMR δC (100 MHz, CDCl3): 151.1, 149.7, 119.4, 113.6, 55.5, 32.0, 29.7, 29.6, 29.4, 
29.3, 28.7, 28.1, 25.9, 22.7, 22.3, 14.2, 13.8, 8.2. HRMS, m/z found (309.2786, 
C20H37O2+ requires 309.2788). 
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Preparation of 3,4-dimethyl-2-propyl-5-undecylfuran 
 
(213) 
Following general procedure for the preparation of dimethyl furans above, from furan 
219 (0.380 g, 1.225 mmol) was obtained the title compound by column chromatography 
(20:1, light petroleum: ethyl acetate) as colourless oil (0.314 g, 0.992 mmol, 81%). 
νmax(neat) /cm-1: 3309, 3155, 2924, 1465. NMR δH (400 MHz, CDCl3): 2.54-2.47 (4H, 
m), 1.85 (6H, s), 1.69-1.55 (4H, m), 1.30-1.27 (16H, m), 0.94 (3H, t, J = 7.2 Hz), 0.85 
(3H, t, J = 7.2 Hz). NMR δC (100 MHz, CDCl3): 148.4, 148.2, 114.6, 114.4, 31.9, 29.7, 
29.67, 29.65, 29.62, 29.4, 29.3, 28.8, 28.0, 26.1, 22.9, 22.1, 14.1, 13.8, 8.3. HRMS, m/z 
found (293.2853, C20H37O+ requires 293.2839). 
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Preparation of (4-methyl-2-pentyl-5-undecylfuran-3-yl)methanol 
 
(220) 
Following general procedure for the reduction of ester above, from 𝛽-keto 188 (0.059 
g, 0.341 mmol) and propargylic carbonate 217 (0.092 g, 0.342 mmol) was obtained the 
title compound by column chromatography (15:1, light petroleum: ethyl acetate) as 
colourless oil (0.060 g, 0.19 mmol, 55%). νmax(neat) /cm-1: 3417, 3387, 3305, 3155, 
2924, 1465. NMR δH (400 MHz, CDCl3): 4.43 (2H, s), 2.58 (2H, t, J = 7.2 Hz), 2.51 
(2H, t, J = 7.2 Hz), 1.97 (3H, s), 1.62-1.56 (4H, m), 1.33-1.27 (20H, m), 0.92-0.76 (6H, 
m). NMR δC (100 MHz, CDCl3): 151.2, 149.5, 119.1, 113.5, 55.5, 31.9, 31.4, 29.68, 
29.66, 29.63, 29.4, 29.3, 29.2, 28.7, 28.6, 26.0, 25.9, 22.7, 22.4, 14.1, 14.0, 8.1. HRMS, 
m/z found (321.3164, C22H41O2+ requires 321.3152). 
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Preparation of 3,4-dimethyl-2-pentyl-5-undecylfuran 
 
(214) 
Following general procedure for the preparation of dimethyl furans above, from furan 
220 (60 mg, 0.19 mmol) was obtained the title compound by column chromatography 
(25:1, light petroleum: ethyl acetate) as colourless oil (48 mg, 0.152 mmol, 80%). 
νmax(neat) /cm-1: 3055, 2931, 2854, 1427. NMR δH (400 MHz, CDCl3): 2.50 (4H, t, J = 
7.6 Hz), 1.85 (6H, s), 1.62-1.54 (4H, m), 1.33-1.27 (20H, m), 0.92-0.88 (6H, m). NMR 
δC (100 MHz, CDCl3): 148.45, 148.43, 114.4, 31.9, 31.4, 29.74, 29.70, 29.6, 29.4, 29.3, 
29.2, 28.8, 28.5, 26.1, 26.0, 22.7, 22.5, 14.17, 14.10, 8.4. HRMS, m/z found 407.3143, 
C22H40ONa+ requires 407.3132).  
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